Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.21.B28 - fibroblast activation protein alpha subunit

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Aberrant Crypt Foci
A Porcine Model of Familial Adenomatous Polyposis.
Identification and quantification of aberrant crypt foci in the colon of Min mice--a murine model of familial adenomatous polyposis.
Abscess
Anal complications after restorative proctocolectomy (J-pouch).
Familial amyloidotic polyneuropathy type I with extracellular superoxide dismutase mutation: a case report.
Radiotherapy in the treatment of aggressive fibromatosis: experience from a single institution.
Acquired Immunodeficiency Syndrome
FAP: an exclusion-based parental assignment program with enhanced predictive functions
Acromegaly
Fibroblast activation protein is a GH target: A prospective study of patients with acromegaly before and after treatment.
Acute Coronary Syndrome
Changes in concentrations of circulating fibroblast activation protein alpha are associated with myocardial damage in patients with acute ST-elevation MI.
Circulating concentrations of fibroblast activation protein ? in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA.
Expression of fibroblast activation protein in human coronary vessels.
Adenocarcinoma
Adenocarcinoma at the Ileostomy Site After a Proctocolectomy for Ulcerative Colitis and/or Familial Adenomatous Polyposis: An Overview.
Adenocarcinomas After Prophylactic Surgery For Familial Adenomatous Polyposis.
Adenomas of the common bile duct in familial adenomatous polyposis.
Ampullary cancer in a patient with familial adenomatous polyposis - a rare case report and current status of management.
An immunohistologic study of the feto-acinar pancreatic protein (FAP) in the normal pancreas, chronic pancreatitis, pancreatic adenocarcinoma, and intraabdominal metastases of adenocarcinomas.
APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse.
Cancer in an unexpected site post pouch surgery for familial adenomatous polyposis (FAP).
Cap-assisted endoscopy increases ampulla of Vater visualization in high-risk patients.
Carcinoma of the papilla of Vater in a brother and sister with familial adenomatous polyposis.
Celiac disease and other precursors to small-bowel malignancy.
Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature.
Characterization of adenocarcinoma of the lung in a familial adenomatous polyposis patient.
Chromosome 5 allele loss in human colorectal carcinomas.
Clinicopathologic and Molecular Characteristics of Familial Adenomatous Polyposis-associated Traditional Serrated Adenoma.
Detection of genetic abnormalities in neoplasms from Greek patients with FAP.
Development and endoscopic appearance of colorectal tumors are characterized by the expression profiles of miRNAs.
Diagnostic delay, symptoms and stage of colorectal cancer.
Do we know all there is to know about Familial Adenomatous Polyposis?
Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
ERbeta expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis.
Expression of EGFR, HER2, Phosphorylated ERK and Phosphorylated MEK in Colonic Neoplasms of Familial Adenomatous Polyposis Patients.
Expression Profiling of Proliferation and Apoptotic Markers along the Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis Patients.
Familial Adenomatous Polyposis Complicated by Acute Myelogenous Leukemia.
Familial adenomatous polyposis: prevalence of adenomas in the ileal pouch after restorative proctocolectomy.
FAP related periampullary adenocarcinoma.
FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.
Fibroblast activation protein and its prognostic significance in correlation with vascular endothelial growth factor in pancreatic adenocarcinoma.
Fibroblast-activation protein: valuable marker of cutaneous epithelial malignancy.
Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations.
Gastric adenocarcinoma arising from fundic gland polyps in a patient with familial adenomatous polyposis syndrome.
Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis.
Gastric neoplasms in familial adenomatous polyposis: A follow-up strategy for patients with or without atrophic gastritis.
Genetic alteration of colorectal adenoma-carcinoma sequence among gastric adenocarcinoma and dysplastic lesions in a patient with attenuated familial adenomatous polyposis.
Genome Wide Methylome Alterations in Lung Cancer.
Histological assessment of the distal 'doughnut' in patients undergoing stapled restorative proctocolectomy with high or low anal transection.
Immune Microenvironment: New Insight for Familial Adenomatous Polyposis.
Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Increased expression of cytoplasmic HuR in familial adenomatous polyposis.
Jejunal cancer in patients with familial adenomatous polyposis.
Juvenile polyposis syndrome might be misdiagnosed as familial adenomatous polyposis: a case report and literature review.
Localization of the gene for familial adenomatous polyposis on chromosome 5.
Macroscopic and histologic regression of duodenal polyposis with FOLFOX4 chemotherapy for an ileal pouch adenocarcinoma in a patient with familial adenomatous polyposis.
Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis.
Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestine.
Mycophenolate Mofetil Alone and in Combination with Tacrolimus Inhibits the Proliferation of HT-29 Human Colonic Adenocarcinoma Cell Line and Might Interfere with Colonic Tumorigenesis.
Nonampullary Duodenal Adenomas in Familial Adenomatous Polyposis and Sporadic Patients Lack the DNA Content Abnormality That is Characteristic of the Adenoma-Carcinoma Sequence Involved in the Development of Other Gastrointestinal Malignancies.
p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event?
Pancreas-preserving total duodenectomy versus standard pancreatoduodenectomy for patients with familial adenomatous polyposis and polyps in the duodenum.
Peptide Patterns as Discriminating Biomarkers in Plasma of Patients With Familial Adenomatous Polyposis.
Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations.
Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) followed by radiation and 5-fluorouracil in locally advanced pancreatic cancer.
Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer.
Rectal cancer after prolonged sulindac chemoprevention. A case report.
Resection of small bowel adenocarcinoma liver metastasis combined with neoadjuvant and adjuvant chemotherapy results in extended disease-free period-a case report.
Retention of the fetoacinar pancreatic (FAP) protein to the endoplasmic reticulum of tumor cells.
Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation.
Surveillance and Treatment of Periampullary and Duodenal Adenomas in Familial Adenomatous Polyposis.
Transduodenal resection of peri-ampullary lesions.
[A novel APC gene germline mutation in a familial adenomatous polyposis pedigree]
[Adenomatous polyposis of the gallbladder and Gardner's syndrome. A rare association]
[Current status of follow-up of the upper digestive tract in familial adenomatous polyposis.]
[Familial adenomatous polyposis: what is new for the clinician?]
[Familiar adenomatous polyposis: report of 2 cases].
[Molecular genetics of colorectal cancer and carcinogenesis]
Adenocarcinoma of Lung
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts.
Lung adenocarcinoma associated with familial adenomatous polyposis. Clear cell carcinoma with beta-catenin accumulation accompanied by atypical adenomatous hyperplasia.
Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation.
The prognostic significance of fibroblast activation protein-? in human lung adenocarcinoma.
[SP13786 Inhibits the Migration and Invasion of Lung Adenocarcinoma Cell A549 ?by Supressing Stat3-EMT via CAFs Exosomes].
Adenoma
32P-postlabelling studies of target tissues and bile from patients with familial adenomatous polyposis and from unaffected controls.
5'-Cytosine DNA-methyltransferase mRNA levels in hereditary colon carcinoma.
?-Catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis.
?-catenin Helices in the Cytoplasm of Sporadic and FAP Duodenal Adenomas.
A molecular rationale for the how, when and why of colorectal cancer screening.
A new phenotypic manifestation of familial adenomatous polyposis.
A novel pathogenic large germline deletion in adenomatous polyposis coli gene in a Chinese family with familial adenomatous polyposis.
A novel pathogenic single nucleotide germline deletion in APC gene in a four generation Chinese family with familial adenomatous polyposis.
A Porcine Model of Familial Adenomatous Polyposis.
A review of physical abnormalities in familial adenomatous polyposis.
A two-step model for colon adenoma initiation and progression caused by APC loss.
Adenoma development in familial adenomatous polyposis and MUTYH-associated polyposis: somatic landscape and driver genes.
Adenomas of the common bile duct in familial adenomatous polyposis.
Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II.
Alteration of O6-methylguanine-DNA methyltransferase in colorectal neoplasms in sporadic and familial adenomatous polyposis patients.
An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis.
Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis.
APC gene mutations in a jejunal adenoma causing intussusception in a patient with familial adenomatous polyposis.
APC in the regulation of intestinal crypt fission.
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis.
APC mutation spectrum in ileoanal pouch polyps resembles that of colorectal polyps.
APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC.
APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
Approaches to endoscopic ampullectomy.
Arylamine N-acetyltransferase type 2 and glutathione S-transferases M1 and T1 polymorphisms in familial adenomatous polyposis.
Aspirin and familial adenomatous polyposis: coming full circle.
Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.
Attenuated adenomatous polyposis of the large bowel: Present and future.
Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP.
Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH.
Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission.
Burden and profile of somatic mutation in duodenal adenomas from patients with familial adenomatous- and MUTYH-associated polyposis.
Can resistant starch and/or aspirin prevent the development of colonic neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 Study.
Celecoxib and tauro-ursodeoxycholic acid co-treatment inhibits cell growth in familial adenomatous polyposis derived LT97 colon adenoma cells.
Cell proliferation of the duodenal mucosa in patients affected by familial adenomatous polyposis.
Characteristics and Clinical Outcomes of Duodenal Neoplasia in Japanese Patients With Familial Adenomatous Polyposis.
Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
Characterization of two novel adenomatous polyposis coli (APC) gene mutations in patients with familial adenomatous polyposis (FAP).
Chemoprevention in familial adenomatous polyposis.
Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Chemoprevention with special reference to inherited colorectal cancer.
Chromosomal instability in MYH- and APC-mutant adenomatous polyps.
Chromosome changes in desmoid tumors developed in patients with familial adenomatous polyposis.
Clinical characteristics of familial adenomatous polyposis and management of duodenal adenomas.
Clinical features of familial adenomas polyps in Chinese and establishment of its immortal lymphocyte cell lines.
Clinicopathologic and Molecular Characteristics of Familial Adenomatous Polyposis-associated Traditional Serrated Adenoma.
Coexisting carcinoid tumors in familial adenomatous polyposis-associated upper intestinal adenomas.
COL11A1 in FAP polyps and in sporadic colorectal tumors.
Cold snare polypectomy effectively reduces polyp burden in familial adenomatous polyposis.
Colon Crypts of Subjects With Familial Adenomatous Polyposis Show an Increased Number of LGR5+ Ectopic Stem Cells.
Colonic and duodenal flat adenomas in children with classical familial adenomatous polyposis.
Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis.
Colorectal cancer and nonsteroidal anti-inflammatory drugs.
Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion.
Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Colorectal polyposes: from phenotype to diagnosis.
Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis.
Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.
Combined restorative proctocolectomy and pancreaticoduodenectomy for familial adenomatous polyposis.
Common colorectal cancer risk alleles contribute to the multiple colorectal adenoma phenotype, but do not influence colonic polyposis in FAP.
Common genetic evolutionary pathways in familial adenomatous polyposis tumors.
Complex APC germline mutation associated metaplasia and intraepithelial neoplasia (CAM-IEN) of the gallbladder.
Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients.
Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis.
Connexin43 is overexpressed in Apc(Min/+)-mice adenomas and colocalises with COX-2 in myofibroblasts.
Cyclooxygenase-2 expression in FAP patients carrying germ line MYH mutations.
Cyclooxygenase-2 knockdown by RNA interference in colon cancer.
Cytogenetic analysis of intestinal polyps in polyposis syndromes: comparison with sporadic colorectal adenomas.
Decreased expression of the gut-enriched Krüppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients.
Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention.
Depressed adenoma of the duodenum in patients with familial adenomatous polyposis: endoscopic and immunohistochemical features.
Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP).
Detection of APC gene deletion by double competitive polymerase chain reaction in patients with familial adenomatous polyposis.
Detection of epithelial apoptosis in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.
Detection of genetic abnormalities in neoplasms from Greek patients with FAP.
Development of an aggressive depressed cancer in a case of familial adenomatous polyposis.
Diagnostic values of dual focus narrow band imaging and probe-based confocal laser endomicroscopy in FAP-related duodenal adenoma.
Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis.
Different surgical strategies in the treatment of familial adenomatous polyposis: what's the role of the ileorectal anastomosis?
Differential gene expression profile reveals deregulation of pregnancy specific beta1 glycoprotein 9 early during colorectal carcinogenesis.
DNA aneuploidy and cell proliferation in familial adenomatous polyposis.
DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients.
Does a selective cyclooxygenase-2 inhibitor (tiracoxib) induce clinically sufficient suppression of adenomas in patients with familial adenomatous polyposis? A randomized double-blind placebo-controlled clinical trial.
Duodenal adenoma and cancer in FAP.
Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study.
Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls.
Duodeno-gastric reflux and gastric adenomas: a scintigraphic study in patients with familial adenomatous polyposis.
Dye chromoendoscopy leads to a higher adenoma detection in the duodenum and stomach in patients with familial adenomatous polyposis.
E-cadherin expression is homogeneously reduced in adenoma from patients with familial adenomatous polyposis: an immunohistochemical study of E-cadherin, beta-catenin and cyclooxygenase-2 expression.
Effect of indomethacin suppositories on rectal polyposis in patients with familial adenomatous polyposis.
Effect of physical fitness on colorectal tumor development in patients with familial adenomatous polyposis.
Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.
Effect of the non-steroidal anti-inflammatory drug sulindac on colorectal adenomas of uncolectomized familial adenomatous polyposis.
Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis.
Emergency total proctocolectomy in an uninsured patient with Familial Adenomatous Polyposis Syndrome and acute lower gastrointestinal hemorrhage in a community hospital: A case report.
Endoscopic Management of Ampullary Adenomas in Familial Adenomatous Polyposis Syndrome: A Systematic Review with Pooled Analysis.
Endoscopic Mucosal Resection of Jejunal Polyps using Double-Balloon Enteroscopy.
Endoscopic Papillectomy for Major and Minor Papillary Adenoma in Familial Adenomatous Polyposis.
Endoscopic submucosal hydro-dissection as a rescue treatment of a large recurrent lateral spreading tumor in an ileorectal anastomosis.
Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon.
Epithelial proliferation and differentiation in flat duodenal mucosa of patients with familial adenomatous polyposis.
Evolution of hereditary bowel cancer.
Exclusion of an extracolonic disease modifier locus on chromosome 1p33-36 in a large Swiss familial adenomatous polyposis kindred.
Expansion of a mutated clone: from stem cell to tumour.
Expression of apoptosis repressor with caspase recruitment domain (ARC) in familial adenomatous polyposis (FAP) adenomas and its correlation with DNA mismatch repair proteins, p53, Bcl-2, COX-2 and beta-catenin.
Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam.
Expression of EGFR, HER2, Phosphorylated ERK and Phosphorylated MEK in Colonic Neoplasms of Familial Adenomatous Polyposis Patients.
Expression Profiling of Proliferation and Apoptotic Markers along the Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis Patients.
Extracolonic manifestations of familial adenomatous polyposis: desmoid tumours, and upper gastrointestinal adenomas and carcinomas.
Familial adenomatous polyposis complicated by chronic myelogenous leukemia: response to imatinib mesylate.
Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation?
Familial adenomatous polyposis-associated and sporadic pyloric gland adenomas of the upper gastrointestinal tract share common genetic features.
Familial Adenomatous Polyposis-associated Traditional Serrated Adenoma of the Small Intestine: A Clinicopathologic and Molecular Analysis.
Familial adenomatous polyposis.
Familial adenomatous polyposis: a case report and histologic mucin study.
Familial adenomatous polyposis: prevalence of adenomas in the ileal pouch after restorative proctocolectomy.
Feasibility and diagnostic utility of video capsule endoscopy for the detection of small bowel polyps in patients with hereditary polyposis syndromes.
Frequency and Features of Duodenal Adenomas in Patients With MUTYH-Associated Polyposis.
Frequency of Small Bowel Polyps in Patients with Duodenal Adenoma but without Familial Adenomatous Polyposis.
From gene mutations to tumours--stem cells in gastrointestinal carcinogenesis.
Functional characterization of CNOT3 variants identified in familial adenomatous polyposis adenomas.
Functional outcome after colectomy and ileorectal anastomosis compared with proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis.
Gastric Adenomas and their management in Familial Adenomatous Polyposis.
Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course.
Gastric and duodenal polyps in familial adenomatous polyposis patients: Conventional endoscopy vs virtual chromoendoscopy (fujinon intelligent color enhancement) in dysplasia evaluation.
Gastric carcinoids in a patient with pernicious anemia and familial adenomatous polyposis.
Gastric duodenal metaplasia in duodenal adenomas.
Gastric neoplasms in familial adenomatous polyposis: A follow-up strategy for patients with or without atrophic gastritis.
Gastric tumours in FAP.
Gastroduodenal lesions in familial adenomatous polyposis.
Gastrointestinal stem cells and cancer: bridging the molecular gap.
Gene Expression Changes Accompanying the Duodenal Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis.
Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease.
Genetic alteration of colorectal adenoma-carcinoma sequence among gastric adenocarcinoma and dysplastic lesions in a patient with attenuated familial adenomatous polyposis.
Genetic dissection of the Mom5 modifier locus and evaluation of Mom5 candidate genes.
Genetic Manipulation of Homologous Recombination In Vivo Attenuates Intestinal Tumorigenesis.
Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis.
Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis.
Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma.
Germline and somatic mutations in exon 15 of the APC gene and K-ras mutations in duodenal adenomas in patients with familial adenomatous polyposis.
Hereditary colorectal cancer syndromes.
Hereditary intestinal polyposis syndromes.
High frequency of K-ras mutations in sporadic colorectal adenomas.
High prevalence of adenomas and microadenomas of the duodenal papilla and periampullary region in patients with familial adenomatous polyposis.
High resolution endoscopy and the additional value of chromoendoscopy in the evaluation of duodenal adenomatosis in patients with familial adenomatous polyposis.
High-grade pancreatic intraepithelial neoplasia in a patient with familial adenomatous polyposis.
Histochemical study of apoptosis and cell proliferation in hereditary intestinal diseases.
Ileal pouch-anal canal anastomosis for familial adenomatous polyposis: early and late results.
Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis.
Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.
Immunohistochemical characteristics of duodenal adenomas in familial adenomatous polyposis with special reference to cell kinetics.
In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis.
Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP).
Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis.
Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Increased epithelial cell proliferation in the ileal pouch mucosa of patients with familial adenomatous polyposis.
Increased expression of cytoplasmic HuR in familial adenomatous polyposis.
Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.
Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients.
Increased prevalance of colorectal adenoma in patients with sporadic duodenal adenoma.
Indications for local excision of ampullary lesions associated with familial adenomatous polyposis.
Intraepithelial bodies in colorectal adenomas: Leuchtenberger bodies revisited.
Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer.
Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype.
Jejunal cancer in patients with familial adenomatous polyposis.
Juvenile polyposis syndrome might be misdiagnosed as familial adenomatous polyposis: a case report and literature review.
K-ras gene mutation in colorectal adenomas and carcinomas from familial adenomatous polyposis patients.
K-ras2 activation and genome instability increase proliferation and size of FAP adenomas.
Laparoscopic double-tract reconstruction after total gastrectomy for postoperative duodenal surveillance: Case series.
let-7e downregulation characterizes early phase colonic adenoma in APCMin/+ mice and human FAP subjects.
LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs.
Location in the large bowel influences the APC mutations observed in FAP adenomas.
Long-term outcomes of metachronous neoplasms in the ileal pouch and rectum after surgical treatment in patients with familial adenomatous polyposis.
Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.
Loss of colonic HLA antigens in familial adenomatous polyposis.
Loss of extracellular E-cadherin in the normal mucosa of duodenum and colon of patients with familial adenomatous polyposis.
Low colonic glutathione detoxification capacity in patients at risk for colon cancer.
Management of ampullary adenomas in familial adenomatous polyposis syndrome: 16 years of experience from a tertiary cancer center.
Management of duodenal adenomas in 98 patients with familial adenomatous polyposis.
Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
Microvascular structure of benign and malignant tumors of the colon in humans.
Minor Papilla Adenoma Management in Patients with Pancreas Divisum and Familial Adenomatous Polyposis.
Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis.
Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families: a different spectrum of mutations?
Molecular analysis of the APC and MYH genes in Czech families affected by FAP or multiple adenomas: 13 novel mutations.
Molecular analysis of the APC gene in Sicilian patients with familial adenomatous polyposis (F.A.P.).
Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis.
Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestine.
Mucosectomy With Handsewn Anastomosis Reduces the Risk of Adenoma Formation in the Anorectal Segment After Restorative Proctocolectomy for Familial Adenomatous Polyposis.
Multiple adenomatous duodenal polyposis.
Multistage vector delivery of sulindac and silymarin for prevention of colon cancer.
MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.
Natural history of ampullary adenoma in familial adenomatous polyposis: reconfirmation of benign nature during extended surveillance.
No evidence for overexpression of the p53 protein and mutations in exons 4-9 of the p53 gene in a large family with adenomatous polyposis.
Non-polypoid adenoma of the large intestine.
Nonampullary duodenal adenoma: Current understanding of its diagnosis, pathogenesis, and clinical management.
Nonampullary Duodenal Adenomas in Familial Adenomatous Polyposis and Sporadic Patients Lack the DNA Content Abnormality That is Characteristic of the Adenoma-Carcinoma Sequence Involved in the Development of Other Gastrointestinal Malignancies.
Nonpolypoid adenomas and adenocarcinomas found in background mucosa of surgically resected colons.
Nonsteroidal anti-inflammatory drug use and sporadic colorectal adenomas.
Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.
Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9.
Nuclear localization of immunoreactive beta-catenin is specific to familial adenomatous polyposis in papillary thyroid carcinoma.
Nuclear translocation of beta-catenin in colorectal cancer.
Occurrence of adenomas in the pouch and small intestine of FAP patients after proctocolectomy with ileoanal pouch construction.
Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas.
Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.
Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patients.
p53 and K-ras status in duodenal adenomas in familial adenomatous polyposis.
p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event?
Pancreaticoduodenectomy for dysplastic duodenal adenoma in a patient with familial adenomatous polyposis.
Pathology of the hereditary colorectal carcinoma.
Peptide Patterns as Discriminating Biomarkers in Plasma of Patients With Familial Adenomatous Polyposis.
Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations.
Pharmacotherapy for inherited colorectal cancer.
Phenotype of cytochrome P450 CYP2D6 in patients with familial adenomatous polyposis.
Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa.
Phenotypic variation in colorectal adenoma/cancer expression in two families. Hereditary flat adenoma syndrome.
Pilot study of oral anthocyanins for colorectal cancer chemoprevention.
Polyclonal origin of colonic adenomas in an XO/XY patient with FAP.
Polyp Progression in Paediatric Patients with Familial Adenomatous Polyposis - A Single Centre Experience.
Polyp Progression in Paediatric Patients With Familial Adenomatous Polyposis: A Single-centre Experience.
Possible role of telomerase activation in the multistep tumor progression of periampullary lesions in patients with familial adenomatous polyposis.
Pouch adenomas in Familial Adenomatous Polyposis after restorative proctocolectomy.
Prevalence and risk factors for adenomas in the ileal pouch and the afferent loop after restorative proctocolectomy for patients with familial adenomatous polyposis.
Prevalence of Adenomas and Carcinomas in the Ileal Pouch After Proctocolectomy in Patients with Familial Adenomatous Polyposis.
Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas.
Prevention of early-onset familial/hereditary colon cancer: new models and mechanistic biomarkers (review).
Preventive Anti-inflammatory Diet to Reduce Gastrointestinal Inflammation in Familial Adenomatous Polyposis Patients: A Prospective Pilot Study.
Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.
Primary high-grade neuroendocrine carcinoma emerging from an adenomatous polyp in the setting of familial adenomatous polyposis.
Programmed cell death in colorectal carcinogenesis.
Proliferative characteristics of differentiated cells in familial adenomatous polyposis-associated duodenal adenomas.
Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
Prophylactic colectomy and rectal preservation in FAP: systematic endoscopic follow-up and adenoma destruction changes natural history of polyposis.
Prospective enteroscopic evaluation of jejunal polyposis in patients with familial adenomatous polyposis and advanced duodenal polyposis.
Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis.
Protein-losing enteropathy in a patient with familial adenomatous polyposis and advanced colon cancer.
Quantitation of APC mRNA in human tissues.
Rapid Rectal Polyposis Development in a Patient With Familial Adenomatous Polyposis.
Recurrent idiopathic pancreatitis in familial adenomatous polyposis: report of a case-series and review of the literature.
Recurrent polyps in the ileo-anal pouch or rectum in familial adenomatous polyposis.
Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers.
Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations.
Regression of Colonic Adenomas After Treatment With Sulindac in Familial Adenomatous Polyposis: A Case With a 2-Year Follow-up Without a Prophylactic Colectomy.
Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis.
Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited.
Risk of developing adenomas and carcinomas in the ileal pouch in patients with familial adenomatous polyposis.
Risk of ileal pouch neoplasms in patients with familial adenomatous polyposis.
Safety of cold snare polypectomy for duodenal adenomas in familial adenomatous polyposis: a prospective exploratory study.
Searching for mutations : familial adenomatous polyposis as a case study.
Serrated adenoma in familial adenomatous polyposis: relation to germline APC gene mutation.
Serrated adenoma of the duodenum.
Serrated adenomas in FAP. Familial adenomatous polyposis.
Serrated adenomas with a BRAF mutation in a young patient with familial adenomatous polyposis.
Serum nutrients and habitual dietary intake in colectomized FAP patients in Norway.
Significance of apoptosis in the process of tumorigenesis in colorectal mucosa and adenomas in FAP patients.
Silencing the intestinal GUCY2C tumor suppressor axis requires APC loss of heterozygosity.
Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
Size-dependent expression of cyclooxygenase-2 in sporadic colorectal adenomas relative to adenomas in patients with familial adenomatous polyposis.
Small-bowel diagnosis in patients with familial adenomatous polyposis: comparison of push enteroscopy, capsule endoscopy, ileoscopy, and enteroclysis.
Small-intestinal involvement in familial adenomatous polyposis: evaluation by double-balloon endoscopy and intraoperative enteroscopy.
Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients.
Somatic c.34G>T KRAS mutation: a new prescreening test for MUTYH-associated polyposis?
Somatic Mutations of the CDC4 (FBXW7) Gene in Hereditary Colorectal Tumors.
Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis.
Sulindac and polyp regression.
Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors.
Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines.
Supplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysis.
Surgery for the teenager with familial adenomatous polyposis: ileo-rectal anastomosis or restorative proctocolectomy?
Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres.
Surveillance and Treatment of Periampullary and Duodenal Adenomas in Familial Adenomatous Polyposis.
Surveillance of duodenal polyps in familial adenomatous polyposis: progress report.
Synchronous primary carcinomas of the ampulla of Vater and ascending colon in a patient with multiple flat adenomas.
Syndromic Gastric Polyps: At the Crossroads of Genetic and Environmental Cancer Predisposition.
Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis.
Telomerase activity and p53 gene mutation in familial polyposis coli.
The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade.
The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme.
The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history.
The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis.
The development of duodenal microadenomas in FAP patients: the human correlate of the Min mouse.
The Effect of Metformin in Treatment of Adenomas in Patients with Familial Adenomatous Polyposis.
The effect of Ursodesoxycholic acid on duodenal adenomas in familial adenomatous polyposis: a prospective randomized placebo-control trial.
The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients.
The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis.
The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.
The Influence of Curcumin, Quercetin, and Eicosapentaenoic Acid on the Expression of Phase II Detoxification Enzymes in the Intestinal Cell Lines HT-29, Caco-2, HuTu 80, and LT97.
The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program.
The patient with multiple intestinal polyps.
The Role of Cell Proliferation and Crypt Fission in Adenoma Aggressiveness: a Comparison of Ileoanal Pouch and Rectal Adenomas in FAP.
The Safety and Efficacy of Celecoxib in Children With Familial Adenomatous Polyposis.
The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.
The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis.
Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.
Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis.
Transcript dosage effect in familial adenomatous polyposis: model offered by two kindreds with exon 9 APC gene mutations.
Tryptophan Metabolism as Source of New Prognostic Biomarkers for FAP Patients.
Two cases of 5q deletions in patients with familial adenomatous polyposis: possible link with Caroli's disease.
Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development.
Upper gastrointestinal disease in patients with familial adenomatous polyposis.
Upper gastrointestinal neoplasia in familial adenomatous polyposis: prevalence, endoscopic features and management.
Upper GI involvement in children with familial adenomatous polyposis syndrome: single-center experience and meta-analysis of the literature.
Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms.
Variability in the severity of colonic disease in familial adenomatous polyposis results from differences in tumour initiation rather than progression and depends relatively little on patient age.
Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas.
Wnt signalling in adenomas of familial adenomatous polyposis patients.
[A Case of Duodenal Cancer with Familial Adenomatous Polyposis].
[A novel APC gene germline mutation in a familial adenomatous polyposis pedigree]
[Ampullectomy in benign lesion: indications and results]
[Application of serum protein markers to distinguish familial adenomatous polyposis (FAP) and sporadic colorectal adenomas]
[Aspirin suppresses microsatellite instability]
[Autoregulatory growth control of adenomatous polyps and carcinogenesis in the colorectal region. Basics of tumor surgery Part I]
[Chemoprevention of familial cancer]
[Current status of hereditary gastrointestinal neoplasms].
[Differential diagnostics of hereditary colorectal cancer syndromes. The role of pathology].
[Effects of cyclooxygenase-2 and proliferating cell nuclear antigen on the onset and development of familial adenomatous polyposis]
[Familial adenomatous polyposis coli in the Czech population. I. Detection of an additional 3 mutations out of a total of 7 in exon 15 of the APC gene]
[Familial adenomatous polyposis with papillary thyroid cancer:a case report].
[Familiar adenomatous polyposis: report of 2 cases].
[Full thickness resection of a pyloric adenoma in the proximal duodenum in a 67-year-old patient with attenuated polyposis coli].
[Gastric adenoma of pyloric type associated with familial adenomatous polyposis: A rare histological type not to be overlooked].
[Genetic analysis in familial adenomatous polyposis]
[Hereditary colorectal cancer]
[Microsatellite instability and relative gene expressions in sporadic and familial adenomatous polyposis adenomas]
[Molecular genetics of colorectal cancer and carcinogenesis]
[Mutation of APC gene in sporadic colorectal tumors]
[Rectal carcinoma in a patient with familial adenomatous polyposis coli after colectomy with ileorectal anastomosis and consecutive chemoprevention with sulindac suppositories]
[Regional growth preferences in hereditary, synchronous, and metachronous colorectal carcinomas. Basics of tumor surgery Part II]
[Technique of pancreas-preserving duodenectomy]
[The effects of sulindac on the pathology of colorectal remnant polyps of familial adenomatous polyposis (FAP) patients]
[Two cases of multiple adenomas in the ileal pouch after total proctocolectomy in patients with familial adenomatous polyposis]
Adenoma, Islet Cell
Pancreatic islet cell tumour in a patient with familial adenomatous polyposis.
Adenoma, Liver Cell
Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli.
Adenoma, Oxyphilic
Altered Tissue and Plasma Levels of Fibroblast Activation Protein-? (FAP) in Renal Tumours.
Adenoma, Pleomorphic
Fibroblast-activation protein: valuable marker of cutaneous epithelial malignancy.
Gardner's syndrome presenting with a fibromatous tumour of the parotid.
Adenoma, Villous
Combined restorative proctocolectomy and pancreaticoduodenectomy for familial adenomatous polyposis.
Laparoscopic Pancreas-Sparing Duodenectomy with Roux en Y Reconstruction for Duodenal Polyposis.
Adenomatous Polyposis Coli
A case report of desmoid tumour-a forgotten aspect of FAP?
A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer Survivors.
A novel APC mutation identified in a large Chinese family with familial adenomatous polyposis and a brief literature review.
A novel large deletion in the APC gene associated with Gardner syndrome in a Chinese family.
A novel large germ line deletion in adenomatous polyposis coli (APC) gene associated with familial adenomatous polyposis.
A novel pathogenic germline mutation in the adenomatous polyposis coli gene in a Chinese family with familial adenomatous coli.
A novel pathogenic germline mutation in the adenomatous polyposis coli gene in a Tunisian family with FAP.
A Patient With Desmoid Tumors and Familial FAP Having Frame Shift Mutation of the APC Gene.
A population perspective on multistage carcinogenesis.
A review of physical abnormalities in familial adenomatous polyposis.
A unique case of two somatic APC mutations in an early onset cribriform-morular variant of papillary thyroid carcinoma and overview of the literature.
About a case of familial adenomatous polyposis.
Adenocarcinomas After Prophylactic Surgery For Familial Adenomatous Polyposis.
Adenomatous polyposis coli gene large deletions in Iranian patients with familial adenomatous polyposis.
Adenomatous Polyposis Syndromes: Diagnosis and Management.
Adrenal masses in patients with familial adenomatous polyposis.
Allele-Specific Expression of APC in Adenomatous Polyposis Families.
Alteration of O6-methylguanine-DNA methyltransferase in colorectal neoplasms in sporadic and familial adenomatous polyposis patients.
American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in familial adenomatous polyposis syndromes.
An APC Mutation in a Large Chinese Kindred With Familial Adenomatous Polyposis Was Identified Using Both Next Generation Sequencing and Simple STR Marker Haplotypes.
An atypical presentation of small bowel obstruction and perforation secondary to sporadic synchronous intra-abdominal desmoid tumours.
An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis.
Anaerobes and their fermentation products in faeces of patients with familial adenomatous polyposis before and after subtotal colectomy and ileorectal anastomosis.
APC mutation spectrum in ileoanal pouch polyps resembles that of colorectal polyps.
APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".
Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature.
Aspiration and imprint cytopathology of thyroid carcinoma associated with familial adenomatous polyposis.
Association of extracolonic manifestations of familial adenomatous polyposis with acetylation phenotype in a large FAP kindred.
Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP.
Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis.
Autocatalytic Tissue Polymerization Reaction Mechanism in Colorectal Cancer Development and Growth.
Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH.
Beta-catenin mutations in sporadic fundic gland polyps.
Bilateral breast fibromatosis after silicone prosthetics in a patient with classic familial adenomatous polyposis: A case report.
Bilateral Sertoli cell tumors of the testis-a likely new extracolonic manifestation of familial adenomatous polyposis.
Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission.
CD36 - a plausible modifier of disease phenotype in familial adenomatous polyposis.
Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
Characterization of adenocarcinoma of the lung in a familial adenomatous polyposis patient.
Characterization of two novel adenomatous polyposis coli (APC) gene mutations in patients with familial adenomatous polyposis (FAP).
Clinical Utility Gene Card for: Familial adenomatous polyposis (FAP) and attenuated FAP (AFAP)--update 2014.
Clinical utility gene card for: Familial adenomatous polyposis (FAP) and attenuated FAP (AFAP).
Close linkage of a highly polymorphic marker (D5S37) to familial adenomatous polyposis (FAP) and confirmation of FAP localization on chromosome 5q21-q22.
Colonic polyps in children and adolescents.
Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis.
Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines.
Comparison of dysplastic fundic gland polyps in patients with and without familial adenomatous polyposis.
Complex APC germline mutation associated metaplasia and intraepithelial neoplasia (CAM-IEN) of the gallbladder.
Congenital Hypertrophy of Retinal Pigment Epithelium for Diagnosis of Familial Adenomatous Polyposis - the First FAP registry in Iran
Congenital hypertrophy of the retinal pigment epithelium serves as a clinical marker in a family with familial adenomatous polyposis.
Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.
Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients.
Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancers.
Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis.
Detection of 12 germ-line mutations in the adenomatous polyposis coli gene by polymerase chain reaction.
Detection of a heterozygous germline APC mutation in a three-generation family with familial adenomatous polyposis using targeted massive parallel sequencing in Vietnam.
Detection of APC gene deletions using quantitative multiplex PCR of short fluorescent fragments.
Development of an aggressive depressed cancer in a case of familial adenomatous polyposis.
Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: variations with phenotype.
Do we know all there is to know about Familial Adenomatous Polyposis?
Duodeno-gastric reflux and gastric adenomas: a scintigraphic study in patients with familial adenomatous polyposis.
Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis.
Endoscopic management of duodenal adenomatosis in familial adenomatous polyposis-A case-based review.
Endoscopic management of familial adenomatous polyposis in patients refusing colectomy.
Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival.
Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation.
Extracolonic features of familial adenomatous polyposis in patients with sporadic colorectal cancer.
Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.
Familial adenomatous polyposis (FAP): Genotype correlation to FAP phenotype with osteomas and sebaceous cysts.
Familial adenomatous polyposis coli in South Africa--molecular basis and diagnosis.
Familial Adenomatous Polyposis Complicated by Acute Myelogenous Leukemia.
Familial adenomatous polyposis in an adolescent with coexisting schizophrenia: treatment strategies and implications.
Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.
Familial adenomatous polyposis of the colon.
Familial Adenomatous Polyposis-associated, Cribriform Morular Variant of PTC harboring a K-RAS mutation: Case presentation and Review of Molecular Mechanisms.
Familial adenomatous polyposis.
Familial adenomatous polyposis: genetics and epidemiology.
Familial adenomatous polyposis: should patients undergo surveillance of the upper gastrointestinal tract?
Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation.
Familial papillary thyroid carcinoma is genetically distinct from familial adenomatous polyposis coli.
FAP Flap: A Volte Face to Familial Adenomatous Polyposis.
Frequent CpG island methylation in sporadic and syndromic gastric fundic gland polyps.
Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas.
Gardner syndrome: skin manifestations, differential diagnosis and management.
Gastrointestinal polyposis syndromes for the general gastroenterologist.
Gastrointestinal tract cancers: Genetics, heritability and germ line mutations.
Genetic evidence that Turcot syndrome is not allelic to familial adenomatous polyposis.
Genetic heterogeneity of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in families with familial adenomatous polyposis.
Genetic predisposition to clinical manifestations in familial adenomatous polyposis with special reference to duodenal lesions.
Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle.
Genetic testing and counseling in familial adenomatous polyposis.
Genetics of hereditary colorectal cancer.
Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families.
Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
Germline mutations in the 3' part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli.
Hearing Status of Children and Adolescents With Familial Adenomatous Polyposis.
Hereditary colorectal cancer syndromes.
High cumulative risk of colorectal cancers and desmoid tumours and fibromatosis in South Asian APC mutation carriers.
High frequency of K-ras mutations in sporadic colorectal adenomas.
Identification of APC exon 15 mutations in families suspected of familial adenomatous polyposis (FAP).
Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: Relationship with colonic metaplasia.
Improved predictive carrier testing for familial adenomatous polyposis using DNA from a single archival specimen and polymorphic markers with multiple alleles.
Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP).
Intestinal flora of FAP patients containing APC-like sequences.
Investigating polymorphisms by bioinformatics is a potential cost-effective method to screen for germline mutations in Chinese familial adenomatous polyposis patients.
Knowledge of the adenomatous polyposis coli gene and its clinical application.
Multiple adenomatous duodenal polyposis.
Multistep carcinogenesis in colorectal cancers.
Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription.
Mutation analysis of the MYH gene in unrelated Czech APC mutation-negative polyposis patients.
Mutational screening through comprehensive bioinformatics analysis to detect novel germline mutations in the APC gene in patients with familial adenomatous polyposis (FAP).
MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.
MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype.
MYH polyposis syndrome: clinical findings, genetics issues and management.
Non-allelic heterogeneity of familial adenomatous polyposis.
Nonpolypoid adenomas and adenocarcinomas found in background mucosa of surgically resected colons.
Not all pediatric intestinal polyps are alike.
Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9.
Novel germline APC mutations in Swedish patients with familial adenomatous polyposis and Gardner syndrome.
Novel germline mutations in the APC gene of Cypriot patients with familial and sporadic adenomatous polyposis.
Novel mutations of the APC gene in familial adenomatous polyposis in Greek patients.
Nuclear localization of immunoreactive beta-catenin is specific to familial adenomatous polyposis in papillary thyroid carcinoma.
Pathology of the hereditary colorectal carcinoma.
Pineoblastoma presenting in familial adenomatous polyposis (FAP): random association, FAP variant or Turcot syndrome?
Polymorphisms in the adenomatous polyposis coli gene in Slovak families suspected of FAP.
Polyposis coli, craniofacial exostosis and astrocytoma: the concomitant occurrence of the Gardner's and Turcot syndromes.
Predictive cytogenetic biomarkers for colorectal neoplasia in medium risk patients.
Predictive value of congenital hypertrophy of the retinal pigment epithelium as a clinical marker for familial adenomatous polyposis.
Preimplantation genetic diagnosis of familial adenomatous polyposis.
Presentation, management and outcomes of ileoanal pouch cancer: a single-centre experience.
Presymptomatic diagnosis of familial adenomatous polyposis coli.
Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review.
Prevalence of skin lesions in familial adenomatous polyposis: a marker for presymptomatic diagnosis?
Prevention of colorectal cancer in high-risk populations: the increasing role for endoscopy and chemoprevention in FAP and HNPCC.
Psychosocial impact of familial adenomatous polyposis on young adults: a qualitative study.
Pulmonary sclerosing hemangioma associated with familial adenomatous polyposis.
Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients.
Results after restorative proctocolectomy and ileal pouch-anal anastomosis in patients with familial adenomatous polyposis and coexisting colorectal cancer.
Retinal pigment epithelial lesions associated with a sporadic case of familial adenomatous polyposis.
Revolutionary advances in the diagnosis and treatment of familial adenomatous polyposis.
Role of APC and DNA mismatch repair genes in the development of colorectal cancers.
Screening for an inherited susceptibility to colorectal cancer.
Screening practice for familial adenomatous polyposis: the potential for regional registers.
Secretory phospholipase A2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis.
Serrated adenomas in FAP. Familial adenomatous polyposis.
Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene.
Small-intestinal involvement in familial adenomatous polyposis: evaluation by double-balloon endoscopy and intraoperative enteroscopy.
Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients.
Sporadic Desmoid-Type Fibromatosis Occurring at Laparoscopic Trocar Site: An Unusual Entity.
Synchronous primary carcinomas of the ampulla of Vater and ascending colon in a patient with multiple flat adenomas.
Synonymous mutation adenomatous polyposis coli?486s affects exon splicing and may predispose patients to adenomatous polyposis coli/mutY DNA glycosylase mutation?negative familial adenomatous polyposis.
Systemic cytotoxic chemotherapy and radiation therapy for desmoid in familial adenomatous polyposis.
The ABC of APC.
The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history.
The Broad Variability in Dental Age Observed among Childhood Survivors Is Cancer Specific.
The evolution of colorectal cancer genetics-Part 2: clinical implications and applications.
The genetic basis of colonic adenomatous polyposis syndromes.
The molecular genetics of colorectal cancer.
The presymptomatic molecular diagnosis of familial adenomatous polyposis in Singapore.
The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.
Three novel mutations of APC gene in Chinese patients with familial adenomatous polyposis.
Transcript dosage effect in familial adenomatous polyposis: model offered by two kindreds with exon 9 APC gene mutations.
Upper intestinal surveillance in familial adenomatous polyposis.
Uses of a familial adenomatous polyposis registry.
Yield of Colonoscopy in Identification of Newly Diagnosed Desmoid-Type Fibromatosis with Underlying Familial Adenomatous Polyposis.
[Application of serum protein markers to distinguish familial adenomatous polyposis (FAP) and sporadic colorectal adenomas]
[Differential diagnostics of hereditary colorectal cancer syndromes. The role of pathology].
[Familial adenomatous polyposis coli in the Czech population. I. Detection of an additional 3 mutations out of a total of 7 in exon 15 of the APC gene]
[Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms]
[Osteomatous jaw lesions in familial adenomatous polyposis]
[Preclinical and prenatal diagnosis of familial adenomatous polyposis]
[Retinal changes in patients with familial adenomatous polyposis]
[Surgical aspects of indications and techniques for adenomatous polyposis variants].
[Turcot syndrome--a rare extra-intestinal manifestation of familial adenomatous polyposis?]
Adenomatous Polyps
A novel pathogenic splice acceptor site germline mutation in intron 14 of the APC gene in a Chinese family with familial adenomatous polyposis.
An APC Mutation in a Large Chinese Kindred With Familial Adenomatous Polyposis Was Identified Using Both Next Generation Sequencing and Simple STR Marker Haplotypes.
Aspirin Prevents Colorectal Cancer by Normalizing EGFR Expression.
Clinicopathological features of familial adenomatous polyposis in Korean patients.
Cumulative risk of developing polyps or malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis.
Extra-intestinal manifestations of familial adenomatous polyposis.
Familial Adenomatous Polyposis Complicated by Acute Myelogenous Leukemia.
Familial adenomatous polyposis complicated by chronic myelogenous leukemia: response to imatinib mesylate.
Familial adenomatous polyposis predisposes to pathologic exposure of the stomach to bilirubin.
Familial adenomatous polyposis.
Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis.
Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis.
Germline mutations of the MYH gene in Korean patients with multiple colorectal adenomas.
Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients.
Intestinal flora of FAP patients containing APC-like sequences.
Introduction of human adenomatous polyposis coli gene into Min mice via cationic liposomes.
Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype.
Localization of the genetic defect in familial adenomatous polyposis within a small region of chromosome 5.
miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Molecular analysis of the APC gene in Sicilian patients with familial adenomatous polyposis (F.A.P.).
Mutation analysis of the APC gene in Taiwanese FAP families: low incidence of APC germline mutation in a distinct subgroup of FAP families.
Mutational Analysis of a Familial Adenomatous Polyposis Pedigree with Bile Duct Polyp Phenotype.
Novel APC mutations in Czech and Slovak FAP families: clinical and genetic aspects.
Novel mutations of the APC gene and genetic consequences of splicing mutations in the Czech FAP families.
NSAID use and decreased risk of gastrointestinal cancers.
Oestrogen receptor beta isoform expression in sporadic colorectal cancer, familial adenomatous polyposis and progressive stages of colorectal cancer.
Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).
Recurrent polyps in the ileo-anal pouch or rectum in familial adenomatous polyposis.
Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
Retinal pigment epithelial lesions associated with a sporadic case of familial adenomatous polyposis.
Sporadic pediatric severe familial adenomatous polyposis: A case report.
Submerged gel electrophoresis on Spreadex gels--a new method for APC gene mutation detection.
The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP).
The use of DNA markers in the pre-clinical diagnosis of familial adenomatous polyposis.
Thyroid carcinoma as first manifestation of familial adenomatous polyposis.
Use of NSAIDs for the chemoprevention of colorectal cancer.
[Chronic polyps in the stomach and jejunum in a patient with familial adenomatous polyposis].
[Familiar adenomatous polyposis: report of 2 cases].
[Genetic counseling, surgical prophylaxis and treatment for familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer]
[Positional cloning of genes responsible for hereditary tumors]
[Turcot syndrome--a rare extra-intestinal manifestation of familial adenomatous polyposis?]
Adrenocortical Adenoma
Biallelic APC Inactivation Was Responsible for Functional Adrenocortical Adenoma in Familial Adenomatous Polyposis with Novel Germline Mutation of the APC Gene: Report of a Case.
Inactivation of the APC Gene Is Constant in Adrenocortical Tumors from Patients with Familial Adenomatous Polyposis but Not Frequent in Sporadic Adrenocortical Cancers.
Primary aldosteronism in a patient with familial adenomatous polyposis.
Adrenocortical Carcinoma
Inactivation of the APC Gene Is Constant in Adrenocortical Tumors from Patients with Familial Adenomatous Polyposis but Not Frequent in Sporadic Adrenocortical Cancers.
Alopecia
[FEP and FAP combination chemotherapy in advanced gastric cancer. Research Group for Gastric Cancer]
Alzheimer Disease
Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
New therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration.
[Amyloidosis and neurological disorders: Treatable amyloidosis].
Amyloid Neuropathies
"Sporadic" prealbumin-related amyloid polyneuropathy: report of two cases.
Bulbar palsy in senile onset familial amyloid polyneuropathy (30Val-->Met): transthyretin-amyloid deposits in the hypoglossal nerve root.
De novo hereditary (familial) amyloid polyneuropathy (FAP) in a FAP liver recipient.
Focus on autonomic dysfunction in familial amyloidotic polyneuropathy (FAP).
Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
Metabolic turn over of amyloid fibrils and post-treatment regression of amyloid deposits in systemic amyloidosis with polyneuropathy.
Molecular genetics of amyloid neuropathy in Europe.
Regional difference and similarity of familial amyloidosis with polyneuropathy in France.
Amyloid Neuropathies, Familial
A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.
An Isolated Case of Late-onset Amyloidogenic Transthyretin Type Familial Amyloid Polyneuropathy Associated with a Mutant Transthyretin Substituting Methionine for Valine at Position 30 Showing Latent Progressive Cardiac Involvement Confirmed by Serial Annual Electrocardiograms.
Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.
Clinical features and diagnosis by recombinant DNA techniques of familial amyloid polyneuropathy in Japan.
Clinical picture and outcome of transthyretin-related familial amyloid polyneuropathy (FAP) in Japanese patients.
Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis.
Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
Genetically determined neuropathies.
Late-onset familial amyloid polyneuropathy in Japan.
Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys.
Nonfamilial prealbumin-type amyloid polyneuropathy.
Operative risks of domino liver transplantation for the FAP liver donor and the FAP liver recipient.
Pituicytoma with gelsolin amyloid deposition.
Regional differences and similarities of FAP in Sweden.
Role of the disease in the psychological impact of pre-symptomatic testing for SCA2 and FAP ATTRV30M: Experience with the disease, kinship and gender of the transmitting parent.
Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation.
The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation.
[Familial amyloid polyneuropathy type IV (Finnish type)--a clinicopathological study]
[Recent advances of the treatment in metabolic disorders]
[Sequential heart and liver transplantation for familial amyloid polyneuropathy].
[Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
Amyloidosis
A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindred.
Amyloid fibril protein in familial amyloidosis with cranial neuropathy and corneal lattice dystrophy (FAP type IV) is related to transthyretin.
Amyloidosis and Ocular Involvement: an Overview.
An Isolated Case of Late-onset Amyloidogenic Transthyretin Type Familial Amyloid Polyneuropathy Associated with a Mutant Transthyretin Substituting Methionine for Valine at Position 30 Showing Latent Progressive Cardiac Involvement Confirmed by Serial Annual Electrocardiograms.
Annual electrocardiograms consistent with silent progression of cardiac involvement in sporadic familial amyloid polyneuropathy: a case report.
Autonomic neuropathy in familial amyloidotic polyneuropathy. A clinical study based on heart rate variability.
Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
Change in the age of onset in patients with familial amyloidotic polyneuropathy type I.
Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.
Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family--a follow-up autopsy report.
Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis.
Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers.
Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.
Endoscopic and pathological manifestations of the gastrointestinal tract in familial amyloidotic polyneuropathy type I (Met30).
Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
Extracellular matrix markers for disease progression and follow-up of therapies in familial amyloid polyneuropathy V30M TTR-related.
Familial amyloidotic polyneuropathy and transthyretin.
Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
Fundus autofluorescence imaging in hereditary ATTR amyloidosis with ocular involvement.
Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients.
Indications for liver transplantation in patients with amyloidosis: a single-center experience with 11 cases.
Lipid droplets are present in amyloid deposits in familial amyloidotic polyneuropathy and dialysis related amyloidosis.
Low erythropoietin production in familial amyloidosis TTR V30M is not related with renal congophilic amyloid deposition. A clinicopathologic study of twelve cases.
Marked cardiomegaly in a patient with familial amyloidotic polyneuropathy after orthotopic liver transplantation: a case study.
Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene.
Metabolic turn over of amyloid fibrils and post-treatment regression of amyloid deposits in systemic amyloidosis with polyneuropathy.
Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
Multimodal retinal imaging in a Chinese kindred with familial amyloid polyneuropathy secondary to transthyretin Ile107Met mutation.
Multimodal retinal imaging of familial amyloid polyneuropathy.
No association between apolipoprotein E epsilon4 allele and the age of onset in type I familial amyloid polyneuropathy.
Orthotopic liver transplantation for familial amyloidotic polyneuropathy.
Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.
Peripheral nerve amyloidosis.
Pituicytoma with gelsolin amyloid deposition.
Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study.
Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis.
Recent advances in transthyretin amyloidosis therapy.
Restriction fragment length polymorphism analysis of mutated transthyretin in vitreous amyloidosis.
Sulfite and base for the treatment of familial amyloidotic polyneuropathy: two additive approaches to stabilize the conformation of human amyloidogenic transthyretin.
Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation.
Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy.
The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis.
The pathological and biochemical identification of possible seed-lesions of transmitted transthyretin amyloidosis after domino liver transplantation.
Transthyretin Tyr69-to-Ile mutation (double-nucleotide substitution in codon 69) in a Japanese familial amyloidosis patient with cardiomyopathy and carpal tunnel syndrome.
Type I familial amyloid polyneuropathy and pontine haemorrhage.
Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL-amyloidosis.
Variant transthyretin in blood circulation can transverse the blood-cerebrospinal barrier: qualitative analyses of transthyretin metabolism in sequential liver transplantation.
Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin.
Vitreous Amyloidosis as the Presenting Symptom of Familial Amyloid Polyneuropathy TTR Val30Met in a Portuguese Patient.
Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights.
[Amyloid neuropathy]
[Amyloidosis and neurological disorders: Treatable amyloidosis].
[Analyses of amyloid formation mechanism in familial amyloidotic polyneuropathy and therapeutic trial]
[Familial amyloid polyneuropathy type IV (Finnish type)--a clinicopathological study]
[Familial amyloidosis of the Finnish type (FAP) with extraocular muscle involvement]
[Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis]
[Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
Amyloidosis, Familial
Identification of carriers of a variant plasma prealbumin (transthyretin) associated with familial amyloidotic polyneuropathy type I.
[Application to transthyretin analysis]
[Variable clinical manifestations of familial amyloid polyneuropathy and living related liver transplantation]
Amyotrophic Lateral Sclerosis
Lipid droplets are present in amyloid deposits in familial amyloidotic polyneuropathy and dialysis related amyloidosis.
Q-Rich Yeast Prion [
Anemia
Autonomic dysfunction and anemia in neurologic disorders.
Familial adenomatous polyposis and Crohn's disease in one patient: dilemmas and concerns.
Food assistance programmes are indirectly associated with anaemia status in children <5 years old in Mexico.
Kidney and anemia in familial amyloidosis type I.
Long-term treatment of anemia with recombinant human erythropoietin in familial amyloidosis TTR V30M.
Profunda femoris artery pseudoaneurysm following revision for femoral shaft fracture nonunion.
Secondary hypoplastic anemia in patients with familial amyloidotic polyneuropathy.
[Familial amyloidotic polyneuropathy (FAP) type I and the therapies]
Anemia, Aplastic
Secondary hypoplastic anemia in patients with familial amyloidotic polyneuropathy.
Anemia, Pernicious
Gastric carcinoids in a patient with pernicious anemia and familial adenomatous polyposis.
Anencephaly
A 2015 global update on folic acid-preventable spina bifida and anencephaly.
A 2017 global update on folic acid-preventable spina bifida and anencephaly.
Reductions in child mortality by preventing spina bifida and anencephaly: Implications in achieving Target 3.2 of the Sustainable Development Goals in developing countries.
Aneurysm, False
Fatal Complication after Thrombin Injection for Post-Catheterization Femoral Pseudoaneurysm.
Ultrasound-guided thrombin injection for treatment of iatrogenic femoral artery pseudoaneurysms compared with open surgery: first experiences from a single institution.
Angiofibroma
Genetic evidence that juvenile nasopharyngeal angiofibroma is an integral FAP tumour.
Anus Neoplasms
A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
Aortic Diseases
MDCT distinguishing features of focal aortic projections (FAP) in acute clinical settings.
Apnea
ACUTE APNEA SWIMMING: METABOLIC RESPONSES AND PERFORMANCE.
Arrhythmias, Cardiac
99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy.
Arrhythmia--a pitfall in tests of cardiac autonomic function after liver transplantation for familial amyloidotic polyneuropathy: a long-term follow-up of Swedish patients.
Blood pressure overshoot after tilt reversal in patients with familial amyloidotic polyneuropathy.
Continuous development of arrhythmia is observed in Swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant).
Electrophysiological mechanisms of sophocarpine as a potential antiarrhythmic agent.
Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients.
Outcome of exercise electrocardiography in familial amyloidotic polyneuropathy patients, Portuguese type, under evaluation for liver transplantation.
Ventricular late potentials in familial amyloidotic polyneuropathy.
Arterial Occlusive Diseases
Criteria from intra-arterial femoral artery pressure measurements combined with reactive hyperaemia to assess the aorto-iliac segment; a prospective study.
Arteriovenous Malformations
Pollicization after radical resection of diffuse arteriovenous malformation of the thumb--a case report.
Arthritis
A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation.
An improved production and purification protocol for recombinant soluble human fibroblast activation protein alpha.
Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis.
Fibroblast activation protein-?: a key modulator of the microenvironment in multiple pathologies.
Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics.
Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritis.
Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy.
Arthritis, Rheumatoid
Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes.
Asthma
Association between functional abdominal pain disorders and asthma in adolescents: A cross-sectional study.
Astrocytoma
Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-? in transformed astrocytic cells.
Ataxia
Q-Rich Yeast Prion [
Ataxia Telangiectasia
Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.
Atherosclerosis
An improved production and purification protocol for recombinant soluble human fibroblast activation protein alpha.
Deletion of fibroblast activation protein provides atheroprotection.
Expression of fibroblast activation protein in human coronary vessels.
Fibroblast activation protein regulates lesion burden and the fibro-inflammatory response in Apoe-deficient mice in a sexually dimorphic manner.
Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics.
Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy.
Atrial Fibrillation
Pacemaker treatment in familial amyloidosis with polyneuropathy.
Slow pathway elimination using antegrade conduction improvement with fast atrial pacing during AVNRT radiofrequency ablation: a proof-of-concept study.
[Natural history of and risk factors for idiopathic atrial fibrillation recurrence (FAP Registry)]
Atrioventricular Block
Prophylactic pacemaker implantation in familial amyloid polyneuropathy.
Autoimmune Diseases
Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein.
Bone Resorption
Identification of Fibroblast Activation Protein as an Osteogenic Suppressor and Anti-osteoporosis Drug Target.
Bradycardia
Electrophysiologic effects of atropine and isoproterenol on the cardiac conduction system in familial amyloid polyneuropathy.
Management of a patient with familial amyloid polyneuropathy type I with lumbar epidural anaesthesia.
Brain Neoplasms
Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis.
Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy.
Prolactinoma as the first manifestation of Gardner's syndrome.
The Somatic Mutation Hit on Top of Genetic APC mutations Cause Skin Tumor.
Breast Neoplasms
Double mutation of APC and BRCA1 in an Italian family.
Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma.
Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines.
FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.
Fibroblast activation protein-? promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.
Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer.
Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
Short hairpin RNA targeting of fibroblast activation protein inhibits tumor growth and improves the tumor microenvironment in a mouse model.
Targeting inhibition of fibroblast activation protein-? and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.
Tumor elastography and its association with cell-free tumor DNA in the plasma of breast tumor patients: a pilot study.
Bronchial Hyperreactivity
Bronchial hyperreactivity in patients with familial amyloidotic polyneuropathy and autonomic neuropathy.
Bulbar Palsy, Progressive
Bulbar palsy in senile onset familial amyloid polyneuropathy (30Val-->Met): transthyretin-amyloid deposits in the hypoglossal nerve root.
Bundle-Branch Block
An Isolated Case of Late-onset Amyloidogenic Transthyretin Type Familial Amyloid Polyneuropathy Associated with a Mutant Transthyretin Substituting Methionine for Valine at Position 30 Showing Latent Progressive Cardiac Involvement Confirmed by Serial Annual Electrocardiograms.
Carcinogenesis
A novel pathogenic germline mutation in the adenomatous polyposis coli gene in a Chinese family with familial adenomatous coli.
A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice.
Age-dependent susceptibility to azoxymethane-induced and spontaneous tumorigenesis in the Min/+ mouse.
Alteration of O6-methylguanine-DNA methyltransferase in colorectal neoplasms in sporadic and familial adenomatous polyposis patients.
Analysis of expression levels of markers associated with tumor proliferation and angiogenesis in familial adenomatous polyposis.
Analysis of Wnt/Beta catenin signalling in desmoid tumors.
Apc-driven colon carcinogenesis in Pirc rat is strongly reduced by polyethylene glycol.
Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature.
Assessment of circulating microRNA specific for patients with familial adenomatous polyposis.
Association of Pathogenic Missense and Nonsense Mutations in Mitochondrial COII Gene with Familial Adenomatous Polyposis (FAP).
Biallelic inactivation of the APC gene in hepatoblastoma.
Biliary bile acid profiles in patients with familial adenomatous polyposis before and after colectomy.
Burden and profile of somatic mutation in duodenal adenomas from patients with familial adenomatous- and MUTYH-associated polyposis.
Characterization of adenocarcinoma of the lung in a familial adenomatous polyposis patient.
Chemopreventive agents inhibit aberrant proliferation of the aneuploid phenotype in a colon epithelial cell line established from Apc 1638N [+/-] mouse.
Chemopreventive effects of orange peel extract (OPE). I: OPE inhibits intestinal tumor growth in ApcMin/+ mice.
Chromosome 5 allele loss at the glucocorticoid receptor locus in human colorectal carcinomas.
Clinicopathologic and Molecular Characteristics of Familial Adenomatous Polyposis-associated Traditional Serrated Adenoma.
Colorectal cancer with and without microsatellite instability involves different genes.
Combinatorial prevention of carcinogenic risk in a model for familial colon cancer.
Comparison of dysplastic fundic gland polyps in patients with and without familial adenomatous polyposis.
Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma.
Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: variations with phenotype.
Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients.
Duodenal adenoma surveillance in patients with familial adenomatous polyposis.
Epithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors?
Familial adenomatous polyposis and changes in the gut microbiota: New insights into colorectal cancer carcinogenesis.
Familial adenomatous polyposis: a case report and histologic mucin study.
FAP Associated Papillary Thyroid Carcinoma: A Peculiar Subtype of Familial Nonmedullary Thyroid Cancer.
Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival.
Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through ?-catenin signaling pathway.
Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
Fucoxanthin Prevents Colorectal Cancer Development in Dextran Sodium Sulfate-treated Apc Min/+ Mice.
Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli.
Identification and quantification of aberrant crypt foci in the colon of Min mice--a murine model of familial adenomatous polyposis.
Impact of dietary amino acids and polyamines on intestinal carcinogenesis and chemoprevention in mouse models.
Importance of sessile serrated lesions in a patient with familial adenomatous polyposis.
Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis.
Loss of colonic HLA antigens in familial adenomatous polyposis.
Map syndrome (MYH Associated Polyposis) colorectal cancer, etiopathological connections.
Mechanisms of APC-driven tumorigenesis: lessons from mouse models.
Modulation by dietary factors in murine FAP models.
Molecular and phenotypic markers of hamartomatous polyposis syndromes in the gastrointestinal tract.
Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
Molecular nature of chromosome 5q loss in colorectal tumors and desmoids from patients with familial adenomatous polyposis.
Molecular Predicators of Duodenal Familial Adenomatous Polyposis Chemoprevention: Do Chemopreventive Drugs Hit Their Presumed Molecular Targets?
Mouse fibroblast-activation protein--conserved Fap gene organization and biochemical function as a serine protease.
Multistage carcinogenesis: population-based model for colon cancer.
Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.
Mutational Analysis of a Familial Adenomatous Polyposis Pedigree with Bile Duct Polyp Phenotype.
Mutational screening through comprehensive bioinformatics analysis to detect novel germline mutations in the APC gene in patients with familial adenomatous polyposis (FAP).
Mutations of the PIK3CA gene in hereditary colorectal cancers.
Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
On the edge of validation--cancer protease fibroblast activation protein.
Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.
Ornithine decarboxylase and polyamines in familial adenomatous polyposis.
Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event?
Prevention of early-onset familial/hereditary colon cancer: new models and mechanistic biomarkers (review).
Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis.
Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice.
Serrated adenomas with a BRAF mutation in a young patient with familial adenomatous polyposis.
Serum metabolite profiling of familial adenomatous polyposis using ultra performance liquid chromatography and tandem mass spectrometry.
Significance of apoptosis in the process of tumorigenesis in colorectal mucosa and adenomas in FAP patients.
Silibinin Suppresses Spontaneous Tumorigenesis in APC (min/+) Mouse Model by Modulating Beta-Catenin Pathway.
Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients.
The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis.
The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment.
Tumor elastography and its association with cell-free tumor DNA in the plasma of breast tumor patients: a pilot study.
[Effects of cyclooxygenase-2 and proliferating cell nuclear antigen on the onset and development of familial adenomatous polyposis]
[Molecular genetics of colorectal cancer and carcinogenesis]
Carcinoid Tumor
Coexisting carcinoid tumors in familial adenomatous polyposis-associated upper intestinal adenomas.
FAP with concurrent duodenal adenomatous polyposis and carcinoid tumor.
Gastric carcinoids in a patient with pernicious anemia and familial adenomatous polyposis.
Laparoscopic double-tract reconstruction after total gastrectomy for postoperative duodenal surveillance: Case series.
Metastatic carcinoid and islet cell tumours of the pancreas: a phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin.
Carcinoma
A case of familial adenomatous polyposis complicated by thyroid carcinoma, carcinoma of the ampulla of vater and adrenocortical adenoma.
A case of myoepithelial carcinoma displaying biallelic inactivation of the tumour suppressor gene APC in a patient with familial adenomatous polyposis.
A molecular rationale for the how, when and why of colorectal cancer screening.
A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.
A two-step model for colon adenoma initiation and progression caused by APC loss.
Adrenocortical tumor in a patient with familial adenomatous polyposis: a case associated with a complete inactivating mutation of the APC gene and unusual histological features.
Altered Tissue and Plasma Levels of Fibroblast Activation Protein-? (FAP) in Renal Tumours.
Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.
Characteristics and Clinical Outcomes of Duodenal Neoplasia in Japanese Patients With Familial Adenomatous Polyposis.
Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
Characterization of adenocarcinoma of the lung in a familial adenomatous polyposis patient.
Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas.
Chromosome changes in desmoid tumors developed in patients with familial adenomatous polyposis.
Clinical analysis of eight kindreds of familial adenomatous polyposis.
Closure of loop ileostomy after low anterior rectal resection and restorative proctocolectomy.
Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis.
Common genetic evolutionary pathways in familial adenomatous polyposis tumors.
Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein.
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.
Cytogenetic analysis of intestinal polyps in polyposis syndromes: comparison with sporadic colorectal adenomas.
Detection of HPV in oral rinse samples from OPSCC and non-OPSCC patients.
Development of an aggressive depressed cancer in a case of familial adenomatous polyposis.
Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis.
Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients.
Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.
Double-balloon endoscopy facilitates efficient endoscopic resection of duodenal and jejunal polyps in patients with familial adenomatous polyposis.
Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
Duodenal adenomatosis in familial adenomatous polyposis. DAF Project Group.
Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis.
Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation.
Epithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors?
Expression of EGFR, HER2, Phosphorylated ERK and Phosphorylated MEK in Colonic Neoplasms of Familial Adenomatous Polyposis Patients.
Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines.
Expression Profiling of Proliferation and Apoptotic Markers along the Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis Patients.
Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.
Familial adenomatous polyposis: a case report and review of the literature.
Familial adenomatous polyposis: case report and review of extracolonic manifestations.
FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.
Fundic gland polyp dysplasia is common in familial adenomatous polyposis.
Gardner's syndrome presenting with a fibromatous tumour of the parotid.
Gastric carcinoma and familial adenomatous polyposis (FAP).
Genetic alteration of colorectal adenoma-carcinoma sequence among gastric adenocarcinoma and dysplastic lesions in a patient with attenuated familial adenomatous polyposis.
Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis.
Guide to endoscopy of the ileo-anal pouch following restorative proctocolectomy with ileal pouch-anal anastomosis; indications, technique, and management of common findings.
Ileal pouch-anal anastomosis with mesorectal excision for rectal cancer complicating familial adenomatous polyposis.
Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules.
Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.
Increased epithelial cell proliferation in the ileal pouch mucosa of patients with familial adenomatous polyposis.
Increased expression of cytoplasmic HuR in familial adenomatous polyposis.
Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients.
Indications for local excision of ampullary lesions associated with familial adenomatous polyposis.
Induction Chemotherapy Using FAP for Patients with Stage II/III Squamous Cell Carcinoma of the Esophagus.
Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer.
Jejunal cancer in patients with familial adenomatous polyposis.
K-ras gene mutation in colorectal adenomas and carcinomas from familial adenomatous polyposis patients.
Localization of the genetic defect in familial adenomatous polyposis within a small region of chromosome 5.
Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery.
Long-term outcomes of metachronous neoplasms in the ileal pouch and rectum after surgical treatment in patients with familial adenomatous polyposis.
Loss of normal allele of the APC gene in an adrenocortical carcinoma from a patient with familial adenomatous polyposis.
Low colonic glutathione detoxification capacity in patients at risk for colon cancer.
Management of duodenal adenomatosis in FAP: single centre experience.
Microvascular structure of benign and malignant tumors of the colon in humans.
Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
Mucosectomy With Handsewn Anastomosis Reduces the Risk of Adenoma Formation in the Anorectal Segment After Restorative Proctocolectomy for Familial Adenomatous Polyposis.
Mutations of the PIK3CA gene in hereditary colorectal cancers.
Next-Generation Sequencing for Non-Ampullary Duodenal Carcinoma Suggesting the Existence of an Adenoma-Carcinoma Sequence.
No evidence for overexpression of the p53 protein and mutations in exons 4-9 of the p53 gene in a large family with adenomatous polyposis.
Nuclear localization of immunoreactive beta-catenin is specific to familial adenomatous polyposis in papillary thyroid carcinoma.
Pancreaticoduodenectomy for dysplastic duodenal adenoma in a patient with familial adenomatous polyposis.
Peptide Patterns as Discriminating Biomarkers in Plasma of Patients With Familial Adenomatous Polyposis.
Phase II trial of combination chemotherapy with fluorouracil (F), doxorubicin (A), and cisplatin (P) (Fap) in hormonally resistant metastatic prostatic adenocarcinoma.
Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.
Prevalence of Adenomas and Carcinomas in the Ileal Pouch After Proctocolectomy in Patients with Familial Adenomatous Polyposis.
Programmed cell death in colorectal carcinogenesis.
Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model.
Rectal and pouch recurrences after surgical treatment for familial adenomatous polyposis.
Recurrent pancreatitis caused by ampullary carcinoma and minor papilla adenoma in familial polyposis: report of a case.
Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations.
Risk of developing adenomas and carcinomas in the ileal pouch in patients with familial adenomatous polyposis.
Risk of ileal pouch neoplasms in patients with familial adenomatous polyposis.
Role of Alpha-Smooth Muscle Actin and Fibroblast Activation Protein Alpha in Ovarian Neoplasms.
Searching for mutations : familial adenomatous polyposis as a case study.
Severe colonic dysplasia in a child with familial adenomatous polyposis.
Severe dysplasia in children with familial adenomatous polyposis: rare or simply overlooked?
Silencing the intestinal GUCY2C tumor suppressor axis requires APC loss of heterozygosity.
Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients.
Somatic Mutations of the CDC4 (FBXW7) Gene in Hereditary Colorectal Tumors.
Species-crossreactive scFv against the tumor stroma marker "fibroblast activation protein" selected by phage display from an immunized FAP-/- knock-out mouse.
Spontaneous mutation in familial adenomatous polyposis.
Stromal factors involved in human prostate cancer development, progression and castration resistance.
Surgical options for familial adenomatous polyposis.
Surveillance and Treatment of Periampullary and Duodenal Adenomas in Familial Adenomatous Polyposis.
Telomerase activity and p53 gene mutation in familial polyposis coli.
The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history.
The clinical [corrected] background of familial adenomatous polyposis. History, epidemiology, diagnosis and treatment.
The diagnostic value of the foetoacinar pancreatic (FAP) protein in cancer of the pancreas; a comparative study with CA19/9.
The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients.
The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions.
Transduodenal resection of peri-ampullary lesions.
Tryptophan Metabolism as Source of New Prognostic Biomarkers for FAP Patients.
Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development.
Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms.
[A case of multiple advanced esophageal carcinomas with abdominal LN metastases showing complete response after chemoradiotherapy with concurrent cisplatin, 5-FU and adriamycin chemotherapy]
[A case of T4 esophageal squamous cell carcinoma in esophagogastric junction effectively treated by neoadjuvant FAP therapy]
[Construction of a eukaryotic expression vector of fibroblast activation protein and establishment of its stable over-expression in the oral squamous cell carcinoma].
[COX-2 associated loss of apoptosis activity in intestinal neoplams in Apc gene knock-out mice]
[Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register]
[Effects of cyclooxygenase-2 and proliferating cell nuclear antigen on the onset and development of familial adenomatous polyposis]
[Familial adenomatous polyposis coli in the Czech population. I. Detection of an additional 3 mutations out of a total of 7 in exon 15 of the APC gene]
[Microsatellite instability and relative gene expressions in sporadic and familial adenomatous polyposis adenomas]
[Neoadjuvant chemotherapy and concurrent radiochemotherapy for advanced esophageal carcinoma potentially invading adjacent structures]
[Pathogenesis and histomorphology of ampullary carcinomas and their precursor lesions. Review and individual findings]
[Rectal carcinoma in a patient with familial adenomatous polyposis coli after colectomy with ileorectal anastomosis and consecutive chemoprevention with sulindac suppositories]
[Regional growth preferences in hereditary, synchronous, and metachronous colorectal carcinomas. Basics of tumor surgery Part II]
[Use of molecular genetics in the early diagnosis of familial adenomatous polyposis]
Carcinoma in Situ
Indications for local excision of ampullary lesions associated with familial adenomatous polyposis.
Carcinoma, Hepatocellular
Biallelic inactivation of the APC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli.
Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules.
Improvising hepatic venous outflow and inferior vena cava reconstruction for combined heart and liver and sequential liver transplantations.
Single-centre experience of liver transplantation for familial amyloidotic polyneuropathy of non-Val30Met variants in Chinese patients.
The Expression of FAP in Hepatocellular Carcinoma Cells is Induced by Hypoxia and Correlates with Poor Clinical Outcomes.
Carcinoma, Neuroendocrine
Primary high-grade neuroendocrine carcinoma emerging from an adenomatous polyp in the setting of familial adenomatous polyposis.
Carcinoma, Ovarian Epithelial
Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines.
Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer.
Carcinoma, Papillary
Familial adenomatous polyposis (Gardner's syndrome) and thyroid carcinoma. A case report and review of the literature.
Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma.
Pancreatic islet cell tumour in a patient with familial adenomatous polyposis.
The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas.
[A Case of Metachronous Multiple Thyroid Papillary Carcinoma with FAP].
[A Case of Papillary Carcinoma of Thyroid Associated with Familial Adenomatous Polyposis in a Younger Woman].
Carcinoma, Renal Cell
Altered Tissue and Plasma Levels of Fibroblast Activation Protein-? (FAP) in Renal Tumours.
The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions.
Carcinoma, Squamous Cell
Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules.
Induction Chemotherapy Using FAP for Patients with Stage II/III Squamous Cell Carcinoma of the Esophagus.
Cardiomegaly
A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
Marked cardiomegaly in a patient with familial amyloidotic polyneuropathy after orthotopic liver transplantation: a case study.
Cardiomyopathies
99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy.
Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?
Potential treatment of transthyretin-type amyloidoses by sulfite.
Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type.
Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy.
Transthyretin mutation (TTRGly47Ala) associated with familial amyloid polyneuropathy in a French family.
[Sequential heart and liver transplantation for familial amyloid polyneuropathy].
Cardiomyopathy, Restrictive
Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy.
Carpal Tunnel Syndrome
[Indications for simultaneous origin of a German and American family with type II hereditary amyloid neuropathy]
Central Nervous System Diseases
Clinical features and diagnosis by recombinant DNA techniques of familial amyloid polyneuropathy in Japan.
Central Nervous System Neoplasms
CRIBRIFORM-MORULAR VARIANT OF THYROID CANCER - A RED FLAG FOR FAMILIAL ADENOMATOUS POLYPOSIS.
Cerebellar Ataxia
Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family--a follow-up autopsy report.
[Diagnosis by recombinant DNA techniques and clinical features of familial amyloid polyneuropathy]
Cerebral Amyloid Angiopathy
Familial amyloidotic polyneuropathy (ATTR Val30Met) with widespread cerebral amyloid angiopathy and lethal cerebral hemorrhage.
Cholangiocarcinoma
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment.
Cholangitis
Adenomas of the common bile duct in familial adenomatous polyposis.
Cholangitis, Sclerosing
Guide to endoscopy of the ileo-anal pouch following restorative proctocolectomy with ileal pouch-anal anastomosis; indications, technique, and management of common findings.
Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation.
Chondroblastoma
Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.
Chondrosarcoma
Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.
Ciliopathies
Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder.
Citrullinemia
[Recent advances of the treatment in metabolic disorders]
Colic
Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis.
[Ileo-anal anastomosis in familial adenomatous polyposis: procedure of choice?]
Colitis
An audit of quality of life and functional outcome following restorative proctocolectomy and ileoanal pouch surgery in familial polyposis coli.
Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir.
Female fertility after colorectal surgery for familial adenomatous polyposis: a nationwide cross-sectional study.
Functional outcome and quality of life after restorative proctocolectomy and ileal pouch-anal anastomosis.
Histological assessment of the distal 'doughnut' in patients undergoing stapled restorative proctocolectomy with high or low anal transection.
Outcome of 200 restorative proctocolectomy operations: the John Radcliffe Hospital experience.
[Differential indications for ileoanal pouch anastomosis : Ulcerative colitis, familial adenomatous polyposis, synchronous colorectal cancer - Crohn's disease, constipation].
[Ileal pouch anal-anastomosis without protective ileostomy]
Colitis, Ulcerative
Adenocarcinoma arising at ileostomy sites: Two cases and a review of the literature.
Closure of loop ileostomy after low anterior rectal resection and restorative proctocolectomy.
Coexisting carcinoid tumors in familial adenomatous polyposis-associated upper intestinal adenomas.
Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli.
Endoscopical and histological aspects of inflammatory changes in J-pouch mucosa.
Familial adenomatous polyposis: a case report and histologic mucin study.
Female fecundity before and after operation for familial adenomatous polyposis.
Functional outcome and quality of life after restorative proctocolectomy and ileal pouch-anal anastomosis.
Histological assessment of the distal 'doughnut' in patients undergoing stapled restorative proctocolectomy with high or low anal transection.
Inflammatory bowel disease and familial adenomatous polyposis.
NOD2 genetic variants predispose one of two familial adenomatous polyposis siblings to pouchitis through microbiome dysbiosis.
Omega-3 Polyunsaturated Fatty Acids and Their Bioactive Metabolites in Gastrointestinal Malignancies Related to Unresolved Inflammation. A Review.
Outcome of 200 restorative proctocolectomy operations: the John Radcliffe Hospital experience.
Pouch and pouchitis.
Pouchitis Is a Common Complication in Patients With Familial Adenomatous Polyposis Following Ileal Pouch-Anal Anastomosis.
Pouchitis: pathogenesis, diagnosis, and management.
Presentation, management and outcomes of ileoanal pouch cancer: a single-centre experience.
Restorative proctocolectomy - a nine year experience at the King Faisal specialist hospital.
Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited.
Restorative proctocolectomy with ileal pouch-anal anastomosis in 203 patients: the Auckland experience.
Review of our ileal pouch experience in the light of literature.
School Attendance in Children With Functional Abdominal Pain and Inflammatory Bowel Diseases.
Severity of complications following restorative proctocolectomy in children is related to staging not diagnosis.
Surgical considerations in FAP-related pouch surgery: Could we do better?
[Colorectal cancer before 45 years of age]
[Differential indications for ileoanal pouch anastomosis : Ulcerative colitis, familial adenomatous polyposis, synchronous colorectal cancer - Crohn's disease, constipation].
[Overexpression of B7-1 amd B7-2 by LFA-1 positive lymphocytes in chronic inflammatory bowel diseases]
[Pre- and postoperative quality of life of patients with ulcerative colitis and familial adenomatous polyposis with ileoanal pouch operation]
[Progress in oncological visceral surgery: colon carcinoma]
Colonic Diseases
Cribriform morular variant of papillary thyroid carcinoma: clinical and cytomorphological features on fine-needle aspiration.
Multiplex PCR analysis and genotype-phenotype correlations of frequent APC mutations.
The lectin Griffonia simplicifolia I-A4 (GS I-A4) specifically recognizes terminal alpha-linked N-acetylgalactosaminyl groups and is cytotoxic to the human colon cancer cell lines LS174t and SW1116.
Colonic Neoplasms
A case of carcinoma of the papilla of Vater in a young man after subtotal colectomy for familial adenomatous polyposis.
A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan.
A neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicity.
A population perspective on multistage carcinogenesis.
A potential life-saving diagnosis-recognizing Turcot syndrome.
Absence of stimulation of poly(ADP-ribose) polymerase activity in patients predisposed to colon cancer.
Biallelic APC Inactivation Was Responsible for Functional Adrenocortical Adenoma in Familial Adenomatous Polyposis with Novel Germline Mutation of the APC Gene: Report of a Case.
Broad phenotypic spectrum in familial adenomatous polyposis; from early onset and severe phenotypes to late onset of attenuated polyposis with the first manifestation at age 72.
Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients.
Celecoxib and tauro-ursodeoxycholic acid co-treatment inhibits cell growth in familial adenomatous polyposis derived LT97 colon adenoma cells.
Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature.
Chemoprevention of familial adenomatous polyposis by bromo-noscapine (EM011) in the Apc(Min/+) mouse model.
Clinical analysis of eight kindreds of familial adenomatous polyposis.
Clinical implications of fibroblast activation protein in patients with colon cancer.
Clinical outcomes of gastric polyps and neoplasms in patients with familial adenomatous polyposis.
Clinicopathological features of familial adenomatous polyposis in Korean patients.
Coexisting carcinoid tumors in familial adenomatous polyposis-associated upper intestinal adenomas.
Cohorts with familial disposition for colon cancers in chemoprevention trials.
Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion.
Early onset of dysplasia in polyps in children with familial adenomatous polyposis: case report and literature review.
Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP)
Genetic testing in hereditary colorectal cancer: indications and procedures.
HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis.
Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: Relationship with colonic metaplasia.
Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation.
Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype.
Lessons from the genetics of colon cancer.
Localization of the genetic defect in familial adenomatous polyposis within a small region of chromosome 5.
Molecular nature of chromosome 5q loss in colorectal tumors and desmoids from patients with familial adenomatous polyposis.
Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis.
Multiple colon polyposis.
Multistage carcinogenesis: population-based model for colon cancer.
NSAID use and decreased risk of gastrointestinal cancers.
Phenotypic variation in colorectal adenoma/cancer expression in two families. Hereditary flat adenoma syndrome.
Phenotypic variation in hereditary nonpolyposis colon cancer syndrome. Association with infiltrative fibromatosis (desmoid tumor).
Prednisolone therapy for intra-abdominal desmoid tumors in a patient with familial adenomatous polyposis.
Presymptomatic diagnosis of familial adenomatous polyposis coli.
Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer.
Progression to advanced neoplasia is infrequent in post colectomy familial adenomatous polyposis patients under endoscopic surveillance.
Protein-losing enteropathy in a patient with familial adenomatous polyposis and advanced colon cancer.
Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model.
Stem cell models for genetically predisposed colon cancer.
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.
The different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum.
The in vivo rate of somatic adenomatous polyposis coli mutation.
The lectin Griffonia simplicifolia I-A4 (GS I-A4) specifically recognizes terminal alpha-linked N-acetylgalactosaminyl groups and is cytotoxic to the human colon cancer cell lines LS174t and SW1116.
The link between colon cancer and congenital hypertrophy of the retinal pigment epithelium (CHRPE).
The molecular and genetic basis of colon cancer.
Three cases with familial adenomatous polyposis diagnosed as having malignant lesions in the course of a long-term trial using docosahexanoic acid (DHA)-concentrated fish oil capsules.
[Colorectal cancer before 45 years of age]
[Familiar adenomatous polyposis: report of 2 cases].
[Positional cloning of genes responsible for hereditary tumors]
[Proctocolectomy with ileoanal anastomosis: morbidity and functional results in patients with and without colorectal cancer]
Colorectal Neoplasms
A beta-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of beta-catenin germline mutations in FAP patients.
A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan.
A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer Survivors.
A new germline stop codon mutation in exon 15 of the APC gene predisposing to familial adenomatous polyposis.
A novel bioactive derivative of eicosapentaenoic acid (EPA) suppresses intestinal tumor development in Apc?14/+ mice.
A novel pathogenic single nucleotide germline deletion in APC gene in a four generation Chinese family with familial adenomatous polyposis.
A novel pathogenic splice acceptor site germline mutation in intron 14 of the APC gene in a Chinese family with familial adenomatous polyposis.
A Pilot Low-Inflammatory Dietary Intervention to Reduce Inflammation and Improve Quality of Life in Patients With Familial Adenomatous Polyposis: Protocol Description and Preliminary Results.
A Porcine Model of Familial Adenomatous Polyposis.
Age of onset in familial adenomatous polyposis: heterogeneity within families and among APC mutations.
Alteration of O6-methylguanine-DNA methyltransferase in colorectal neoplasms in sporadic and familial adenomatous polyposis patients.
Alternative treatments for prophylaxis of colorectal cancer in familial adenomatous polyposis.
Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
Analysis of Wnt/Beta catenin signalling in desmoid tumors.
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
APC mutation in the alternatively spliced region of exon 9 associated with late onset familial adenomatous polyposis.
APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC.
APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".
APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
Aspirin and familial adenomatous polyposis: coming full circle.
Assay for Detecting the I1307K Susceptibility Allele within the Adenomatous Polyposis ColiGene.
Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology.
Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.
c.1439delA frameshift deletion mutation in familial adenomatous polyposis.
Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families.
Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis.
Causes of death in familial adenomatous polyposis.
Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register.
Changing causes of mortality in patients with familial adenomatous polyposis.
Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
Chemoprevention of colorectal cancer.
Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
Chromosome 18 allele loss at the D18S6 locus in human colorectal carcinomas.
Chromosome 5 allele loss in human colorectal carcinomas.
Clinical analysis of eight kindreds of familial adenomatous polyposis.
Clinical characteristics and outcomes in familial adenomatous polyposis patients with a long-term treatment of celecoxib: a matched cohort study.
Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes.
Clinical features of familial adenomas polyps in Chinese and establishment of its immortal lymphocyte cell lines.
Clinical implications of fibroblast activation protein in patients with colon cancer.
COL11A1 in FAP polyps and in sporadic colorectal tumors.
Colorectal cancer cell intrinsic fibroblast activation protein alpha binds to Enolase1 and activates NF-?B pathway to promote metastasis.
Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion.
Colorectal cancer in familial adenomatous polyposis.
Colorectal cancer in two pre-teenage siblings with familial adenomatous polyposis.
Colorectal cancer surveillance behaviors among members of typical and attenuated FAP families.
Colorectal cancer with and without microsatellite instability involves different genes.
Colorectal malignancies in HIV-positive patients.
Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.
Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines.
Common colorectal cancer risk alleles contribute to the multiple colorectal adenoma phenotype, but do not influence colonic polyposis in FAP.
Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer.
Congenital hypertrophy of the retinal pigment epithelium and mandibular osteomata as markers in familial colorectal cancer.
Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients.
CpG island methylation in aberrant crypt foci of the colorectum.
Cytogenetic characterization of a colon adenocarcinoma from a familial polyposis coli patient.
Depressed-Type Colonic Lesions and "De Novo" Cancer in Familial Adenomatous Polyposis: A Colonoscopist's Viewpoint.
Desmoid Tumors in Familial Adenomatous Polyposis.
Detection of APC mutations by a yeast-based protein truncation test (YPTT).
Diagnostic delay, symptoms and stage of colorectal cancer.
Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: variations with phenotype.
Different familial adenomatous polyposis phenotypes resulting from deletions of the entire APC exon 15.
Different surgical strategies in the treatment of familial adenomatous polyposis: what's the role of the ileorectal anastomosis?
Differential gene expression profile reveals deregulation of pregnancy specific beta1 glycoprotein 9 early during colorectal carcinogenesis.
DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients.
Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis.
Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification.
Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls.
Education and management of patients with familial adenomatous polyposis. Are we making progress? A case report.
Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis.
Effects of carcinogenesis on colonic thymidine kinase activity in familial adenomatous polyposis.
Endoscopic management of duodenal adenomatosis in familial adenomatous polyposis-A case-based review.
Endoscopic management of familial adenomatous polyposis in patients refusing colectomy.
Endoscopic screening and surgery for familial adenomatous polyposis: dangerous delays.
Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival.
Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females.
ERbeta expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis.
Evaluation of endoscopic characteristics of upper gastrointestinal polyps in patients with familial adenomatous polyposis.
Expansion of a mutated clone: from stem cell to tumour.
Expression and Localization of Insulin Receptor Substrate 2 in Normal Intestine and Colorectal Tumors. Regulation by Intestine-specific Transcription Factor CDX2.
Extra-intestinal manifestations of familial adenomatous polyposis.
Factors affecting pouch-related outcomes after restorative proctocolectomy.
Familial adenomatous polyposis in China.
Familial adenomatous polyposis.
Familial adenomatous polyposis: a case report and review of the literature.
Familial adenomatous polyposis: a case study.
Familial adenomatous polyposis: case report and review of extracolonic manifestations.
Familial adenomatous polyposis: complex patient management.
Familial adenomatous polyposis: from bedside to bench and vice versa. A tribute to the somatic cell geneticist P. Meera Khan.
Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer.
Familial colorectal cancer and familial adenomatous polyposis.
FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression.
Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.
Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry.
From gene mutations to tumours--stem cells in gastrointestinal carcinogenesis.
Functional outcome after colectomy and ileorectal anastomosis compared with proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis.
Gardner's syndrome presenting with a fibromatous tumour of the parotid.
Gastrointestinal stem cells and cancer: bridging the molecular gap.
Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease.
Gene tests and counseling for colorectal cancer risk: lessons from familial polyposis.
Genetic changes at the beta-2-adrenergic receptor locus on chromosome 5 in human colorectal carcinomas.
Genetic linkage map of six polymorphic DNA markers around the gene for familial adenomatous polyposis on chromosome 5.
Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle.
Genetic screening for colorectal cancer and intervention.
Genetic testing in hereditary colorectal cancer: indications and procedures.
Genetics of hereditary colorectal cancer.
Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis.
Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis.
Germline APC mutation (Gln1317) in a cancer-prone family that does not result in familial adenomatous polyposis.
Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer.
Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: Clinical characteristics and rationale for surveillance screening.
Hereditary intestinal polyposis syndromes.
High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes.
High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis.
Ileal pouch-anal canal anastomosis for familial adenomatous polyposis: early and late results.
Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules.
Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.
Importance of sessile serrated lesions in a patient with familial adenomatous polyposis.
Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis.
Increased expression of cytoplasmic HuR in familial adenomatous polyposis.
Increased stem cell somatic mutation in the non-neoplastic colorectal mucosa of patients with familial adenomatous polyposis.
Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer.
Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level.
Is laparoscopic surgery an option to support prophylactic colectomy in adolescent patients with Familial Adenomatous Polyposis (FAP)?
K-ras gene mutation in colorectal adenomas and carcinomas from familial adenomatous polyposis patients.
Knowledge of the adenomatous polyposis coli gene and its clinical application.
Label-free global serum proteomic profiling reveals novel celecoxib-modulated proteins in familial adenomatous polyposis patients.
Laparoscopic colectomy and restorative proctocolectomy for familial adenomatous polyposis.
Large intron 14 rearrangement in APC results in splice defect and attenuated FAP.
Lectin staining of neoplastic and normal background colorectal mucosa in nonpolyposis and polyposis patients.
Long-term outcome of familial adenomatous polyposis patients after restorative coloproctectomy.
Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP.
Malignant familial adenomatous polyposis treated by laparoscopic colectomy and ileal pouch anal anastomosis: a case report.
Manic Fringe deficiency imposes Jagged1 addiction to intestinal tumor cells.
Map syndrome (MYH Associated Polyposis) colorectal cancer, etiopathological connections.
Mechanisms of APC-driven tumorigenesis: lessons from mouse models.
miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Modulation by dietary factors in murine FAP models.
Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas.
Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition.
Molecular nature of chromosome 5q loss in colorectal tumors and desmoids from patients with familial adenomatous polyposis.
Molecular, cytogenetic, and phenotypic studies of a constitutional reciprocal translocation t(5;10)(q22;q25) responsible for familial adenomatous polyposis in a Dutch pedigree.
Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene.
Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription.
Mutation analysis of the APC gene in Taiwanese FAP families: low incidence of APC germline mutation in a distinct subgroup of FAP families.
Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.
Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.
Mutations of the APC (adenomatous polyposis coli) gene in FAP (familial polyposis coli) patients and in sporadic colorectal tumors.
MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer.
MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.
Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9.
Novel APC mutations in Czech and Slovak FAP families: clinical and genetic aspects.
Novel Missense Mutation at Codon 2774 (C.8321 G>A) p.S2774N of APC Gene in a Denovo Case of Familial Adenomatous Polyposis.
Oestrogen receptor beta isoform expression in sporadic colorectal cancer, familial adenomatous polyposis and progressive stages of colorectal cancer.
Outcome of familial adenomatous polyposis: a retrospective study.
Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
Overview of screening and management of familial adenomatous polyposis.
Parental Attitudes, Beliefs, and Perceptions about Genetic Testing for FAP and Colorectal Cancer Surveillance in Minors.
Peptide Patterns as Discriminating Biomarkers in Plasma of Patients With Familial Adenomatous Polyposis.
Phase II Trial of Single Agent Val-boroPro (Talabostat) Inhibiting Fibroblast Activation Protein in Patients with Metastatic Colorectal Cancer.
Possible involvement of hyperlipidemia in increasing risk of colorectal tumor development in human familial adenomatous polyposis.
Predictive cytogenetic biomarkers for colorectal neoplasia in medium risk patients.
Predictive values of FAP and HGF for tumor angiogenesis and metastasis in colorectal cancer.
Preliminary results of the molecular diagnosis of familial adenomatous polyposis in Cuban families.
Prevention of colorectal cancer in high-risk populations: the increasing role for endoscopy and chemoprevention in FAP and HNPCC.
Primary high-grade neuroendocrine carcinoma emerging from an adenomatous polyp in the setting of familial adenomatous polyposis.
Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis.
Quality of life after prophylactic colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis.
Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test.
Rapid Rectal Polyposis Development in a Patient With Familial Adenomatous Polyposis.
Rectal eversion and double-stapled ileal pouch anal anastomosis in familial adenomatous polyposis syndrome.
Results after restorative proctocolectomy and ileal pouch-anal anastomosis in patients with familial adenomatous polyposis and coexisting colorectal cancer.
Results of national registration of familial adenomatous polyposis.
Revolutionary advances in the diagnosis and treatment of familial adenomatous polyposis.
Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis.
Screening practice for familial adenomatous polyposis: the potential for regional registers.
Segmental resection with primary anastomosis is not always safe in splenic flexure perforation.
Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
Smad3 Deficiency Promotes Tumorigenesis in the Distal Colon of ApcMin/+ Mice.
Soluble E-cadherin as a serum biomarker candidate: Elevated levels in patients with late-stage colorectal carcinoma and FAP.
Somatic Mutations of the CDC4 (FBXW7) Gene in Hereditary Colorectal Tumors.
Sulindac and polyp regression.
Surgical Interventions, Malignancies, and Causes of Death in a FAP Patient Registry.
Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis.
Surveillance recommendations for patients with Lynch syndrome and FAP : a monocentric study.
Survival of familial adenomatous polyposis coexistence colorectal cancer in Iran.
Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer.
Synchronous primary carcinomas of the ampulla of Vater and ascending colon in a patient with multiple flat adenomas.
Systemic considerations with pigmented fundus lesions and retinal pigment epithelium hamartomas in Turcot syndrome.
The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history.
The clinical [corrected] background of familial adenomatous polyposis. History, epidemiology, diagnosis and treatment.
The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients.
The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management.
The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP).
The genomics of colorectal cancer: state of the art.
The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register.
The link between colon cancer and congenital hypertrophy of the retinal pigment epithelium (CHRPE).
The Prevalence of Thyroid Cancer and Benign Thyroid Disease in Patients With Familial Adenomatous Polyposis May Be Higher Than Previously Recognized.
The Singapore Polyposis Registry.
The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase.
Thymidine kinase activity in familial adenomatous polyposis.
Transition state analogue of MTAP extends lifespan of APCMin/+ mice.
Use of the lectin from Amaranthus caudatus as a histochemical probe of proliferating colonic epithelial cells.
Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene.
Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours.
Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutation.
[A Case of Papillary Carcinoma of Thyroid Associated with Familial Adenomatous Polyposis in a Younger Woman].
[Complex screening of family members at risk for familial adenomatous polyposis]
[Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register]
[Desmoid tumors in patients with familial adenomatous polyposis]
[Detection of germline mutations in the APC gene with the protein truncation test]
[Expression and clinical significance of fibroblast activation protein in colorectal carcinoma tissue].
[Familial adenomatous polyposis: what is new for the clinician?]
[Familial polyposis coli]
[Gardner fibroma: case report and discussion of a new soft tissue tumor entity]
[Genetics of colorectal cancer. I. Non-polyposis and polyposis forms of hereditary colorectal cancer]
[Hereditary colorectal cancer]
[Indications for restorative proctocolectomy in systemic colorectal diseases (ulcerative colitis and familial adenomatous polyposis coli)]
[Mutation of APC gene in sporadic colorectal tumors]
[Overexpression of B7-1 amd B7-2 by LFA-1 positive lymphocytes in chronic inflammatory bowel diseases]
[Positional cloning of genes responsible for hereditary tumors]
[Proctocolectomy with ileoanal anastomosis: morbidity and functional results in patients with and without colorectal cancer]
[Prognosis in familial adenomatous polyposis. Results from the Polyposis Registry]
[Recent trends in studies on carcinogenesis in familial adenomatous polyposis]
[Strategy for surgery in familial adenomatous polyposis patients with invasive colorectal cancer].
[Treatment of familial adenomatous polyposis and family screening.]
[Two cases of multiple adenomas in the ileal pouch after total proctocolectomy in patients with familial adenomatous polyposis]
Colorectal Neoplasms, Hereditary Nonpolyposis
Chemoprevention of colorectal cancer.
Colon Crypts of Subjects With Familial Adenomatous Polyposis Show an Increased Number of LGR5+ Ectopic Stem Cells.
Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients.
Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification.
Gastrointestinal tract cancers: Genetics, heritability and germ line mutations.
Gender-Specific Aspects of Lynch Syndrome and Familial Adenomatous Polyposis.
Genetics of hereditary colorectal cancer.
Health behaviors in patients and families with hereditary colorectal cancer.
Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome.
Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management.
Increased stem cell somatic mutation in the non-neoplastic colorectal mucosa of patients with familial adenomatous polyposis.
Lower fecal pH may be a novel indicator of pouchitis after IPAA in patients with FAP or metachronous Lynch syndrome.
Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis.
MYH polyposis syndrome: clinical findings, genetics issues and management.
Phenotypic variation in hereditary nonpolyposis colon cancer syndrome. Association with infiltrative fibromatosis (desmoid tumor).
Quality of life after prophylactic colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis.
Role of surgery in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer (Lynch syndrome).
Small bowel endoscopy in familial adenomatous polyposis and Lynch syndrome.
Surveillance recommendations for patients with Lynch syndrome and FAP : a monocentric study.
Synchronous primary carcinomas of the ampulla of Vater and ascending colon in a patient with multiple flat adenomas.
The evolution of colorectal cancer genetics-Part 2: clinical implications and applications.
The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells.
Use of the lectin from Amaranthus caudatus as a histochemical probe of proliferating colonic epithelial cells.
Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutation.
[A Case of Colon Cancer with Familial Adenomatous Polyposis Showing MSI-H and Deletion of MSH2/MSH6 Protein].
[Hereditary colorectal cancer]
Congenital Abnormalities
Accuracy and Safety of Distal Femoral Valgus Correction: A Comparison of Three Techniques.
Rare case of intraintestinal stromal tumors in the patient with familial adenomatous polyposis.
Connective Tissue Diseases
Non-invasive monitoring of finger arterial pressure in patients with Raynaud's phenomenon: effects of exposure to cold.
Corneal Dystrophies, Hereditary
Amyloidosis and Ocular Involvement: an Overview.
[Familial amyloid neuropathies]
Corneal Neovascularization
Expression of MMP, HPSE, and FAP in stroma promoted corneal neovascularization induced by different etiological factors.
Coronary Disease
Outcome of exercise electrocardiography in familial amyloidotic polyneuropathy patients, Portuguese type, under evaluation for liver transplantation.
Cough
Familial amyloid polyneuropathy with chronic paroxysmal dry cough in Mainland China: A Chinese family with a proven heterozygous missense mutation c.349G>T in the transthyretin gene.
COVID-19
Prevention schemes for future fresh agricultural products (FAPs) supply chain: mathematical model and experience of guaranteeing the supply of FAPs during the COVID-19 pandemic.
Cranial Nerve Diseases
[Familial amyloid neuropathies]
[Familial amyloid polyneuropathy type IV (Finnish type)--a clinicopathological study]
[Variable clinical manifestations of familial amyloid polyneuropathy and living related liver transplantation]
Craniopharyngioma
Isolated, giant cerebellopontine angle craniopharyngioma in a patient with Gardner syndrome: case report.
Pediatric craniopharyngioma in association with familial adenomatous polyposis.
Primary cerebellopontine angle craniopharyngioma in a patient with gardner syndrome. Case report and review of the literature.
Crohn Disease
Celiac disease and other precursors to small-bowel malignancy.
Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention.
Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: Relationship with colonic metaplasia.
Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity.
Increased stem cell somatic mutation in the non-neoplastic colorectal mucosa of patients with familial adenomatous polyposis.
Laparoscopic double-tract reconstruction after total gastrectomy for postoperative duodenal surveillance: Case series.
Presentation, management and outcomes of ileoanal pouch cancer: a single-centre experience.
School Attendance in Children With Functional Abdominal Pain and Inflammatory Bowel Diseases.
Surgical load and long-term outcome for patients with Kock continent ileostomy.
The association between Crohn's disease and desmoid tumors: a novel case and review of the literature.
[Overexpression of B7-1 amd B7-2 by LFA-1 positive lymphocytes in chronic inflammatory bowel diseases]
Cystadenoma, Mucinous
A mucinous cystadenoma in rectal cuff of a patient with familial adenomatous polyposis.
Cysts
Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion.
Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts.
Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder.
Multiple oral radiopaque masses leading to Gardner's syndrome diagnosis.
Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis.
The Prevalence of Thyroid Cancer and Benign Thyroid Disease in Patients With Familial Adenomatous Polyposis May Be Higher Than Previously Recognized.
Dentigerous Cyst
Familial adenomatous polyposis.
Dermatitis, Atopic
Relationship between facilitated allergen presentation and the presence of allergen-specific IgE in serum of atopic patients.
Dermoid Cyst
[Familiar adenomatous polyposis: report of 2 cases].
Diabetes Mellitus
Epidemiology and risk factors of pancreatic cancer.
Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma.
Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis.
Diabetes Mellitus, Type 1
Differing haemodynamic and catecholamine responses to exercise in three groups with peripheralautonomic dysfunction: insulin-dependent diabetes mellitus, familial amyloid polyneuropathy and pure autonomic failure.
Diabetes Mellitus, Type 2
Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21.
Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma.
Dry Eye Syndromes
Ocular Manifestations and Therapeutic Options in Patients with Familial Amyloid Polyneuropathy: A Systematic Review.
Topical cyclosporine for severe dry eye disease in liver-transplanted Portuguese patients with familial amyloidotic polyneuropathy (ATTRV30M).
Duodenal Diseases
Prospective enteroscopic evaluation of jejunal polyposis in patients with familial adenomatous polyposis and advanced duodenal polyposis.
The utility of capsule endoscopy small bowel surveillance in patients with polyposis.
Duodenal Neoplasms
A Support Vector Machine Model Predicting the Risk of Duodenal Cancer in Patients with Familial Adenomatous Polyposis at the Transcript Levels.
Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management.
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis?
Cell proliferation of the duodenal mucosa in patients affected by familial adenomatous polyposis.
Characteristics and Clinical Outcomes of Duodenal Neoplasia in Japanese Patients With Familial Adenomatous Polyposis.
Depressed adenoma of the duodenum in patients with familial adenomatous polyposis: endoscopic and immunohistochemical features.
Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register.
Duodenal cancer arising from the remaining duodenum after pylorus-preserving pancreatoduodenectomy for ampullary cancer in familial adenomatous polyposis.
Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls.
Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis.
Dye chromoendoscopy leads to a higher adenoma detection in the duodenum and stomach in patients with familial adenomatous polyposis.
Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee).
Familial adenomatous polyposis at the Tel Aviv Medical Center: demographic and clinical features.
Features of Duodenal Cancer in Patients With Familial Adenomatous Polyposis.
Frequency and Features of Duodenal Adenomas in Patients With MUTYH-Associated Polyposis.
Gene Expression Changes Accompanying the Duodenal Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis.
Isoperistaltic Jejunal Loop Interposition after Total Gastrectomy for Gastric Cancer in Patients with Familial Adenomatous Polyposis.
Malignant change in a duodenal adenoma in familial adenomatous polyposis: report of a case.
Mutagenicity of bile and duodenal adenomas in familial adenomatous polyposis.
Prevalence of gastric and duodenal polyps and risk factors for duodenal neoplasm in korean patients with familial adenomatous polyposis.
Spigelman stage IV duodenal polyposis does not precede most duodenal cancer cases in patients with familial adenomatous polyposis.
Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: A nationwide retrospective cohort study.
Surgical management of familial adenomatous polyposis: pancreas-sparing duodenectomy or pancreaticoduodenectomy (Whipple procedure).
Surveillance and Treatment of Periampullary and Duodenal Adenomas in Familial Adenomatous Polyposis.
Surveillance of duodenal polyps in familial adenomatous polyposis: progress report.
Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer.
The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.
Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis.
Duodenogastric Reflux
Duodeno-gastric reflux and gastric adenomas: a scintigraphic study in patients with familial adenomatous polyposis.
Familial adenomatous polyposis predisposes to pathologic exposure of the stomach to bilirubin.
Dyspnea
[Myocardiopathy caused by Portuguese-type familial amyloidotic polyneuropathy. Sequential morphologic and functional study of 60 patients]
Ectodermal Dysplasia
A novel AXIN2 germline variant associated with attenuated FAP without signs of oligondontia or ectodermal dysplasia.
Eczema
Relationship between facilitated allergen presentation and the presence of allergen-specific IgE in serum of atopic patients.
Endemic Diseases
Recent advances in transthyretin amyloidosis therapy.
[Newly developed drug therapies for familial amyloid polyneuropathy: diflunisal and tafamidis].
Endometrial Neoplasms
Three cases with familial adenomatous polyposis diagnosed as having malignant lesions in the course of a long-term trial using docosahexanoic acid (DHA)-concentrated fish oil capsules.
Eosinophilia
IL-33, IL-25 and TSLP contribute to development of fungal-associated protease-induced innate-type airway inflammation.
Epidermal Cyst
A case report of desmoid tumour-a forgotten aspect of FAP?
A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis.
Assay for Detecting the I1307K Susceptibility Allele within the Adenomatous Polyposis ColiGene.
Association of extracolonic manifestations of familial adenomatous polyposis with acetylation phenotype in a large FAP kindred.
Familial adenomatous polyposis (FAP): Genotype correlation to FAP phenotype with osteomas and sebaceous cysts.
Familial adenomatous polyposis.
Familial adenomatous polyposis: not all masses are desmoids.
Familial polyposis coli: clinical manifestations, evaluation, management and treatment.
Mucoepidermoid carcinoma: A yet unreported cancer associated with familial adenomatous polyposis.
Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene.
Epilepsies, Partial
Resting-state EEG theta activity reflects degree of genetic determination of the major epilepsy syndromes.
Epilepsy
Resting-state EEG theta activity reflects degree of genetic determination of the major epilepsy syndromes.
Epilepsy, Generalized
Resting-state EEG theta activity reflects degree of genetic determination of the major epilepsy syndromes.
Erectile Dysfunction
[Autonomic dysfunction in FAP: its therapeutic effect by liver transplantation]
Esophageal Neoplasms
FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.
Neoadjuvant chemotherapy (FAP) for advanced esophageal cancer.
[A case of advanced esophageal cancer with large liver metastasis successfully treated with FAP therapy]
[Preoperative neoadjuvant chemotherapy with a combination of 5-fluorouracil, adriamycin and cisplatin (FAP) for advanced esophageal cancer invading trachea or main bronchus]
Esophageal Squamous Cell Carcinoma
[A case of T4 esophageal squamous cell carcinoma in esophagogastric junction effectively treated by neoadjuvant FAP therapy]
Fasciitis
A subset of cranial fasciitis is associated with dysregulation of the Wnt/beta-catenin pathway.
Fatty Liver
Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21.
[The evaluation value of transient elastography for liver characteristics in obese children].
Fecal Incontinence
Long-term clinical outcomes and follow-up status in Japanese patients with familial adenomatous polyposis after radical surgery: a descriptive, retrospective cohort study from a single institute.
fibroblast activation protein alpha subunit deficiency
Deletion of fibroblast activation protein provides atheroprotection.
Expression of the fibroblast activation protein during mouse embryo development.
Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma.
Fibroma
A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses.
Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion.
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis.
Bilateral breast fibromatosis after silicone prosthetics in a patient with classic familial adenomatous polyposis: A case report.
Familial adenomatous polyposis.
Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation.
Gardner syndrome with a giant mass in the thoracic cavity: a case report and analysis of the related complications.
Gardner's syndrome in a 75-year-old woman.
Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.
Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis.
Identification of previously unrecognized FAP in children with Gardner fibroma.
Mucoepidermoid carcinoma: A yet unreported cancer associated with familial adenomatous polyposis.
Multiple oral radiopaque masses leading to Gardner's syndrome diagnosis.
Neonatal Gardner fibroma: a sentinel presentation of severe familial adenomatous polyposis.
Prolactinoma as the first manifestation of Gardner's syndrome.
Yield of Colonoscopy in Identification of Newly Diagnosed Desmoid-Type Fibromatosis with Underlying Familial Adenomatous Polyposis.
[Desmoid tumour as indication of familial adenomatous polyposis.]
[Desmoid tumour as indication of familial adenomatous polyposis].
[Gardner fibroma: case report and discussion of a new soft tissue tumor entity]
Fibromatosis, Abdominal
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis.
Fibromatosis, Aggressive
3' Mutation of the APC gene and family history of FAP in a patient with apparently sporadic desmoid tumors.
A case of myoepithelial carcinoma displaying biallelic inactivation of the tumour suppressor gene APC in a patient with familial adenomatous polyposis.
A case report of desmoid tumour-a forgotten aspect of FAP?
A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor.
A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses.
A novel large deletion in the APC gene associated with Gardner syndrome in a Chinese family.
A Patient With Desmoid Tumors and Familial FAP Having Frame Shift Mutation of the APC Gene.
Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion.
Abdominal Desmoid: Course, Severe Outcomes, and Unique Genetic Background in a Large Local Series.
Aggressive mutation in a familial adenomatous polyposis syndrome family: when phenotype guides clinical surveillance.
Analysis of Wnt/Beta catenin signalling in desmoid tumors.
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis.
APC mutations in FAP-associated desmoid tumours are non-random but not 'just right'.
Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts.
Assay for Detecting the I1307K Susceptibility Allele within the Adenomatous Polyposis ColiGene.
Association of extracolonic manifestations of familial adenomatous polyposis with acetylation phenotype in a large FAP kindred.
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis?
Carbon ion radiotherapy for desmoid tumor of the abdominal wall: a case report.
Characterization of two novel adenomatous polyposis coli (APC) gene mutations in patients with familial adenomatous polyposis (FAP).
Chromosome changes in desmoid tumors developed in patients with familial adenomatous polyposis.
Clinically Inapparent Adrenal Mass in a Patient with Familial Adenomatous Polyposis.
Colonic adenomatous polyposis syndromes: clinical management.
Comparison of sporadic and FAP-associated desmoid-type fibromatoses.
Cortisol producing adrenal adenoma--a new manifestation of Gardner's syndrome.
Cranial desmoid tumor associated with homozygous inactivation of the adenomatous polyposis coli gene in a 2-year-old girl with familial adenomatous polyposis.
Cribiform variant of papillary thyroid cancer and familial adenomatous polyposis.
CT appearances of desmoid tumours in familial adenomatous polyposis: further observations.
CTNNB1 Genotyping and APC Screening in Pediatric Desmoid Tumors: A Proposed Alogrithm.
Current ideas in desmoid tumours.
Dacarbazine-Doxorubicin therapy ameliorated an extremely aggressive mesenteric desmoid tumor associated with familial adenomatous polyposis: report of a case.
Desmoid Tumor as an Initial Presentation of Familial Adenomatous Polyposis: A Review of the Literature.
Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis.
Desmoid tumors -- a characterization of patients seen at Mayo Clinic 1976-1999.
Desmoid Tumors Characteristics, Clinical Management, Active Surveillance, and Description of Our FAP Case Series.
Desmoid tumors complicating Familial Adenomatous Polyposis: a meta-analysis mutation spectrum of affected individuals.
Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis.
Desmoid Tumors in Familial Adenomatous Polyposis.
Desmoid tumors in patients with familial adenomatous polyposis.
Desmoid Tumors of the Bilateral Breasts in a Patient Without Gardner Syndrome: A Case Report and Review of the Literature.
Desmoid tumour biology in patients with familial adenomatous polyposis coli.
Desmoid tumour in familial adenomatous polyposis patients: responses to treatments.
Desmoid tumours complicating familial adenomatous polyposis.
Desmoid tumours in familial adenomatous polyposis.
Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations.
Desmoids in familial adenomatous polyposis are monoclonal proliferations.
Desmoids in familial adenomatous polyposis.
Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: variations with phenotype.
Diffusion tensor imaging (DTI) of desmoid tumours in familial adenomatous polyposis: Initial experience.
Disorders of the rectus abdominis muscle and sheath: a 22-year experience.
Does early colectomy increase desmoid risk in familial adenomatous polyposis?
Does ileoanal pouch surgery increase the risk of desmoid in patients with familial adenomatous polyposis?
Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register.
Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation.
Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity.
Extracolonic manifestations of familial adenomatous polyposis: desmoid tumours, and upper gastrointestinal adenomas and carcinomas.
Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.
Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.
Familial adenomatous polyposis.
Familial adenomatous polyposis: a case report and review of the literature.
Familial adenomatous polyposis: case report and review of extracolonic manifestations.
Familial adenomatous polyposis: not all masses are desmoids.
Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation.
Familial polyposis coli: clinical manifestations, evaluation, management and treatment.
Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas.
Gardner syndrome with giant abdominal desmoid tumor during pregnancy: a case report.
Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder.
Gastric polyposis and desmoid tumours as a new familial adenomatous polyposis clinical variant associated with APC mutation at the extreme 3'-end.
Gender-Specific Aspects of Lynch Syndrome and Familial Adenomatous Polyposis.
Gene expression in aggressive fibromatosis.
Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease.
Genetic Counselor Practices Involving Pediatric Patients with FAP: an Investigation of their Self-Reported Strategies for Genetic Testing and Hepatoblastoma Screening.
Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis.
Gradually shrinking intra-abdominal desmoid tumor derived from the stomach in a young boy: a case report.
Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene.
High cumulative risk of colorectal cancers and desmoid tumours and fibromatosis in South Asian APC mutation carriers.
Highly aggressive thoracic desmoid tumors in adolescent siblings with fatal outcomes in an FAP kindred: a need for increased vigilance and intervention in at-risk AYAs.
Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.
Identification a nonsense mutation of APC gene in Chinese patients with familial adenomatous polyposis.
Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis.
Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours.
Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence.
Imaging assessment of desmoid tumours in familial adenomatous polyposis: is state-of-the-art 1.5 T MRI better than 64-MDCT?
In the beginning there was colectomy: current surgical options in familial adenomatous polyposis.
Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis.
Ki-67 expression and residual tumour (R) classification are associated with disease-free survival in desmoid tumour patients.
Lack of telomerase in desmoids occurring sporadically and in association with familial adenomatous polyposis.
Long-term outcome of familial adenomatous polyposis patients after restorative coloproctectomy.
Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.
Loss of normal allele of the APC gene in an adrenocortical carcinoma from a patient with familial adenomatous polyposis.
Management of mesenteric desmoid tumours in familial adenomatous polyposis.
Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors.
Modification of growth of desmoid tumours in tissue culture by anti-oestrogenic substances: a preliminary report.
Molecular nature of chromosome 5q loss in colorectal tumors and desmoids from patients with familial adenomatous polyposis.
Mucoepidermoid carcinoma: A yet unreported cancer associated with familial adenomatous polyposis.
Multiple desmoid tumors in a patient with familial adenomatous polyposis caused by the novel W421X mutation.
Mutation spectrum of the APC gene in 83 Korean FAP families.
Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours.
Novel germline APC mutations in Swedish patients with familial adenomatous polyposis and Gardner syndrome.
Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment.
Pancreas- and Pylorus-Preserving Duodenectomy for Advanced Familial Duodenal Polyposis.
Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis.
Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis.
Prednisolone therapy for intra-abdominal desmoid tumors in a patient with familial adenomatous polyposis.
Prolactinoma as the first manifestation of Gardner's syndrome.
Radiotherapy in the treatment of aggressive fibromatosis: experience from a single institution.
Recurrent giant cranial desmoid tumor in a 3-year-old boy with familial adenomatous polyposis requiring bifrontoparietal cranioplasty: case report.
Risk factors predicting intra-abdominal desmoids in familial adenomatous polyposis: a single centre experience.
Risk of desmoid formation after laparoscopic versus open colectomy and ileorectal anastomosis for familial adenomatous polyposis.
Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene.
Short bowel syndrome after continence-preserving procedures.
Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis.
Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review.
Surgical considerations in FAP-related pouch surgery: Could we do better?
Surveillance and Treatment of Periampullary and Duodenal Adenomas in Familial Adenomatous Polyposis.
Systemic cytotoxic chemotherapy and radiation therapy for desmoid in familial adenomatous polyposis.
TALEN-mediated apc mutation in Xenopus tropicalis phenocopies familial adenomatous polyposis.
The association between Crohn's disease and desmoid tumors: a novel case and review of the literature.
The clinical course of intra-abdominal desmoid tumours in patients with familial adenomatous polyposis.
The clinical [corrected] background of familial adenomatous polyposis. History, epidemiology, diagnosis and treatment.
The enigma of desmoid tumors.
The management of desmoids in patients with familial adenomatous polyposis (FAP).
The Somatic Mutation Hit on Top of Genetic APC mutations Cause Skin Tumor.
The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis.
Yield of Colonoscopy in Identification of Newly Diagnosed Desmoid-Type Fibromatosis with Underlying Familial Adenomatous Polyposis.
[A Case in Which a Patient Was Operated for Intra-Abdominal Desmoid Tumors after Total Colectomy in FAP].
[A case of familial adenomatous polyposis presenting with thyroid cancer].
[Aggressive fibromatosis: clinical aspects].
[Agressive fibromatosis: genetic and biological correlations].
[Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register]
[Desmoid tumors in patients with familial adenomatous polyposis]
[Desmoid tumors in three patients]
[Desmoid tumour as indication of familial adenomatous polyposis.]
[Desmoid tumour as indication of familial adenomatous polyposis].
[Familial adenomatous polyposis. Problems encountered with rectum preservation in surgical treatment and life expectancy]
[Familial adenomatous polyposis: what is new for the clinician?]
[Familiar adenomatous polyposis: report of 2 cases].
[Gardner fibroma: case report and discussion of a new soft tissue tumor entity]
[Retroperitoneal desmoid tumor with kidney failure in familial adenomatous polyposis]
[The desmoid problem]
Fibrosarcoma
Bispecific single-chain diabody-immunoliposomes targeting endoglin (CD105) and fibroblast activation protein (FAP) simultaneously.
Dataset on FAP-induced emergence of spontaneous metastases and on the preparation of activatable FAP-targeting immunoliposomes to detect the metastases.
Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways.
Integral membrane protease fibroblast activation protein sensitizes fibrosarcoma to chemotherapy and alters cell death mechanisms.
Food Hypersensitivity
Parental perception of their child's quality of life in children with non-immunoglobulin-E-mediated gastrointestinal allergies.
Gallbladder Neoplasms
[A case of successful treatment with combined 5-fluorouracil, adriamycin, cisplatin (FAP) therapy followed by Gemcitabine, UFT therapy and intra-arterial FAP therapy for unresectable advanced gallbladder cancer]
Ganglion Cysts
Focus on autonomic dysfunction in familial amyloidotic polyneuropathy (FAP).
Ganglioneuroma
Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.
Gardner Syndrome
A case report of desmoid tumour-a forgotten aspect of FAP?
A novel large deletion in the APC gene associated with Gardner syndrome in a Chinese family.
A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion.
Adenomas of the common bile duct in familial adenomatous polyposis.
Association of extracolonic manifestations of familial adenomatous polyposis with acetylation phenotype in a large FAP kindred.
Cortisol producing adrenal adenoma--a new manifestation of Gardner's syndrome.
Desmoid Tumors of the Bilateral Breasts in a Patient Without Gardner Syndrome: A Case Report and Review of the Literature.
Early detection of nonpolypoid cancers in the rectal remnant in patients with familial adenomatous polyposis/Gardner's syndrome.
Familial adenomatous polyposis (FAP): Genotype correlation to FAP phenotype with osteomas and sebaceous cysts.
Familial adenomatous polyposis and benign intracranial tumors: a new variant of Gardner's syndrome.
Familial adenomatous polyposis.
Familial polyposis coli: clinical manifestations, evaluation, management and treatment.
Gardner syndrome: skin manifestations, differential diagnosis and management.
Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder.
Gardner's syndrome in a 75-year-old woman.
Gardner-associated fibroma of the neck: role of a multidisciplinary evaluation for familial adenomatous polyposis diagnosis.
Genetic testing for familial adenomatous polyposis.
Hyperpigmented lesions of the retinal pigment epithelium in familial adenomatous polyposis.
Mucoepidermoid carcinoma: A yet unreported cancer associated with familial adenomatous polyposis.
Multidisciplinary treatment of desmoid tumours in Gardner's syndrome due to a large interstitial deletion of chromosome 5q.
Novel germline APC mutations in Swedish patients with familial adenomatous polyposis and Gardner syndrome.
Ocular manifestations of familial adenomatous polyposis (Gardner syndrome).
Oral and maxillofacial manifestations of familial adenomatous polyposis.
Polyposis coli, craniofacial exostosis and astrocytoma: the concomitant occurrence of the Gardner's and Turcot syndromes.
Rare case of intraintestinal stromal tumors in the patient with familial adenomatous polyposis.
Revolutionary advances in the diagnosis and treatment of familial adenomatous polyposis.
Risk of cancer development in the rectal remnant of patients with familial adenomatous polyposis/Gardner's syndrome.
Self-surveillance for genetic predisposition to cancer: behaviors and emotions.
Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene.
Systemic considerations with pigmented fundus lesions and retinal pigment epithelium hamartomas in Turcot syndrome.
[A case of Gardner's syndrome associated with thyroid carcinoma]
[Clinical features and current progress of familial adenomatous polyposis]
[Clinicopathologic and molecular features of cribriform morular variant of papillary thyroid carcinoma].
[Familial nonmedullary thyroid cancer]
[Familiar adenomatous polyposis: report of 2 cases].
[Hereditary thyroid cancer]
[Molecular biological background of FAP and HNPCC, and treatment strategies of both diseases depend upon genetic information]
Gastritis
[Electrogastrography in children with functional abdominal pain and gastritis]
Gastritis, Atrophic
Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis.
Gastroesophageal Reflux
Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review.
Quality of life for children with functional abdominal pain: a comparison study of patients' and parents' perceptions.
Gastrointestinal Diseases
Clinical outcomes of gastric polyps and neoplasms in patients with familial adenomatous polyposis.
Functional abdominal pain in childhood and adolescence increases risk for chronic pain in adulthood.
Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review.
Pregnancy does not influence colonic polyp multiplicity but may modulate upper gastrointestinal disease in patients with FAP.
Gastrointestinal Hemorrhage
Ex vivo resection and intestinal autotransplantation for a large mesenteric desmoid tumor secondary to familial adenomatous polyposis: A case report and literature review.
Symptomatic familial adenomatous polyposis in an adolescent: A case report.
[Familiar adenomatous polyposis: report of 2 cases].
Gastrointestinal Neoplasms
Changing causes of mortality in patients with familial adenomatous polyposis.
Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma.
Guidelines for the clinical management of familial adenomatous polyposis (FAP).
Outcomes and complications of radiation therapy in patients with familial adenomatous polyposis.
Preventative strategies for periampullary tumours in FAP.
Surgical Interventions, Malignancies, and Causes of Death in a FAP Patient Registry.
Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis.
Upper gastrointestinal polyps in familial adenomatous polyposis.
[Familial adenomatous polyposis. Problems encountered with rectum preservation in surgical treatment and life expectancy]
Gastrointestinal Stromal Tumors
Rare case of intraintestinal stromal tumors in the patient with familial adenomatous polyposis.
Genetic Diseases, Inborn
A novel large deletion in the APC gene associated with Gardner syndrome in a Chinese family.
Death Anxiety and Symbolic Immortality in Relatives at Risk for Familial Amyloid Polyneuropathy Type I (FAP I, ATTR V30M).
Genetic analysis of familial amyloidotic polyneuropathy, an autosomal dominant disease.
SCA-1 micro-heterogeneity in the fate decision of dystrophic fibro/adipogenic progenitors.
Glaucoma
25-gauge vitrectomy to treat ocular complications of familial amyloid polyneuropathy.
A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Aqueous humor erythropoietin levels in open-angle glaucoma patients with and without TTR V30M familial amyloid polyneuropathy.
Aqueous outflow system in familial amyloidotic polyneuropathy, Portuguese type.
Baerveldt glaucoma drainage implant surgery for secondary glaucoma in patients with transthyretin-related familial amyloid polyneuropathy.
Comparison between Fundus Automated Perimetry and Humphrey Field Analyzer: Performance and usability of the Fundus Automated Perimetry and Humphrey Field Analyzer in healthy, ocular hypertensive, and glaucomatous patients.
Comparison of Compass and Humphrey perimeters in detecting glaucomatous defects.
Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients.
Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy.
Nonpenetrating deep sclerectomy as an effective treatment of glaucoma related to familial amyloid polyneuropathy.
Ocular Manifestations and Therapeutic Options in Patients with Familial Amyloid Polyneuropathy: A Systematic Review.
Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up.
Secondary glaucoma in patients with familial amyloidotic polyneuropathy.
Transscleral Cyclophotocoagulation in Familial Amyloidotic Polyneuropathy Secondary Glaucoma after Ahmed Valve Implantation: A Case Series Study.
Transthyretin synthesis in rabbit ciliary pigment epithelium.
Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients.
[Ocular involvement in familial amyloid polyneuropathy].
[The ocular involvement in the transthyretin-related familial amyloid polyneuropathy].
Glioblastoma
Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-? in transformed astrocytic cells.
Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy.
FAP-specific PET signaling shows a moderately positive correlation with relative CBV and no correlation with ADC in 13 IDH wildtype glioblastomas.
Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma Angiogenesis.
Heterogeneity of molecular forms of dipeptidyl peptidase-IV and fibroblast activation protein in human glioblastomas.
Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules.
Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.
Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.
Glioma
An update on the CNS manifestations of brain tumor polyposis syndromes.
Brain tumor-polyposis syndrome: two genetic diseases?
Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.
Prolactinoma as the first manifestation of Gardner's syndrome.
Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.
Species-specific real-time RT-PCR analysis of expression of stromal cell genes in a tumor xenotransplantation model in mice.
Turcot's syndrome and familial adenomatous polyposis associated with brain tumor: review of related literature.
Glycogen Storage Disease Type VI
Over-The-Scope-Clip pre-mounted onto a double balloon enteroscope for fast and successful closure of post-EMR jejunal perforation: case report.
[Pulmonary involvement in familial amyloid polyneuropathy type I]
Goiter
The Prevalence of Thyroid Cancer and Benign Thyroid Disease in Patients With Familial Adenomatous Polyposis May Be Higher Than Previously Recognized.
Hamartoma Syndrome, Multiple
An unexpected Cowden syndrome case found among members of a large familial adenomatous polyposis kindred.
Colorectal polyposes: from phenotype to diagnosis.
Differentiated thyroid cancer associated with intestinal polyposis syndromes: A review.
Gastrointestinal polyposis syndromes for the general gastroenterologist.
Gastrointestinal tract cancers: Genetics, heritability and germ line mutations.
Hearing Loss
Hearing Status of Children and Adolescents With Familial Adenomatous Polyposis.
Is familial adenomatous polyposis associated with sensorineural hearing loss?
Hearing Loss, Sensorineural
Is familial adenomatous polyposis associated with sensorineural hearing loss?
Heart Block
Pacemaker treatment in familial amyloidosis with polyneuropathy.
Heart Diseases
Echocardiographic assessment of the evolution of amyloid heart disease: a study with familial amyloid polyneuropathy.
Left ventricular systolic and diastolic time intervals in familial amyloid polyneuropathy.
Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis.
[Myocardiopathy caused by Portuguese-type familial amyloidotic polyneuropathy. Sequential morphologic and functional study of 60 patients]
[Usefulness of a complete echographic evaluation of the atrial dimensions for the diagnosis of idiopathic atrial fibrillation]
Heart Failure
Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54.
Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis.
Familial amyloidotic polyneuropathy (ATTR Ser50Ile): the first autopsy case report.
Marked cardiomegaly in a patient with familial amyloidotic polyneuropathy after orthotopic liver transplantation: a case study.
Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy.
[A sporadic case of late onset familial amyloidotic polyneuropathy preceded by cardiac involvement]
Hemangiosarcoma
Comparative stochastic effects of inhaled alpha- and beta-particle-emitting radionuclides in beagle dogs.
Hemochromatosis
Subjects at Risk for Genetic Late-Onset Neurological Diseases: Objective Knowledge.
Hemoptysis
[Pulmonary involvement in familial amyloid polyneuropathy type I]
Hepatoblastoma
A case of myoepithelial carcinoma displaying biallelic inactivation of the tumour suppressor gene APC in a patient with familial adenomatous polyposis.
Biallelic inactivation of the APC gene in hepatoblastoma.
CRIBRIFORM-MORULAR VARIANT OF THYROID CANCER - A RED FLAG FOR FAMILIAL ADENOMATOUS POLYPOSIS.
Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.
Familial adenomatous polyposis in two brothers with hepatoblastoma: implications for diagnosis and screening.
Familial hepatoblastoma and APC gene mutations: renewed call for molecular research.
Genetic Counselor Practices Involving Pediatric Patients with FAP: an Investigation of their Self-Reported Strategies for Genetic Testing and Hepatoblastoma Screening.
Hepatoblastoma and APC gene mutation in familial adenomatous polyposis.
Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: Clinical characteristics and rationale for surveillance screening.
Hepatoblastoma in two cousins in a family with adenomatous polyposis. Report of two cases.
Link confirmed between FAP and hepatoblastoma.
Mortality in young first-degree relatives of patients with familial adenomatous polyposis.
Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
Risk of hepatoblastoma in familial adenomatous polyposis.
The Somatic Mutation Hit on Top of Genetic APC mutations Cause Skin Tumor.
The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds.
Hepatolenticular Degeneration
Considerations for Use of Domino Cross-Auxiliary Liver Transplantation in Metabolic Liver Diseases: A review of Case Studies.
Hirschsprung Disease
Results of the double stapling procedure in colorectal surgery.
Histiocytoma, Benign Fibrous
Pulmonary sclerosing hemangioma associated with familial adenomatous polyposis.
Histiocytoma, Malignant Fibrous
Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.
Hoarseness
Vocal Cord Paralysis and Hypercapnic Respiratory Failure in a Patient with Familial Amyloidotic Polyneuropathy.
Horner Syndrome
Pupil abnormalities in 131 cases of genetically defined inherited peripheral neuropathy.
Huntington Disease
Favourable mutation test outcomes for individuals at risk for Huntington disease change the perspectives of first-degree relatives.
Hydrocephalus
Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene.
Hyperaldosteronism
Aldosterone producing adenoma with a somatic KCNJ5 mutation revealing APC dependent Familial Adenomatous Polyposis.
Hypercholesterolemia
[Fulminant acute pancreatitis]
Hyperemia
Measurements of common femoral artery flow velocity in the evaluation of aortoiliac atherosclerosis. Comparisons between pulsatility index, pressures measurements and pulse-volume recordings.
Simultaneous determination of brachial and femoral arterial pressures during reactive hyperemia and papaverine vasodilation.
Hyperinsulinism
Disturbed metabolism of glucose and related hormones in familial amyloidotic polyneuropathy: hypersensitivities of the autonomic nervous system and therapeutic prevention.
[Nesidioblastosis as extracolonic manifestation associated with adenomatous familial polyposis]
[Sequential liver transplantation: description of the first three patients in Spain]
Hyperlipidemias
Possible involvement of hyperlipidemia in increasing risk of colorectal tumor development in human familial adenomatous polyposis.
Transthyretin in high density lipoproteins: association with apolipoprotein A-I.
Hypersensitivity
Is visceral hypersensitivity correlated with symptom severity in children with functional gastrointestinal disorders?
Serum-IgE-facilitated allergen presentation in atopic disease.
Somatic referral of visceral sensations and rectal sensory threshold for pain in children with functional gastrointestinal disorders.
Hypertension
Aldosterone producing adenoma with a somatic KCNJ5 mutation revealing APC dependent Familial Adenomatous Polyposis.
Variable day/night bias in 24-h non-invasive finger pressure against intrabrachial artery pressure is removed by waveform filtering and level correction.
Hypertriglyceridemia
[Fulminant acute pancreatitis]
Hypoglycemia
Disturbed metabolism of glucose and related hormones in familial amyloidotic polyneuropathy: hypersensitivities of the autonomic nervous system and therapeutic prevention.
[Familial amyloidotic polyneuropathy (FAP) type I and the therapies]
Hypohidrosis
Denervation of eccrine glands in patients with familial amyloidotic polyneuropathy type I.
Hypotension
Haemodynamics during liver transplantation in familial amyloidotic polyneuropathy: study of the intraoperative cardiocirculatory data of 50 patients.
Management of a patient with familial amyloid polyneuropathy type I with lumbar epidural anaesthesia.
Hypotension, Orthostatic
Amyloid Neuropathy with Transthyretin Mutations: Overview and Unique Ala97Ser in Taiwan.
Autonomic dysfunction and anemia in neurologic disorders.
Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Clinical and histopathological features of familial amyloidotic polyneuropathy with transthyretin Val30Ala in a Chinese family.
Familial amyloid polyneuropathy associated with TTRSer50Arg mutation in two Iberian families presenting a novel single base change in the mutant gene.
Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine.
Intranasal L-threo-3,4,-dihydroxyphenylserine in treating diarrhea associated with familial amyloidotic polyneuropathy.
Mass spectrometric measurements of norepinephrine synthesis in man from infusion of stable isotope-labelled L-threo-3,4-dihydroxyphenylserine.
Secondary hypoplastic anemia in patients with familial amyloidotic polyneuropathy.
[Autonomic dysfunction in FAP: its therapeutic effect by liver transplantation]
[Autonomic nerve disorders in generalized amyloidosis]
[Familial amyloidotic polyneuropathy (FAP) type I and the therapies]
Hypothyroidism
Reduced affinity for thyroxine in two of three structural thyroxine-binding prealbumin variants associated with familial amyloidotic polyneuropathy.
The Prevalence of Thyroid Cancer and Benign Thyroid Disease in Patients With Familial Adenomatous Polyposis May Be Higher Than Previously Recognized.
Idiopathic Pulmonary Fibrosis
Bioluminescent Probe for Monitoring Endogenous Fibroblast Activation Protein-Alpha.
Fibroblast Activation Protein specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study.
Immunoglobulin Light-chain Amyloidosis
Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy.
Comparison of electrocardiographic findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic findings.
Endoscopic and pathological manifestations of the gastrointestinal tract in familial amyloidotic polyneuropathy type I (Met30).
Studies on familial amyloid polyneuropathy in Ogawa Village, Japan.
[Amyloidosis and neurological disorders: Treatable amyloidosis].
[Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation]
[Myocardial scintigraphic studies with 123I-MIBG, 201Tl and 99mTc-PYP in patients with cardiac amyloidosis]
Infections
Alternative Approach for Fighting Bacteria and Fungi: Use of Modified Fluorapatite.
Bead-Based Multiplex Genotyping of 58 Cutaneous Human Papillomavirus Types.
Childhood functional abdominal pain and Helicobacter pylori infection.
Designing multi-epitope vaccine candidates against functional amyloids in Pseudomonas aeruginosa through immunoinformatic and structural bioinformatics approach.
Different phenotypes of gastric fundic gland polyposis and cancer in patients with familial adenomatous polyposis depending on Helicobacter pylori infection.
Expression and Localization of Insulin Receptor Substrate 2 in Normal Intestine and Colorectal Tumors. Regulation by Intestine-specific Transcription Factor CDX2.
Fibroblast activation protein is dispensable in the anti-influenza immune response in mice.
Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis.
The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity.
Infertility
Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review.
Inflammatory Bowel Diseases
Chemoprevention of colorectal cancer.
Diagnostic delay, symptoms and stage of colorectal cancer.
NOD2 genetic variants predispose one of two familial adenomatous polyposis siblings to pouchitis through microbiome dysbiosis.
Predictive cytogenetic biomarkers for colorectal neoplasia in medium risk patients.
Quality of life for children with functional abdominal pain: a comparison study of patients' and parents' perceptions.
Influenza, Human
Fibroblast activation protein is dispensable in the anti-influenza immune response in mice.
Intellectual Disability
A de novo deletion of chromosome 5q causing familial adenomatous polyposis, dysmorphic features, and mild mental retardation.
Differences in neuropsychological and behavioral parameters and brain structure in patients with familial adenomatous polyposis: a sibling-paired study.
Intestinal Failure
Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis.
Intestinal Neoplasms
Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis.
Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
The Influence of Curcumin, Quercetin, and Eicosapentaenoic Acid on the Expression of Phase II Detoxification Enzymes in the Intestinal Cell Lines HT-29, Caco-2, HuTu 80, and LT97.
Toll-like receptor 4 regulates spontaneous intestinal tumorigenesis by up-regulating IL-6 and GM-CSF.
Intestinal Obstruction
Multivariate analysis of risk factors for complications after loop ileostomy closure.
Intestinal Perforation
Mesenteric fibromatosis (desmoid tumour) - a rare case report.
Intestinal Polyposis
Differentiated thyroid cancer associated with intestinal polyposis syndromes: A review.
Gardner syndrome with giant abdominal desmoid tumor during pregnancy: a case report.
Multiple oral radiopaque masses leading to Gardner's syndrome diagnosis.
Intussusception
APC gene mutations in a jejunal adenoma causing intussusception in a patient with familial adenomatous polyposis.
Irritable Bowel Syndrome
Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review.
Physical and emotional health of mothers of youth with functional abdominal pain.
[Overlapping of functional gastrointestinal disorders in latinamerican schoolchildren and adolescents].
Ischemic Stroke
Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity.
Jejunal Neoplasms
Double-balloon endoscopy facilitates efficient endoscopic resection of duodenal and jejunal polyps in patients with familial adenomatous polyposis.
Joint Diseases
Joint symptoms after restorative proctocolectomy in ulcerative colitis and familial polyposis coli.
Neuroarthropathy (Charcot joints) in familial amyloid polyneuropathy.
Keloid
Fibroblast activation protein-?: a key modulator of the microenvironment in multiple pathologies.
Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Near-Infrared Fluorescent Molecular Probe for Sensitive Imaging of Keloid.
Keratitis
LASIK: a primer for family physicians.
Keratoacanthoma
Fibroblast-activation protein: valuable marker of cutaneous epithelial malignancy.
Keratoconjunctivitis Sicca
Studies of human tear proteins: 4. Analysis by crossed immunoelectrophoresis of tears in various diseases.
[Ocular involvement in familial amyloid polyneuropathy].
[The ocular involvement in the transthyretin-related familial amyloid polyneuropathy].
Kidney Failure, Chronic
Complete Reversion of Familial Adenomatous Polyposis Phenotype Associated with Tacrolimus and Mycophenolate Mofetil Treatment Following Kidney Transplantation.
End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors.
Kidney Neoplasms
Altered Tissue and Plasma Levels of Fibroblast Activation Protein-? (FAP) in Renal Tumours.
Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.
Lactose Intolerance
Lactose intolerance, lactose malabsorption and genetic predisposition to adult-type hypolactasia in patients after restorative proctocolectomy.
Leprosy
A Mycobacterium leprae gene encoding a fibronectin binding protein is used for efficient invasion of epithelial cells and Schwann cells.
Axon reflex-mediated vasodilation is reduced in proportion to disease severity in TTR-FAP.
Leukemia
Familial adenomatous polyposis complicated by chronic myelogenous leukemia: response to imatinib mesylate.
Retrovirus-mediated gene transfer of transthyretin and transthyretin-methionine 30: a potential tool for the study of amyloidogenesis.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Familial adenomatous polyposis complicated by chronic myelogenous leukemia: response to imatinib mesylate.
Li-Fraumeni Syndrome
Not all pediatric intestinal polyps are alike.
Lipoma
Endoscopic Mucosal Resection of Jejunal Polyps using Double-Balloon Enteroscopy.
Gardner's syndrome in a 75-year-old woman.
[Familiar adenomatous polyposis: report of 2 cases].
Liver Cirrhosis
An improved production and purification protocol for recombinant soluble human fibroblast activation protein alpha.
Fibroblast activation protein in liver fibrosis.
Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis.
Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection.
Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.
Selective Homogeneous Assay for Circulating Endopeptidase Fibroblast Activation Protein (FAP).
Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy.
Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy.
[The evaluation value of transient elastography for liver characteristics in obese children].
Liver Cirrhosis, Alcoholic
Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.
Liver Diseases
Considerations for Use of Domino Cross-Auxiliary Liver Transplantation in Metabolic Liver Diseases: A review of Case Studies.
Effect of tacrolimus and partial hepatectomy on transthyretin metabolism in rats.
Evaluation of operative risk in de novo familial amyloid polyneuropathy retransplantation.
Liver mitochondrial function in familial amyloidotic polyneuropathy.
Quality of life following liver transplantation: a comparative study between Familial Amyloid Neuropathy and liver disease patients.
Liver Failure
Temporary auxiliary partial orthotopic liver transplantation using a small graft for familial amyloid polyneuropathy.
Liver Neoplasms
Adult liver transplantation: the Paul Brousse experience.
Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy.
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
Paul Brousse Liver Transplantation: the first 1,500 cases.
Lung Diseases
Fibroblast Activation Protein specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study.
Lung Injury
Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lung in Mice.
Lung Neoplasms
Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
Familial adenomatous polyposis and lung cancer.
Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation.
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.
Three cases with familial adenomatous polyposis diagnosed as having malignant lesions in the course of a long-term trial using docosahexanoic acid (DHA)-concentrated fish oil capsules.
Lymphatic Metastasis
Altered expression of fibroblast activation protein-? (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
Expression of fibroblast activation protein and the clinicopathological relevance in distal cholangiocarcinoma.
FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.
Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.
Improved cancer detection in Waldeyer's tonsillar ring by 68Ga-FAPI PET/CT imaging.
Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects.
Predictive values of FAP and HGF for tumor angiogenesis and metastasis in colorectal cancer.
Roles of Fibroblast Activation Protein and Hepatocyte Growth Factor Expressions in Angiogenesis and Metastasis of Gastric Cancer.
Lymphoma
ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis.
Burkitt-like lymphoma in a pediatric patient with familial adenomatous polyposis.
Detecting fibroblast activation proteins in lymphoma using 68Ga-FAPI PET/CT.
Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
Malnutrition
Food assistance programmes are indirectly associated with anaemia status in children <5 years old in Mexico.
Mania
Investigating facial affect processing in psychosis: a study using the Comprehensive Affective Testing System.
Marfan Syndrome
Marfan-like habitus and familial adenomatous polyposis in two unrelated males: a significant association?
Medulloblastoma
An update on the CNS manifestations of brain tumor polyposis syndromes.
Brain tumor-polyposis syndrome: two genetic diseases?
Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis.
Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma.
Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.
Prolactinoma as the first manifestation of Gardner's syndrome.
TALEN-mediated apc mutation in Xenopus tropicalis phenocopies familial adenomatous polyposis.
Megacolon
Restorative proctocolectomy - a nine year experience at the King Faisal specialist hospital.
Melanoma
Evaluation of the Radiolabeled Boronic Acid-Based FAP Inhibitor MIP-1232 for Atherosclerotic Plaque Imaging.
Expression of stromal cell markers in distinct compartments of human skin cancers.
FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor.
Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy.
Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules.
Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.
Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
Melanosis
Pigmented mesenteric lymphadenopathy in familial adenomatous polyposis - an unusual cause of intraoperative abandonment of ileo-anal pouch.
Meningioma
Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
Mesenteric Ischemia
Short bowel syndrome after continence-preserving procedures.
Migraine Disorders
Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.
Physical and emotional health of mothers of youth with functional abdominal pain.
Mouth Neoplasms
Human telomerase reverse transcriptase (hTERT) promotes cancer invasion by modulating cathepsin D via early growth response (EGR)-1.
Multiple Endocrine Neoplasia Type 2a
Attitudes regarding predictive genetic testing in minors: a survey of European clinical geneticists.
Self-surveillance for genetic predisposition to cancer: behaviors and emotions.
Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.
[Hereditary thyroid cancer]
Muscle Weakness
Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys.
Vocal Cord Paralysis and Hypercapnic Respiratory Failure in a Patient with Familial Amyloidotic Polyneuropathy.
Muscular Atrophy
Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys.
Role of fibro-adipogenic progenitor cells in muscle atrophy and musculoskeletal diseases.
Muscular Diseases
Adipogenesis of skeletal muscle fibro/adipogenic progenitors is affected by the WNT5a/GSK3/?-catenin axis.
Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys.
Signaling pathways regulating the fate of fibro/adipogenic progenitors (FAPs) in skeletal muscle regeneration and disease.
Muscular Dystrophies
Ciliary Hedgehog Signaling Restricts Injury-Induced Adipogenesis.
Myocardial Infarction
Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction.
Myocardial Ischemia
Hemodynamic profiles during concurrent intraaortic balloon pumping and venoarterial bypass--a canine study comparing subclavian and femoral artery perfusion sites.
Myositis
Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors.
Myotonic Dystrophy
Multiple Familial Pilomatrixomas in Three Generations: An Unusual Clinical Picture.
Neoplasm Metastasis
Altered expression of fibroblast activation protein-? (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
Altered Tissue and Plasma Levels of Fibroblast Activation Protein-? (FAP) in Renal Tumours.
Biallelic APC Inactivation Was Responsible for Functional Adrenocortical Adenoma in Familial Adenomatous Polyposis with Novel Germline Mutation of the APC Gene: Report of a Case.
Clinical implications of fibroblast activation protein in patients with colon cancer.
Colorectal cancer cell intrinsic fibroblast activation protein alpha binds to Enolase1 and activates NF-?B pathway to promote metastasis.
Dataset on FAP-induced emergence of spontaneous metastases and on the preparation of activatable FAP-targeting immunoliposomes to detect the metastases.
Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Expression of fibroblast activation protein and the clinicopathological relevance in distal cholangiocarcinoma.
Expression of stromal cell markers in distinct compartments of human skin cancers.
Familial adenomatous polyposis (Gardner's syndrome) and thyroid carcinoma. A case report and review of the literature.
FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.
Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma.
Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways.
Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.
Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through ?-catenin signaling pathway.
Fibroblast Activation Protein-? as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review.
Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy.
Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
Identification and characterization of the promoter of fibroblast activation protein.
Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens.
Impact of fibroblast activation protein on osteosarcoma cell lines in vitro.
Improved cancer detection in Waldeyer's tonsillar ring by 68Ga-FAPI PET/CT imaging.
Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects.
Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells.
Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma.
Mutations of the PIK3CA gene in hereditary colorectal cancers.
Ovarian metastases of colorectal and duodenal cancer in familial adenomatous polyposis.
Predictive values of FAP and HGF for tumor angiogenesis and metastasis in colorectal cancer.
Primary high-grade neuroendocrine carcinoma emerging from an adenomatous polyp in the setting of familial adenomatous polyposis.
Retention of the fetoacinar pancreatic (FAP) protein to the endoplasmic reticulum of tumor cells.
Roles of Fibroblast Activation Protein and Hepatocyte Growth Factor Expressions in Angiogenesis and Metastasis of Gastric Cancer.
Roles of fibroblasts from the interface zone in invasion, migration, proliferation and apoptosis of gastric adenocarcinoma.
Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer.
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [18F]FDG PET/CT and MRI.
The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases.
The role of fibroblast activation protein in progression and development of osteosarcoma cells.
Tumor-Derived Extracellular Vesicles Promote Activation of Carcinoma-Associated Fibroblasts and Facilitate Invasion and Metastasis of Ovarian Cancer by Carrying miR-630.
Whole genome expression profiling in chewing-tobacco-associated oral cancers: a pilot study.
[A case of advanced esophageal cancer with large liver metastasis successfully treated with FAP therapy]
[A case of advanced gastric cancer responding to an FAP (5-FU, ADM, platinum compounds) combined chemotherapy]
[Cases of postoperative hepatic metastasis from gastric cancer in which hepatic arterial infusion chemotherapy with 5-FU, adriamycin and cisplatin was performed after TS-1 chemotherapy]
[Familial adenomatous polyposis and liver metastases from a neuroendocrine tumor].
[Molecular genetics of colorectal cancer and carcinogenesis]
[Mutation of APC gene in sporadic colorectal tumors]
[Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report]
[Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports]
Neoplasms
"High rate of recurrent adenomatosis during endoscopic surveillance after duodenectomy in patients with familial adenomatous polyposis"
3' Mutation of the APC gene and family history of FAP in a patient with apparently sporadic desmoid tumors.
5-Fluorouracil, interferon-alpha-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Hellenic Co-operative Oncology Group.
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.
68Ga-FAPI-PET/CT in patients with various gynecological malignancies.
A case of carcinoma of the papilla of Vater in a young man after subtotal colectomy for familial adenomatous polyposis.
A case of familial adenomatous polyposis complicated by thyroid carcinoma, carcinoma of the ampulla of vater and adrenocortical adenoma.
A case of myoepithelial carcinoma displaying biallelic inactivation of the tumour suppressor gene APC in a patient with familial adenomatous polyposis.
A case report of desmoid tumour-a forgotten aspect of FAP?
A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan.
A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor.
A molecular rationale for the how, when and why of colorectal cancer screening.
A neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicity.
A new conditional Apc-mutant mouse model for colorectal cancer.
A Novel Chemiluminescence Probe for Sensitive Detection of Fibroblast Activation Protein-Alpha In Vitro and in Living Systems.
A novel exon duplication event leading to a truncating germ-line mutation of the APC gene in a familial adenomatous polyposis family.
A novel large deletion in the APC gene associated with Gardner syndrome in a Chinese family.
A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors.
A Patient With Desmoid Tumors and Familial FAP Having Frame Shift Mutation of the APC Gene.
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.
A phase I study of FAP (5-Fluorouracil, ?-interferon and cisplatin) combined with methotrexate for the treatment of advanced urothelial malignancies.
A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice.
A proposed staging system and stage-specific interventions for familial adenomatous polyposis.
A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation.
A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.
A Support Vector Machine Model Predicting the Risk of Duodenal Cancer in Patients with Familial Adenomatous Polyposis at the Transcript Levels.
A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts.
Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management.
About a case of familial adenomatous polyposis.
Absence of germline mutations in exons 5-9 of the p53 gene in patients with Li-Fraumeni-like (SBLA) and familial adenomatous polyposis heritable cancer syndromes.
Activatable Near-Infrared Fluorescent Probe for In Vivo Imaging of Fibroblast Activation Protein-alpha.
Adenocarcinoma after ileoanal anastomosis for familial adenomatous polyposis: review of risk factors and current surveillance apropos of a case.
Adenocarcinoma at the Ileostomy Site After a Proctocolectomy for Ulcerative Colitis and/or Familial Adenomatous Polyposis: An Overview.
Adrenocortical tumor in a patient with familial adenomatous polyposis: a case associated with a complete inactivating mutation of the APC gene and unusual histological features.
Advanced duodenal neoplasia and carcinoma in familial adenomatous polyposis: outcomes of surgical management.
Age- and Gender-Specific Risk of Thyroid Cancer in Patients with Familial Adenomatous Polyposis.
Aggressive mutation in a familial adenomatous polyposis syndrome family: when phenotype guides clinical surveillance.
Alteration of O6-methylguanine-DNA methyltransferase in colorectal neoplasms in sporadic and familial adenomatous polyposis patients.
Altered expression of fibroblast activation protein-? (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
Altered Tissue and Plasma Levels of Fibroblast Activation Protein-? (FAP) in Renal Tumours.
Ampullary cancer in a patient with familial adenomatous polyposis - a rare case report and current status of management.
An immunohistologic study of the feto-acinar pancreatic protein (FAP) in the normal pancreas, chronic pancreatitis, pancreatic adenocarcinoma, and intraabdominal metastases of adenocarcinomas.
An improved production and purification protocol for recombinant soluble human fibroblast activation protein alpha.
An update on the CNS manifestations of brain tumor polyposis syndromes.
Analysis of adenomatous polyposis coli gene in thyroid tumours.
Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.
Analysis of expression levels of markers associated with tumor proliferation and angiogenesis in familial adenomatous polyposis.
Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
Analysis of Wnt/Beta catenin signalling in desmoid tumors.
Anti-cancer therapies targeting the tumor stroma.
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein.
APC gene mutations causing familial adenomatous polyposis in Polish patients.
APC I1307K mutations and forkhead box gene (FOXO1A): another piece of an interesting correlation.
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis.
APC mutation spectrum in ileoanal pouch polyps resembles that of colorectal polyps.
APC mutations in FAP-associated desmoid tumours are non-random but not 'just right'.
APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".
APC rearrangements in familial adenomatous polyposis: heterogeneity of deletion lengths and breakpoint sequences underlies similar phenotypes.
APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse.
Apc-driven colon carcinogenesis in Pirc rat is strongly reduced by polyethylene glycol.
Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts.
Are there two sides to colorectal cancer?
Assay for Detecting the I1307K Susceptibility Allele within the Adenomatous Polyposis ColiGene.
Assessing barriers to a rational chemoprevention trial design in young patients with familial adenomatous polyposis.
Association of extracolonic manifestations of familial adenomatous polyposis with acetylation phenotype in a large FAP kindred.
Association of Pathogenic Missense and Nonsense Mutations in Mitochondrial COII Gene with Familial Adenomatous Polyposis (FAP).
Attenuated adenomatous polyposis of the large bowel: Present and future.
Autocatalytic Tissue Polymerization Reaction Mechanism in Colorectal Cancer Development and Growth.
Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH.
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models.
Bilateral Sertoli cell tumors of the testis-a likely new extracolonic manifestation of familial adenomatous polyposis.
Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma.
Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis.
Broad phenotypic spectrum in familial adenomatous polyposis; from early onset and severe phenotypes to late onset of attenuated polyposis with the first manifestation at age 72.
Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Burden and profile of somatic mutation in duodenal adenomas from patients with familial adenomatous- and MUTYH-associated polyposis.
Burkitt-like lymphoma in a pediatric patient with familial adenomatous polyposis.
Cancer genetics: colorectal cancer as a model.
Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients.
Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Cancer-associated stroma significantly contributes to the mesenchymal subtype signature of serous ovarian cancer.
Cancer: screening for thyroid cancer in patients with FAP is worthwhile.
Carbon ion radiotherapy for desmoid tumor of the abdominal wall: a case report.
Care of patients and their families with familial adenomatous polyposis.
Causes of death in familial adenomatous polyposis.
CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma.
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis.
Cell proliferation of the duodenal mucosa in patients affected by familial adenomatous polyposis.
Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature.
Characteristics and Clinical Outcomes of Duodenal Neoplasia in Japanese Patients With Familial Adenomatous Polyposis.
Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma.
Characterization of adenocarcinoma of the lung in a familial adenomatous polyposis patient.
Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin.
Chemoprevention of familial adenomatous polyposis by bromo-noscapine (EM011) in the Apc(Min/+) mouse model.
Chemopreventive agents inhibit aberrant proliferation of the aneuploid phenotype in a colon epithelial cell line established from Apc 1638N [+/-] mouse.
Childhood hepatocellular tumors in FAP.
Chromosome changes in desmoid tumors developed in patients with familial adenomatous polyposis.
Cleavage of Type I Collagen by Fibroblast Activation Protein-? Enhances Class A Scavenger Receptor Mediated Macrophage Adhesion.
Clinical analysis of eight kindreds of familial adenomatous polyposis.
Clinical characteristics and adequate treatment of familial adenomatous polyposis combined with desmoid tumors.
Clinical characteristics of familial adenomatous polyposis and management of duodenal adenomas.
Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes.
Clinical implications of fibroblast activation protein in patients with colon cancer.
Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy.
Clinical outcomes of gastric polyps and neoplasms in patients with familial adenomatous polyposis.
Clinically Inapparent Adrenal Mass in a Patient with Familial Adenomatous Polyposis.
Coexistence of Peripheral Spondyloarthritis and Familial Adenomatous Polyposis: A Rare Case Report with Treatment Contradictions and Review of the Literature.
Colectomy with ileorectal anastomosis lowers rectal mucosal cell proliferation in familial adenomatous polyposis.
Colon fibroblasts from Pirc rats (F344/NTac-Apcam1137 ) exhibit a proliferative and inflammatory phenotype that could support early stages of colon carcinogenesis.
Colonic adenomatous polyposis syndromes: clinical management.
Colonic and duodenal flat adenomas in children with classical familial adenomatous polyposis.
Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis.
Combined restorative proctocolectomy and pancreaticoduodenectomy for familial adenomatous polyposis.
Common genetic evolutionary pathways in familial adenomatous polyposis tumors.
Comparative stochastic effects of inhaled alpha- and beta-particle-emitting radionuclides in beagle dogs.
Comparison of dysplastic fundic gland polyps in patients with and without familial adenomatous polyposis.
Comparison of sporadic and FAP-associated desmoid-type fibromatoses.
Complex APC germline mutation associated metaplasia and intraepithelial neoplasia (CAM-IEN) of the gallbladder.
Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients.
Congenital hypertrophy of the retinal pigment epithelium and familial adenomatous polyposis.
Congenital hypertrophy of the retinal pigment epithelium and mandibular osteomata as markers in familial colorectal cancer.
Congenital hypertrophy of the retinal pigment epithelium serves as a clinical marker in a family with familial adenomatous polyposis.
Connexin43 is overexpressed in Apc(Min/+)-mice adenomas and colocalises with COX-2 in myofibroblasts.
Consecutive maintenance of human solitary and hereditary colorectal polyps in SCID mice.
Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein.
Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients.
Cortisol producing adrenal adenoma--a new manifestation of Gardner's syndrome.
Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-? in transformed astrocytic cells.
Cranial desmoid tumor associated with homozygous inactivation of the adenomatous polyposis coli gene in a 2-year-old girl with familial adenomatous polyposis.
Cribiform variant of papillary thyroid cancer and familial adenomatous polyposis.
Cribriform variant papillary thyroid cancer: a characteristic of familial adenomatous polyposis.
Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer.
Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP.
Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer.
CRIBRIFORM-MORULAR VARIANT OF THYROID CANCER - A RED FLAG FOR FAMILIAL ADENOMATOUS POLYPOSIS.
CTNNB1 Genotyping and APC Screening in Pediatric Desmoid Tumors: A Proposed Alogrithm.
Cyclooxygenase-2 knockdown by RNA interference in colon cancer.
Deletion of fibroblast activation protein provides atheroprotection.
Depressed-Type Colonic Lesions and "De Novo" Cancer in Familial Adenomatous Polyposis: A Colonoscopist's Viewpoint.
Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents.
Desmoid Tumor as an Initial Presentation of Familial Adenomatous Polyposis: A Review of the Literature.
Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis.
Desmoid tumors -- a characterization of patients seen at Mayo Clinic 1976-1999.
Desmoid Tumors Characteristics, Clinical Management, Active Surveillance, and Description of Our FAP Case Series.
Desmoid tumors complicating Familial Adenomatous Polyposis: a meta-analysis mutation spectrum of affected individuals.
Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis.
Desmoid Tumors in Familial Adenomatous Polyposis.
Desmoid tumors in patients with familial adenomatous polyposis.
Desmoid tumour biology in patients with familial adenomatous polyposis coli.
Desmoid tumour in familial adenomatous polyposis patients: responses to treatments.
Desmoid tumour in familial adenomatous polyposis. A review of literature.
Desmoid tumours complicating familial adenomatous polyposis.
Detecting fibroblast activation proteins in lymphoma using 68Ga-FAPI PET/CT.
Detection of genetic abnormalities in neoplasms from Greek patients with FAP.
Detection of novel mitochondrial mutations in cytochrome C oxidase subunit 1 (COX1) in patients with familial adenomatous polyposis (FAP).
Development and endoscopic appearance of colorectal tumors are characterized by the expression profiles of miRNAs.
Development of a Cross-Reactive Monoclonal Antibody for Detecting the Tumor Stroma.
Development of an aggressive depressed cancer in a case of familial adenomatous polyposis.
Developmental abnormalities in multiple proliferative tissues of Apc(Min/+) mice.
Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: variations with phenotype.
Different familial adenomatous polyposis phenotypes resulting from deletions of the entire APC exon 15.
Different phenotype manifestation of familial adenomatous polyposis in families with APC mutation at codon 1309.
Differentiated thyroid cancer associated with intestinal polyposis syndromes: A review.
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders.
Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.
Disorders of the rectus abdominis muscle and sheath: a 22-year experience.
DNA adducts detected by 32P-postlabelling, in the intestine of rats given bile from patients with familial adenomatous polyposis and from unaffected controls.
DNA adducts, detected by 32P-postlabelling, in the foregut of patients with familial adenomatous polyposis and in unaffected controls.
Does early colectomy increase desmoid risk in familial adenomatous polyposis?
Does routine colonoscopy help diagnose familial adenomatous polyposis in patients presenting with desmoid tumors but no gastrointestinal symptoms?
Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy.
Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
DPIV/CD26 and FAP in cancer: a tale of contradictions.
Duodenal adenoma and cancer in FAP.
Duodenal adenomatosis in familial adenomatous polyposis.
Duodenal adenomatosis in Japanese patients with familial adenomatous polyposis.
Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis.
Early postoperative and long-term oncological outcomes of laparoscopic treatment for patients with familial adenomatous polyposis.
Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.
Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.
Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis.
Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts.
Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Endoscopic Surveillance of Duodenal Polyposis After Total Gastrectomy in Familial Adenomatous Polyposis.
Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy.
Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon.
Enhanced stem cell survival in familial adenomatous polyposis.
Epithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors?
eRapa restores a normal life span in a FAP mouse model.
ERbeta expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis.
Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation.
Evolution of hereditary bowel cancer.
Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors.
Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade.
Expression of EGFR, HER2, Phosphorylated ERK and Phosphorylated MEK in Colonic Neoplasms of Familial Adenomatous Polyposis Patients.
Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity.
Expression of fetoacinar pancreatic (FAP) protein in the pancreatic human tumor cell line BxPC-3.
Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours.
Expression of the FAP gene in non-fibroblast human cell lines. Development of cancer-associated fibroblast models.
Expression of the fibroblast activation protein during mouse embryo development.
Expression pattern of genes associated with tumor microenvironment in prostate cancer.
Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines.
Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis.
Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.
Familial Adenomatous Polyposis (FAP)-A Case Study and Review of Literature.
Familial adenomatous polyposis and benign intracranial tumors: a new variant of Gardner's syndrome.
Familial adenomatous polyposis and extracolonic cancer.
Familial adenomatous polyposis and lung cancer.
Familial adenomatous polyposis at the Tel Aviv Medical Center: demographic and clinical features.
Familial adenomatous polyposis coli in South Africa--molecular basis and diagnosis.
Familial Adenomatous Polyposis in Children and Adolescents.
Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.
Familial adenomatous polyposis in two brothers with hepatoblastoma: implications for diagnosis and screening.
Familial adenomatous polyposis of the colon.
Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study.
Familial adenomatous polyposis.
Familial adenomatous polyposis: a case report and histologic mucin study.
Familial adenomatous polyposis: a case report and review of the literature.
Familial adenomatous polyposis: case report and review of extracolonic manifestations.
Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer.
Familial adenomatous polyposis: not all masses are desmoids.
Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation.
Familial microsatellite-stable non-polyposis colorectal cancer: incidence and characteristics in a clinic-based population.
Familial polyposis coli: clinical manifestations, evaluation, management and treatment.
Familial Polyposis Coli: The Management of Desmoid Tumor Bleeding.
Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis.
FAP Associated Papillary Thyroid Carcinoma: A Peculiar Subtype of Familial Nonmedullary Thyroid Cancer.
FAP associated thyroid carcinoma in mother and her daughter.
FAP imaging in rare cancer entities-first clinical experience in a broad spectrum of malignancies.
FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression.
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer.
FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.
FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor.
Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis.
Favourable mutation test outcomes for individuals at risk for Huntington disease change the perspectives of first-degree relatives.
Feasibility of endoscopic resection using bipolar snare for nonampullary duodenal tumours in familial adenomatous polyposis patients.
Features of Duodenal Cancer in Patients With Familial Adenomatous Polyposis.
Fibroblast activating protein-? expression in squamous cell carcinoma of the esophagus in primary and irradiated tumors: the use of archival FFPE material for molecular techniques.
Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival.
Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma.
Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Fibroblast activation protein and chronic liver disease.
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma.
Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma Angiogenesis.
Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.
Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers.
Fibroblast activation protein is dispensable in the anti-influenza immune response in mice.
Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata.
Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.
Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites.
Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through ?-catenin signaling pathway.
Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.
Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts.
Fibroblast Activation Protein-? as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review.
Fibroblast activation protein-? promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.
Fibroblast activation protein-?: a key modulator of the microenvironment in multiple pathologies.
Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy.
Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT.
Fibroblast activation protein: A potential therapeutic target in cancer.
Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis.
Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
Fibroblast activation proteins-? suppress tumor immunity by regulating T cells and tumor-associated macrophages.
Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules.
Fibroblast-activation protein: valuable marker of cutaneous epithelial malignancy.
Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment.
Fluorouracil (F), Adriamycin (A), and cisplatin (P) (FAP): combination chemotherapy of advanced esophageal carcinoma.
Founder mutation in familial adenomatous polyposis (FAP) in the Balearic Islands.
Frequencies of mtDNA mutations in primary tissues of colorectal adenopolyps.
Functional outcome after colectomy and ileorectal anastomosis compared with proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis.
Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas.
Gardner syndrome with giant abdominal desmoid tumor during pregnancy: a case report.
Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder.
Gardner's syndrome in a 75-year-old woman.
Gardner's syndrome presenting with a fibromatous tumour of the parotid.
Gastric adenocarcinoma arising from fundic gland polyps in a patient with familial adenomatous polyposis syndrome.
Gastric polyposis and desmoid tumours as a new familial adenomatous polyposis clinical variant associated with APC mutation at the extreme 3'-end.
Gastric tumours in FAP.
Gender-Specific Aspects of Lynch Syndrome and Familial Adenomatous Polyposis.
Gene Expression Changes Accompanying the Duodenal Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis.
Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease.
Genetic alterations of the APC gene in familial adenomatous polyposis patients of the hellenic group for the study of colorectal cancer.
Genetic Counselor Practices Involving Pediatric Patients with FAP: an Investigation of their Self-Reported Strategies for Genetic Testing and Hepatoblastoma Screening.
Genetic evidence that juvenile nasopharyngeal angiofibroma is an integral FAP tumour.
Genetic Manipulation of Homologous Recombination In Vivo Attenuates Intestinal Tumorigenesis.
Genetic susceptibility to non-polyposis colorectal cancer.
Genetics, Inheritance and Strategies for Prevention in Populations at High Risk of Colorectal Cancer (CRC).
Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients.
Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Hereditary Colorectal Tumors Registry.
Genotype to phenotype: Analyzing the effects of inherited mutations in colorectal cancer families.
Germline APC mutation (Gln1317) in a cancer-prone family that does not result in familial adenomatous polyposis.
Germline mutation of ARF in a melanoma kindred.
Glutathione S-transferase Mu phenotype in patients with familial adenomatous polyposis and in unaffected controls.
Gradually shrinking intra-abdominal desmoid tumor derived from the stomach in a young boy: a case report.
Hepatoblastoma and APC gene mutation in familial adenomatous polyposis.
Hepatoblastoma in two siblings and familial adenomatous polyposis: causal nexus or coincidence?
Hepatocellular adenoma associated with familial adenomatous polyposis coli.
Hepatocellular adenoma in a male with familial adenomatous polyposis coli.
Hereditary colorectal cancer syndromes.
Hereditary colorectal cancer.
Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene.
Hereditary intestinal polyposis syndromes.
High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes.
High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis.
High-grade pancreatic intraepithelial neoplasia in a patient with familial adenomatous polyposis.
Highly aggressive thoracic desmoid tumors in adolescent siblings with fatal outcomes in an FAP kindred: a need for increased vigilance and intervention in at-risk AYAs.
Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.
Human papillomavirus in lesions of anogenital mammary-like glands.
Human telomerase reverse transcriptase (hTERT) promotes cancer invasion by modulating cathepsin D via early growth response (EGR)-1.
HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis.
Identification a nonsense mutation of APC gene in Chinese patients with familial adenomatous polyposis.
Identification and characterization of the promoter of fibroblast activation protein.
Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis.
Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor.
Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours.
Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens.
Identification of Lynch syndrome risk variants in the Romanian population.
Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics.
Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence.
IFN/STAT signaling controls tumorigenesis and the drug response in colorectal cancer.
Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography.
Imaging of Fibroblast Activation Protein Alpha Expression in a Preclinical Mouse Model of Glioma Using Positron Emission Tomography.
Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules.
Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia.
Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model.
Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas.
Impact of fibroblast activation protein on osteosarcoma cell lines in vitro.
In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes.
In vivo near-infrared fluorescence imaging of FAP-expressing tumors with activatable FAP-targeted, single-chain Fv-immunoliposomes.
Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis.
Inactivation of the APC Gene Is Constant in Adrenocortical Tumors from Patients with Familial Adenomatous Polyposis but Not Frequent in Sporadic Adrenocortical Cancers.
Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Increased cytosine DNA-methyltransferase activity during colon cancer progression.
Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior.
Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.
Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients.
Increased prevalance of colorectal adenoma in patients with sporadic duodenal adenoma.
Increased stem cell somatic mutation in the non-neoplastic colorectal mucosa of patients with familial adenomatous polyposis.
Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma.
Inducible loss of one Apc allele in Lrig1-expressing progenitor cells results in multiple distal colonic tumors with features of familial adenomatous polyposis.
Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein.
Initial clinical experience with 90Y-FAPI-46 radioligand therapy for advanced stage solid tumors: a case series of nine patients.
Initial results of colorectal polyposis research in Latvia.
Insertion/deletion polymorphism and other restriction fragment length polymorphisms in the MCC gene.
Integral membrane protease fibroblast activation protein sensitizes fibrosarcoma to chemotherapy and alters cell death mechanisms.
Intestinal flora of FAP patients containing APC-like sequences.
Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis.
Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis.
Introduction of human adenomatous polyposis coli gene into Min mice via cationic liposomes.
Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype.
Isolated, giant cerebellopontine angle craniopharyngioma in a patient with Gardner syndrome: case report.
Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
K-ras2 activation and genome instability increase proliferation and size of FAP adenomas.
Knowledge, attitudes, and clinical experience of physicians regarding preimplantation genetic diagnosis for hereditary cancer predisposition syndromes.
Laparoscopic colectomy and restorative proctocolectomy for familial adenomatous polyposis.
Lessons from the genetics of colon cancer.
Leucocyte typing, cytokine expression, and epithelial turnover in the ileal pouch in patients with ulcerative colitis and familial adenomatous polyposis.
Life expectancy in hereditary cancer predisposing diseases: an observational study.
Long-Lasting Bioluminescence Imaging of the Fibroblast Activation Protein by an Amphiphilic Block Copolymer-Based Probe.
Long-term clinical outcomes and follow-up status in Japanese patients with familial adenomatous polyposis after radical surgery: a descriptive, retrospective cohort study from a single institute.
Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery.
Long-term outcome of familial adenomatous polyposis patients after restorative coloproctectomy.
Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.
Loss of colonic HLA antigens in familial adenomatous polyposis.
Loss of normal allele of the APC gene in an adrenocortical carcinoma from a patient with familial adenomatous polyposis.
Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP.
Low colonic glutathione detoxification capacity in patients at risk for colon cancer.
Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects.
Malignancy risk in individuals with familial adenomatous polyposis receiving biologics and immunomodulators.
Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells.
Malignant change in a duodenal adenoma in familial adenomatous polyposis: report of a case.
Management of mesenteric desmoid tumours in familial adenomatous polyposis.
Management of periampullary adenoma.
Manic Fringe deficiency imposes Jagged1 addiction to intestinal tumor cells.
Mechanisms of APC-driven tumorigenesis: lessons from mouse models.
Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors.
Metastatic carcinoid and islet cell tumours of the pancreas: a phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin.
Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
Minor Papilla Adenoma Management in Patients with Pancreas Divisum and Familial Adenomatous Polyposis.
Modification of growth of desmoid tumours in tissue culture by anti-oestrogenic substances: a preliminary report.
Modulation by dietary factors in murine FAP models.
Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas.
Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma.
Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
Molecular nature of chromosome 5q loss in colorectal tumors and desmoids from patients with familial adenomatous polyposis.
Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications.
Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestine.
Mortality in young first-degree relatives of patients with familial adenomatous polyposis.
Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers.
Mouse fibroblast-activation protein--conserved Fap gene organization and biochemical function as a serine protease.
Mucoepidermoid carcinoma: A yet unreported cancer associated with familial adenomatous polyposis.
Multidisciplinary treatment of desmoid tumours in Gardner's syndrome due to a large interstitial deletion of chromosome 5q.
Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis.
Multiple desmoid tumors in a patient with familial adenomatous polyposis caused by the novel W421X mutation.
Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.
Mutation spectrum of the APC gene in 83 Korean FAP families.
Mutational Analysis of a Familial Adenomatous Polyposis Pedigree with Bile Duct Polyp Phenotype.
Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours.
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.
Mutations of the APC (adenomatous polyposis coli) gene.
MUTYH the base excision repair gene family member associated with colorectal cancer polyposis.
Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma.
Neuropeptide?Y, B-type natriuretic peptide, substance?P and peptide?YY are novel substrates of fibroblast activation protein-?.
Next-generation sequencing with comprehensive bioinformatics analysis facilitates somatic mosaic APC gene mutation detection in patients with familial adenomatous polyposis.
Non-polypoid adenoma of the large intestine.
Nonampullary Duodenal Adenomas in Familial Adenomatous Polyposis and Sporadic Patients Lack the DNA Content Abnormality That is Characteristic of the Adenoma-Carcinoma Sequence Involved in the Development of Other Gastrointestinal Malignancies.
Nonpolypoid adenomas and adenocarcinomas found in background mucosa of surgically resected colons.
Novel germline APC mutations in Swedish patients with familial adenomatous polyposis and Gardner syndrome.
Novel germline mutations in the APC gene of Cypriot patients with familial and sporadic adenomatous polyposis.
Novel mutations of the APC gene in familial adenomatous polyposis in Greek patients.
Nuclear localization of immunoreactive beta-catenin is specific to familial adenomatous polyposis in papillary thyroid carcinoma.
Nuclear translocation of beta-catenin in colorectal cancer.
Obesity Enhances the Conversion of Adipose-Derived Stromal/Stem Cells into Carcinoma-Associated Fibroblast Leading to Cancer Cell Proliferation and Progression to an Invasive Phenotype.
Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment.
Oestrogen receptor beta isoform expression in sporadic colorectal cancer, familial adenomatous polyposis and progressive stages of colorectal cancer.
On the edge of validation--cancer protease fibroblast activation protein.
Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.
Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.
One-pot and one-step automated radio-synthesis of [18F]AlF-FAPI-74 using a multi purpose synthesizer: a proof-of-concept experiment.
Ornithine decarboxylase and polyamines in familial adenomatous polyposis.
Outcome of thyroid ultrasound screening in FAP patients with a normal baseline exam.
Outcomes and complications of radiation therapy in patients with familial adenomatous polyposis.
Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
Overexpression of p53 in duodenal tumours in patients with familial adenomatous polyposis.
p53 and K-ras status in duodenal adenomas in familial adenomatous polyposis.
p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event?
Pancreatic islet cell tumour in a patient with familial adenomatous polyposis.
Pancreaticoduodenectomy for dysplastic duodenal adenoma in a patient with familial adenomatous polyposis.
Parental Attitudes, Beliefs, and Perceptions about Genetic Testing for FAP and Colorectal Cancer Surveillance in Minors.
Patients with genetic cancer undergoing surveillance at a specialized clinic rate the quality of their care better than patients at non-specialized clinics.
Peptide Patterns as Discriminating Biomarkers in Plasma of Patients With Familial Adenomatous Polyposis.
Phase II Trial of Single Agent Val-boroPro (Talabostat) Inhibiting Fibroblast Activation Protein in Patients with Metastatic Colorectal Cancer.
Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer.
Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.
Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis.
Possible involvement of hyperlipidemia in increasing risk of colorectal tumor development in human familial adenomatous polyposis.
Possible role of telomerase activation in the multistep tumor progression of periampullary lesions in patients with familial adenomatous polyposis.
Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein.
Pouch polyposis after ileal pouch-anal anastomosis for familial adenomatous polyposis: report of a case.
Pouch reconstruction in the pelvis.
Pouch-anal cancer after restorative proctocolectomy for familial adenomatous polyposis.
Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis.
Predictive diagnosis in familial adenomatous polyposis: evaluation of molecular genetic and ophthalmologic methods.
Predictive values of FAP and HGF for tumor angiogenesis and metastasis in colorectal cancer.
Prednisolone therapy for intra-abdominal desmoid tumors in a patient with familial adenomatous polyposis.
Pregnancy does not influence colonic polyp multiplicity but may modulate upper gastrointestinal disease in patients with FAP.
Presentation, management and outcomes of ileoanal pouch cancer: a single-centre experience.
Prevalence and endoscopic treatment outcomes of upper gastrointestinal neoplasms in familial adenomatous polyposis.
Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas.
Preventative strategies for periampullary tumours in FAP.
Preventive Anti-inflammatory Diet to Reduce Gastrointestinal Inflammation in Familial Adenomatous Polyposis Patients: A Prospective Pilot Study.
Primary cerebellopontine angle craniopharyngioma in a patient with gardner syndrome. Case report and review of the literature.
Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics.
Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer.
Progression to advanced neoplasia is infrequent in post colectomy familial adenomatous polyposis patients under endoscopic surveillance.
Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model.
Psychological distress and use of psychosocial support in familial adenomatous polyposis.
Pulmonary sclerosing hemangioma associated with familial adenomatous polyposis.
Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.
Radiotherapy in the treatment of aggressive fibromatosis: experience from a single institution.
Rapid Target Binding and Cargo Release of Activatable Liposomes Bearing HER2 and FAP Single-Chain Antibody Fragments Reveal Potentials for Image-Guided Delivery to Tumors.
Rare case of intraintestinal stromal tumors in the patient with familial adenomatous polyposis.
Rational Design, Pharmacomodulation, and Synthesis of [68Ga]Ga-Alb-FAPtp-01, a Selective Tumor-Associated Fibroblast Activation Protein Tracer for PET Imaging of Glioma.
Recurrent giant cranial desmoid tumor in a 3-year-old boy with familial adenomatous polyposis requiring bifrontoparietal cranioplasty: case report.
Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations.
Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.
Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.
Relapsing acute pancreatitis due to ampullary adenoma in a patient with familial adenomatous polyposis.
Relative toxicity of chronic irradiation by 45Ca beta particles and 242Cm alpha particles with respect to the production of lung tumors in CBA/Ca mice.
Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice.
Results after restorative proctocolectomy and ileal pouch-anal anastomosis in patients with familial adenomatous polyposis and coexisting colorectal cancer.
Results of ileal J-pouch-anal anastomosis in familial adenomatous polyposis complicated by rectal carcinoma.
Retention of the fetoacinar pancreatic (FAP) protein to the endoplasmic reticulum of tumor cells.
Review of our ileal pouch experience in the light of literature.
RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis.
Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer.
Risk of hepatoblastoma in familial adenomatous polyposis.
Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis.
Risk-reduction surgery in pediatric surgical oncology: A perspective.
Role of Alpha-Smooth Muscle Actin and Fibroblast Activation Protein Alpha in Ovarian Neoplasms.
Role of p53-dependent activation of caspases in chronic obstructive uropathy: evidence from p53 null mutant mice.
Role of upper gastrointestinal surveillance in patients with familial adenomatous polyposis.
Roles of fibroblasts from the interface zone in invasion, migration, proliferation and apoptosis of gastric adenocarcinoma.
Screening practice for familial adenomatous polyposis: the potential for regional registers.
Selective Activation of Anticancer Chemotherapy by Cancer-Associated Fibroblasts in the Tumor Microenvironment.
Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity.
Self-surveillance for genetic predisposition to cancer: behaviors and emotions.
Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells.
Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene.
Short bowel syndrome after continence-preserving procedures.
Short hairpin RNA targeting of fibroblast activation protein inhibits tumor growth and improves the tumor microenvironment in a mouse model.
Simultaneous laparoscopic subtotal colectomy and pancreaticoduodenectomy for colonic FAP and ampullary cancer.
Slow progression of periampullary neoplasia in familial adenomatous polyposis.
Small bowel endoscopy in familial adenomatous polyposis and Lynch syndrome.
Solid-pseudopapillary neoplasm of the pancreas in a patient with familial adenomatous polyposis: a case report.
Soluble E-cadherin as a serum biomarker candidate: Elevated levels in patients with late-stage colorectal carcinoma and FAP.
Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients.
Somatic Mutations of the CDC4 (FBXW7) Gene in Hereditary Colorectal Tumors.
Species-crossreactive scFv against the tumor stroma marker "fibroblast activation protein" selected by phage display from an immunized FAP-/- knock-out mouse.
Species-specific real-time RT-PCR analysis of expression of stromal cell genes in a tumor xenotransplantation model in mice.
Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
Spectrum of mutations in genes associated with familial colorectal cancer syndrome (MLH1, MSH2, PMS2, MSH6, and APC): A not so common hereditary cancer syndrome in Indian population.
Stem cell models for genetically predisposed colon cancer.
Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer.
Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ ?-catenin pathway.
Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer.
Submerged gel electrophoresis on Spreadex gels--a new method for APC gene mutation detection.
Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis.
Successful local excision of ileostomy adenocarcinoma after colectomy for familial adenomatous polyposis: report of a case.
Sulindac in familial adenomatous polyposis: evaluation by nuclear morphometry.
Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase.
Suppressor gene alterations in the colorectal adenoma-carcinoma sequence.
Surgery for the teenager with familial adenomatous polyposis: ileo-rectal anastomosis or restorative proctocolectomy?
Surgical Interventions, Malignancies, and Causes of Death in a FAP Patient Registry.
Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: A nationwide retrospective cohort study.
Surgical treatment in familial adenomatous polyposis.
Surveillance and Treatment of Periampullary and Duodenal Adenomas in Familial Adenomatous Polyposis.
Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer.
Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer.
Systemic cytotoxic chemotherapy and radiation therapy for desmoid in familial adenomatous polyposis.
TALEN-mediated apc mutation in Xenopus tropicalis phenocopies familial adenomatous polyposis.
Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models.
Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.
Targeting fibroblast activation protein in cancer - Prospects and caveats.
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [18F]FDG PET/CT and MRI.
Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.
Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18F-labeled FAP Inhibitor.
Targeting inhibition of fibroblast activation protein-? and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager.
TGF-beta-induced fibroblast activation protein expression, fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910PM.
The application of the fibroblast activation protein ?-targeted immunotherapy strategy.
The clinical course of intra-abdominal desmoid tumours in patients with familial adenomatous polyposis.
The clinical [corrected] background of familial adenomatous polyposis. History, epidemiology, diagnosis and treatment.
The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder.
The development and validation of a combined kinetic fluorometric activity assay for fibroblast activation protein alpha and prolyl oligopeptidase in plasma.
The diagnostic value of the foetoacinar pancreatic (FAP) protein in cancer of the pancreas; a comparative study with CA19/9.
The different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum.
The effect of a germline mutation in the APC gene on ?-catenin in human embryonic stem cells.
The enigma of desmoid tumors.
The Expression of FAP in Hepatocellular Carcinoma Cells is Induced by Hypoxia and Correlates with Poor Clinical Outcomes.
The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases.
The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity.
The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis.
The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP).
The genomics of colorectal cancer: state of the art.
The identification of a novel Paneth cell-associated antigen in a familial adenomatous polyposis mouse model.
The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.
The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment.
The importance of congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis.
The importance of family study in the patients with familial adenomatous polyposis.
The in vivo rate of somatic adenomatous polyposis coli mutation.
The Latest Developments in Imaging of Fibroblast Activation Protein.
The Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein, a toll-like receptor 4 agonist, enhances dendritic cell-based cancer vaccine potency.
The Prevalence and Significance of Jejunal and Duodenal Bulb Polyposis After Duodenectomy in Familial Adenomatous Polyposis: Retrospective Cohort Study.
The prevalence of small intestinal polyps in patients with familial adenomatous polyposis: a prospective capsule endoscopy study.
The Prevalence of Thyroid Cancer and Benign Thyroid Disease in Patients With Familial Adenomatous Polyposis May Be Higher Than Previously Recognized.
The prognostic significance of fibroblast activation protein-? in human lung adenocarcinoma.
The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions.
The role of capsule endoscopy in the detection of small bowel disease.
The role of chromoendoscopy in the surveillance of the duodenum of patients with familial adenomatous polyposis.
The role of fibroblast activation protein in health and malignancy.
The role of fibroblast activation protein in progression and development of osteosarcoma cells.
The role of illness perceptions in adherence to surveillance in patients with familial adenomatous polyposis (FAP).
The Somatic Mutation Hit on Top of Genetic APC mutations Cause Skin Tumor.
The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.
The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis.
Theranostics targeting fibroblast activation protein in the tumor stroma: 64Cu and 225Ac labelled FAPI-04 in pancreatic cancer xenograft mouse models.
Three cases with familial adenomatous polyposis diagnosed as having malignant lesions in the course of a long-term trial using docosahexanoic acid (DHA)-concentrated fish oil capsules.
Thyroid carcinoma associated with familial adenomatous polyposis.
Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D.
Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.
Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis.
Transition state analogue of MTAP extends lifespan of APCMin/+ mice.
Tubulo-papillary adrenocortical adenoma in a patient with familial adenomatous polyposis: A morphologic, ultrastructural and molecular study.
Tumor elastography and its association with cell-free tumor DNA in the plasma of breast tumor patients: a pilot study.
Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.
Tumor-specific crosslinking of GITR as costimulation for immunotherapy.
Two Metachronous Neoplasms in the Radiotherapy Fields of a Young Man With Familial Adenomatous Polyposis.
Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.
Ultrasensitive Fluorescent Probes Reveal an Adverse Action of Dipeptide Peptidase IV and Fibroblast Activation Protein during Proliferation of Cancer Cells.
Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy.
Upper gastrointestinal disease in patients with familial adenomatous polyposis.
Upper gastrointestinal neoplasia in familial adenomatous polyposis: prevalence, endoscopic features and management.
Upper intestinal surveillance in familial adenomatous polyposis.
Using Substrate Specificity of Antiplasmin-cleaving Enzyme for Fibroblast Activation Protein Inhibitor Design.
What is the specific appearance and real frequency of gastric neoplasia in FAP patients?
Wnt signalling in adenomas of familial adenomatous polyposis patients.
[A Case in Which a Patient Was Operated for Intra-Abdominal Desmoid Tumors after Total Colectomy in FAP].
[A case of familial adenomatous polyposis presenting with thyroid cancer].
[A Case of FAP Who Underwent Mucosectomy for Intramucosal Cancer That Repeatedly Developed in the Residual Rectal Mucosa after Stapled Ileal-Pouch Anal Anastomosis].
[A Case of Long-Term Survival of Advanced Esophageal Basaloid Squamous Carcinoma Invading the Trachea].
[Adenomatous polyposis of the gallbladder and Gardner's syndrome. A rare association]
[Aggressive fibromatosis: clinical aspects].
[Agressive fibromatosis: genetic and biological correlations].
[Analysis of KRAS status in cancer tissue with submucosal or deeper invasion in patients with familial adenomatous polyposis].
[Aspirin suppresses microsatellite instability]
[Clinical features and current progress of familial adenomatous polyposis]
[Clinicopathologic and molecular features of cribriform morular variant of papillary thyroid carcinoma].
[Colorectal cancer before 45 years of age]
[Current diagnosis and treatment of desmoid tumours in patients with familial adenomatous polyposis - the surgical view]
[Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register]
[Desmoid tumors in patients with familial adenomatous polyposis]
[Desmoid tumors in three patients]
[Desmoid tumour as indication of familial adenomatous polyposis.]
[Desmoid tumour as indication of familial adenomatous polyposis].
[Diagnosis and treatment of familial adenomatous polyposis]
[Familial adenomatous polyposis (FAP)--diagnosis and management]
[Familial adenomatous polyposis with papillary thyroid cancer:a case report].
[Familial adenomatous polyposis: a follow-up of the extracolonic manifestations]
[Familial adenomatous polyposis: what is new for the clinician?]
[Familiar adenomatous polyposis: report of 2 cases].
[FAP Expression and Its Association with the Prognosis of Gastric Stromal Tumors].
[FEP and FAP combination chemotherapy in advanced gastric cancer. Research Group for Gastric Cancer]
[FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.]
[Genetic counseling, surgical prophylaxis and treatment for familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer]
[Human colorectal cancer cells induce fibroblasts to secrete stromal cell-derived factor 1 (SDF-1) to stimulate cancer cell migration].
[Ileo-anal anastomosis in familial adenomatous polyposis: procedure of choice?]
[MMP- and FAP-mediated non-inflammation-related destruction of cartilage and bone in rheumatoid arthritis]
[Molecular biological background of FAP and HNPCC, and treatment strategies of both diseases depend upon genetic information]
[Molecular genetics of colorectal cancer and carcinogenesis]
[Nesidioblastosis as extracolonic manifestation associated with adenomatous familial polyposis]
[Oncofetal proteins of the exocrine pancreas]
[Promoter hypermethylation and loss of heterozygosity of the APC gene in patients with familial adenomatous polyposis]
[Proteases by reactive stromal cells in cancer: an attractive therapeutic target]
[Rare hereditary syndromes associated with polyposis and the development of malignant tumors].
[Retroperitoneal desmoid tumor with kidney failure in familial adenomatous polyposis]
[Sequential liver transplantation: description of the first three patients in Spain]
[The molecular biology and genetics of colorectal carcinoma]
[Treatment of advanced epidermoid carcinoma of the oesophagus with combined 5-fluorouracil, adriamycin and cis-platinum (FAP)]
[Treatment of familial adenomatous polyposis and family screening.]
Neoplasms, Glandular and Epithelial
Fibroblast activation protein: purification, epitope mapping and induction by growth factors.
Role of Alpha-Smooth Muscle Actin and Fibroblast Activation Protein Alpha in Ovarian Neoplasms.
Neoplastic Syndromes, Hereditary
Are there two sides to colorectal cancer?
Nervous System Diseases
[Amyloidosis and neurological disorders: Treatable amyloidosis].
Neural Tube Defects
A 2019 global update on folic acid-preventable spina bifida and anencephaly.
Neuralgia
Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal.
Neurilemmoma
Impairment of the ubiquitin-proteasome system associated with extracellular transthyretin aggregates in familial amyloidotic polyneuropathy.
Neurobehavioral Manifestations
Functional abdominal pain symptom severity: Associations between cognition and emotion in a pediatric sample.
Neuroblastoma
Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy.
Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.
Neurodegenerative Diseases
Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy.
Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy.
Neuroendocrine Tumors
[A Case of NET G1 of Vater's Papilla in Familial Adenomatous Polyposis-Associated Duodenal Adenomatous Polyposis].
Neurologic Manifestations
Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis.
[Ocular involvement in familial amyloid polyneuropathy].
Nevus
Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
Nevus, Pigmented
Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
Obesity
Adipose tissue contribution to plasma fibroblast growth factor 21 and fibroblast activation protein in obesity.
Epidemiology and risk factors of pancreatic cancer.
Fibro-Adipogenic Remodeling of the Diaphragm in Obesity-Associated Respiratory Dysfunction.
Fibroblast activation protein (FAP) as a novel metabolic target.
Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21.
Fibroblast activation protein restrains adipogenic differentiation and regulates matrix-mediated mTOR signaling.
Higher prevalence of obesity among children with functional abdominal pain disorders.
Role of Metabolic Stress and Exercise in Regulating Fibro/Adipogenic Progenitors.
Ocular Hypertension
Comparison between Fundus Automated Perimetry and Humphrey Field Analyzer: Performance and usability of the Fundus Automated Perimetry and Humphrey Field Analyzer in healthy, ocular hypertensive, and glaucomatous patients.
Odontoma
Assay for Detecting the I1307K Susceptibility Allele within the Adenomatous Polyposis ColiGene.
Oral and maxillofacial manifestations of familial adenomatous polyposis.
Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis.
Olivopontocerebellar Atrophies
A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure.
Oral Manifestations
Florid oral manifestations in an atypical familial adenomatous polyposis family with late presentation of colorectal polyps.
Oral manifestations in patients with familial adenomatous polyposis: A systematic review and meta-analysis.
Orthostatic Intolerance
Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Osteoarthritis
Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis.
Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes.
Osteochondromatosis
Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.
Osteoma
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis.
Assay for Detecting the I1307K Susceptibility Allele within the Adenomatous Polyposis ColiGene.
Association of extracolonic manifestations of familial adenomatous polyposis with acetylation phenotype in a large FAP kindred.
Congenital genetic instability in colorectal carcinomas.
Cortisol producing adrenal adenoma--a new manifestation of Gardner's syndrome.
Cribiform variant of papillary thyroid cancer and familial adenomatous polyposis.
Familial adenomatous polyposis (FAP): Genotype correlation to FAP phenotype with osteomas and sebaceous cysts.
Familial adenomatous polyposis.
Familial adenomatous polyposis: not all masses are desmoids.
Familial polyposis coli: clinical manifestations, evaluation, management and treatment.
Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder.
Gardner's syndrome in a 75-year-old woman.
Genetic Counselor Practices Involving Pediatric Patients with FAP: an Investigation of their Self-Reported Strategies for Genetic Testing and Hepatoblastoma Screening.
Mucoepidermoid carcinoma: A yet unreported cancer associated with familial adenomatous polyposis.
Multidisciplinary treatment of desmoid tumours in Gardner's syndrome due to a large interstitial deletion of chromosome 5q.
Multiple oral radiopaque masses leading to Gardner's syndrome diagnosis.
Novel germline APC mutations in Swedish patients with familial adenomatous polyposis and Gardner syndrome.
Oral and maxillofacial manifestations of familial adenomatous polyposis.
Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis.
Prolactinoma as the first manifestation of Gardner's syndrome.
Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene.
[Dentistry anomalies in patients with Lynch syndrome and familial adenomatous polyposis]
[Familiar adenomatous polyposis: report of 2 cases].
[Osteomatous jaw lesions in familial adenomatous polyposis]
Osteoporosis
Bone mineral density in familial amyloid polyneuropathy and in other neuromuscular disorders.
Identification of Fibroblast Activation Protein as an Osteogenic Suppressor and Anti-osteoporosis Drug Target.
Osteosarcoma
Fibroblast activation protein in osteosarcoma cells promotes angiogenesis via AKT and ERK signaling pathways.
Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.
Impact of fibroblast activation protein on osteosarcoma cell lines in vitro.
Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma.
PODN is a prognostic biomarker and correlated with immune infiltrates in osteosarcoma.
Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.
The role of fibroblast activation protein in progression and development of osteosarcoma cells.
Ovarian Neoplasms
Double mutation of APC and BRCA1 in an Italian family.
Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.
Role of Alpha-Smooth Muscle Actin and Fibroblast Activation Protein Alpha in Ovarian Neoplasms.
Tumor core biopsies adequately represent immune microenvironment of high-grade serous carcinoma.
Overweight
Higher prevalence of obesity among children with functional abdominal pain disorders.
Pancreatic Neoplasms
Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion.
Chemotherapy-induced fulminant acute pancreatitis in pancreatic carcinoma: A case report.
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.
Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model.
Fibroblast activation protein-?-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Gastrointestinal tract cancers: Genetics, heritability and germ line mutations.
Radioimmunolocalization of the monoclonal antibody J28 in early transformation stages in N-nitrosobis(2-hydroxypropyl)amine-induced pancreatic tumors in the Syrian golden hamster.
The diagnostic value of the foetoacinar pancreatic (FAP) protein in cancer of the pancreas; a comparative study with CA19/9.
Theranostics targeting fibroblast activation protein in the tumor stroma: 64Cu and 225Ac labelled FAPI-04 in pancreatic cancer xenograft mouse models.
[Oncofetal proteins of the exocrine pancreas]
Pancreatitis
An immunohistologic study of the feto-acinar pancreatic protein (FAP) in the normal pancreas, chronic pancreatitis, pancreatic adenocarcinoma, and intraabdominal metastases of adenocarcinomas.
Chemotherapy-induced fulminant acute pancreatitis in pancreatic carcinoma: A case report.
Frequency and risk factors for liver disease following pancreatitis: A population-based cohort study.
Recurrent idiopathic pancreatitis in familial adenomatous polyposis: report of a case-series and review of the literature.
Relapsing acute pancreatitis due to ampullary adenoma in a patient with familial adenomatous polyposis.
Risks, Benefits, and Effects on Management for Biopsy of the Papilla in Patients with Familial Adenomatous Polyposis.
Pancreatitis, Chronic
Epidemiology and risk factors of pancreatic cancer.
Papilloma
Identification of unreported putative new bovine papillomavirus types in Brazilian cattle herds.
Paraplegia
Clinical features and diagnosis by recombinant DNA techniques of familial amyloid polyneuropathy in Japan.
Paratuberculosis
Mycobacterium avium subsp. paratuberculosis Fibronectin Attachment Protein activates dendritic cells and induces a Th1 polarization.
Paresis
Difference in gait recovery rate of hemiparetic stroke patients according to paralyzed side: A cross-sectional study based on a retrospective chart review.
Gait characteristics and functional ambulation profile in patients with chronic unilateral stroke.
Paresthesia
Annual electrocardiograms consistent with silent progression of cardiac involvement in sporadic familial amyloid polyneuropathy: a case report.
Familial amyloid polyneuropathy involving a homozygous Val30Met mutation in the amyloidogenic transthyretin gene presenting with superficial siderosis: a case report.
Parkinson Disease
The validity of the GaitRite and the Functional Ambulation Performance scoring system in the analysis of Parkinson gait.
Periodontitis
Detection of Aggregatibacter actinomycetemcomitans leukotoxin and fimbria-associated protein gene genotypes among periodontitis patients and healthy controls: A case-control study.
Peripheral Nervous System Diseases
A circulating, disease-specific, mechanism-linked biomarker for ATTR polyneuropathy diagnosis and response to therapy prediction.
Electromyographic findings in transthyretin (TTR)-related familial amyloid polyneuropathy (FAP).
Familial amyloid polyneuropathy associated with transthyretin Gly42 mutation: a quantitative light and electron microscopic study of the peripheral nervous system.
Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene.
Phenotypic expression of familial amyloid polyneuropathy in Brazil.
Recent advances in the treatment of familial amyloid polyneuropathy.
Recent advances in transthyretin amyloidosis therapy.
Ten-year follow-up of peripheral nerve function in patients with familial amyloid polyneuropathy after liver transplantation.
Variant transthyretin in blood circulation can transverse the blood-cerebrospinal barrier: qualitative analyses of transthyretin metabolism in sequential liver transplantation.
[Application to transthyretin analysis]
[The ocular involvement in the transthyretin-related familial amyloid polyneuropathy].
[Therapeutic strategy for familial amyloid polyneuropathy (FAP)]
Peritonitis
Distinguishing fecal appendicular peritonitis from purulent appendicular peritonitis.
Familial amyloidotic polyneuropathy type I with extracellular superoxide dismutase mutation: a case report.
Peutz-Jeghers Syndrome
Colorectal polyposes: from phenotype to diagnosis.
Differentiated thyroid cancer associated with intestinal polyposis syndromes: A review.
Endoscopic Mucosal Resection of Jejunal Polyps using Double-Balloon Enteroscopy.
Gastrointestinal polyposis syndromes for the general gastroenterologist.
Gastrointestinal tract cancers: Genetics, heritability and germ line mutations.
Heritable colorectal cancer syndromes: recognition and preventive management.
[Rare hereditary syndromes associated with polyposis and the development of malignant tumors].
Phyllodes Tumor
miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors.
Pinealoma
Pineoblastoma presenting in familial adenomatous polyposis (FAP): random association, FAP variant or Turcot syndrome?
Pneumonia
A new mechanism regulating the initiation of allergic airway inflammation.
Polyneuropathies
3rd International Symposium on Familial Amyloidotic Polyneuropathy and other TTR Related Disorders. 2nd International Workshop on Liver Transplantation in FAP. Lisbon, Portugal, October 27-29, 1995. Abstracts.
A 5-Year Follow-Up of The Benefits of an Exercise Training Program in Liver Recipients Transplanted Due to Familial Amyloidotic Polyneuropathy.
A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
Abnormal transthyretin in asymptomatic relatives in familial amyloidotic polyneuropathy.
Acquired amyloid neuropathy in a Portuguese patient after domino liver transplantation.
Amyloidosis and Ocular Involvement: an Overview.
Assessing mNIS+7Ionis and International Neurologists' Proficiency in an FAP Trial.
Bulbar palsy in senile onset familial amyloid polyneuropathy (30Val-->Met): transthyretin-amyloid deposits in the hypoglossal nerve root.
Change in the age of onset in patients with familial amyloidotic polyneuropathy type I.
Clinical features and diagnosis by recombinant DNA techniques of familial amyloid polyneuropathy in Japan.
Diagnostic radioimmunoassay and DNA-analysis in Swedish and Japanese patients with familial amyloidotic polyneuropathy. Homozygosity for the TTR met30 gene.
Domino liver transplantation: risks and benefits.
Effect of tacrolimus and partial hepatectomy on transthyretin metabolism in rats.
Endoscopic and pathological manifestations of the gastrointestinal tract in familial amyloidotic polyneuropathy type I (Met30).
Familial amyloid polyneuropathy.
Familial amyloidotic polyneuropathy (ATTR Val30Met) with widespread cerebral amyloid angiopathy and lethal cerebral hemorrhage.
Familial amyloidotic polyneuropathy: transthyretin (prealbumin) variants in kindreds of Italian origin.
Family studies of the genetic abnormality in transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy.
FAP is a candidate disease in patients with undetermined polyneuropathy.
Genetic analysis of familial amyloidotic polyneuropathy, an autosomal dominant disease.
Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
Identification of carriers of mutant prealbumin gene associated with familial amyloidotic polyneuropathy type I by Southern blot procedures: study of six pedigrees in the Arao district of Japan.
Japanese monozygotic twins with familial amyloidotic polyneuropathy (FAP) (ATTR Val30Met).
Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.
Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation.
Molecular analyses of an acidic transthyretin Asn 90 variant.
Molecular genetics of familial amyloidotic polyneuropathy.
Neuroarthropathy secondary to transthyretin amyloidosis (ATTR V30M).
Ocular microangiopathy in familial amyloidotic polyneuropathy, type I.
Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation.
Q-Rich Yeast Prion [
Recent advances in transthyretin amyloidosis therapy.
Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials.
Role of autonomic nerve functions in patients with familial amyloidotic polyneuropathy as analyzed by laser Doppler flowmetry, capsule hydrograph, and cardiographic R-R interval.
Single-centre experience of liver transplantation for familial amyloidotic polyneuropathy of non-Val30Met variants in Chinese patients.
Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy.
[A late onset familial amyloidotic polyneuropathy (FAP) with a novel variant transthyretin characterized by a basic-for-acidic amino acid substitution (Glu61-->Lys)]
[A sporadic case of late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) inborn habitant of Ehime prefecture]
[Autonomic dysfunction in FAP: its therapeutic effect by liver transplantation]
[Diagnosis by recombinant DNA techniques and clinical features of familial amyloid polyneuropathy]
[Diastolic dysfunction and left ventricular hypertrophy in familial amyloidotic polyneuropathy: a cause-effect relationship?]
[Familial amyloid polyneuropathy: clinicopathological aspects].
[Familial amyloid polyneuropathy].
[Familial amyloidotic polyneuropathies].
[Familial amyloidotic polyneuropathy (FAP) type I and the therapies]
[Late onset of type I familial amyloid neuropathy: results of biopsy from accessory salivary glands]
[Myocardiopathy caused by Portuguese-type familial amyloidotic polyneuropathy. Sequential morphologic and functional study of 60 patients]
[Prenatal diagnosis of familial amyloidotic polyneuropathy]
[Two sibling patients with late-onset familial amyloidotic polyneuropathy and atypical clinical manifestations]
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Immunolocalization and activation of transcription factor nuclear factor kappa B in dysimmune neuropathies and familial amyloidotic polyneuropathy.
Poroma
Fibroblast-activation protein: valuable marker of cutaneous epithelial malignancy.
Pouchitis
Anxiety, depression, and inflammation after restorative proctocolectomy.
Bacterial community diversity in cultures derived from healthy and inflamed ileal pouches after restorative proctocolectomy.
Clinical Outcomes After Ileal Pouch-Anal Anastomosis in Pediatric Patients.
Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis.
Comparison of postoperative outcomes in ulcerative colitis and familial polyposis patients after ileoanal pouch operations.
Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli.
Detection of epithelial apoptosis in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.
Difference in the frequency of pouchitis between ulcerative colitis and familial adenomatous polyposis: is the explanation in peripouch fat?
Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.
Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients?
Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis.
Endoscopical and histological aspects of inflammatory changes in J-pouch mucosa.
Etiology of pouchitis.
Frequency and Risk Factors of Clostridium difficile Infection in Hospitalized Patients With Pouchitis: A Population-based Study.
Genetic and immunological markers in pouchitis.
Incidence and therapeutic outcome of pouchitis for ulcerative colitis in Japanese patients.
Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomatous polyposis.
Lower fecal pH may be a novel indicator of pouchitis after IPAA in patients with FAP or metachronous Lynch syndrome.
NOD2 genetic variants predispose one of two familial adenomatous polyposis siblings to pouchitis through microbiome dysbiosis.
Nonspecific, Acute Pouchitis in Patients with Familial Adenomatous Polyposis: Less Common than We Think.
Pouch reconstruction in the pelvis.
Pouchitis Is a Common Complication in Patients With Familial Adenomatous Polyposis Following Ileal Pouch-Anal Anastomosis.
Pouchitis: pathogenesis, diagnosis, and management.
Predictors of Pouchitis After Ileal Pouch-Anal Anastomosis in Children.
Proliferation of immature plasma cells in pouchitis mucosa in patients with ulcerative colitis.
Prolyl Hydroxylase Inhibition Mitigates Pouchitis.
Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis.
Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited.
The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing.
Precancerous Conditions
[Use of molecular genetics in the early diagnosis of familial adenomatous polyposis]
Pregnancy, High-Risk
Prenatal diagnosis to exclude FAP in a high risk pregnancy.
Prion Diseases
Q-Rich Yeast Prion [
[Amyloidosis and neurological disorders: Treatable amyloidosis].
Prolactinoma
Prolactinoma as the first manifestation of Gardner's syndrome.
Prostatic Neoplasms
A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancer.
Development of a Cross-Reactive Monoclonal Antibody for Detecting the Tumor Stroma.
Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography.
Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
Overcoming stromal barriers to immuno-oncological responses via fibroblast activation protein-targeted therapy.
Protein-Losing Enteropathies
Protein-losing enteropathy in a patient with familial adenomatous polyposis and advanced colon cancer.
Proteinuria
End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors.
Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients.
Pulmonary Disease, Chronic Obstructive
Characterization of a Tumor-Microenvironment-Relevant Gene Set Based on Tumor Severity in Colon Cancer and Evaluation of Its Potential for Dihydroartemisinin Targeting.
Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
Pulmonary Embolism
Outcomes of domino liver transplantation: a single institution's experience.
Pulmonary Emphysema
Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis.
Pulmonary Fibrosis
Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lung in Mice.
Rectal Diseases
Risk factors for secondary proctectomy in patients with familial adenomatous polyposis.
Surgical options for familial adenomatous polyposis.
Rectal Neoplasms
Attenuated familial adenomatous polyposis associated with advanced rectal cancer in a 16-year-old boy: report of a case.
Colectomy with ileorectal anastomosis lowers rectal mucosal cell proliferation in familial adenomatous polyposis.
Colorectal cancer in familial adenomatous polyposis.
Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention.
Does Age Affect Surgical Outcomes After Ileal pouch-Anal Anastomosis in Children?
Experiences with PPH gun stapled ileo or coloanal anastomoses after ultralow rectal resections and proctocolectomies with J pouch reconstructions.
Factors affecting the risk of rectal cancer following rectum-preserving surgery in patients with familial adenomatous polyposis.
Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Hereditary Colorectal Tumors Registry.
Hand-assisted laparoscopic total colorectal resection for familial adenomatous polyposis with coexisting rectal cancer.
Lectin staining of neoplastic and normal background colorectal mucosa in nonpolyposis and polyposis patients.
Outlet Obstruction of Temporary Loop Diverting Ileostomy.
Rectal and pouch recurrences after surgical treatment for familial adenomatous polyposis.
Rectal cancer in a 13-year-old boy without a detectable germline mutation in FAP and HNPCC genes.
Rectal cancer in FAP patient after sulindac.
Rectal cancer risk in patients treated for familial adenomatous polyposis. The Leeds Castle Polyposis Group.
Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.
Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited.
Results of the double stapling procedure in colorectal surgery.
Review of our ileal pouch experience in the light of literature.
Risk of cancer development in the rectal remnant of patients with familial adenomatous polyposis/Gardner's syndrome.
Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis.
The double-barreled wet ileostomy: an alternative method for simultaneous urinary and intestinal diversion without intestinal anastomosis after total colectomy and pelvic exenteration.
[Ileo-anal anastomosis in familial adenomatous polyposis: procedure of choice?]
[Surgical treatment of familial adenomatous polyposis with an open technique. Experience of a third level Latin American center]
Renal Insufficiency
Advanced glycation end product is implicated in amyloid-related kidney complications.
Recent advances in transthyretin amyloidosis therapy.
Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation.
[Application to transthyretin analysis]
[Familial amyloid neuropathies]
[Ocular involvement in familial amyloid polyneuropathy].
Respiratory Insufficiency
Vocal Cord Paralysis and Hypercapnic Respiratory Failure in a Patient with Familial Amyloidotic Polyneuropathy.
Retinal Detachment
Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients.
Retinal Hemorrhage
Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C.
Ocular microangiopathy in familial amyloidotic polyneuropathy, type I.
Retinoblastoma
Fibroblast activation protein-?-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Multistage carcinogenesis: population-based model for colon cancer.
Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.
Rhabdomyosarcoma
Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.
Rheumatic Diseases
Malignancy risk in individuals with familial adenomatous polyposis receiving biologics and immunomodulators.
Sarcoma
Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin.
Fibroblast activation protein: purification, epitope mapping and induction by growth factors.
Ga-68-FAPI as diagnostic tool in sarcoma: Data from the FAPI-PET prospective observational trial.
Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.
Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT.
Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.
Scotoma
Comparison of Compass and Humphrey perimeters in detecting glaucomatous defects.
Seizures
Visualizing GABA A Receptor Trafficking Dynamics with Fluorogenic Protein Labeling.
Sepsis
Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2).
Outcomes of domino liver transplantation: a single institution's experience.
[Sequential liver transplantation: description of the first three patients in Spain]
Sertoli Cell Tumor
Bilateral Sertoli cell tumors of the testis-a likely new extracolonic manifestation of familial adenomatous polyposis.
Shock, Cardiogenic
Spontaneous pericardial hematoma with familial amyloid polyneuropathy.
Shock, Septic
Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2).
Shy-Drager Syndrome
[Development of L-threo-DOPS, a norepinephrine precursor amino acid]
Sick Sinus Syndrome
Pacemaker treatment in familial amyloidosis with polyneuropathy.
Sigmoid Neoplasms
[A case of desmoid tumor and advanced sigmoid colon cancer with liver metastasis in familial adenomatous polyposis (FAP)].
Sleep Wake Disorders
Sleep characteristics of youth with functional abdominal pain and a healthy comparison group.
Spinal Cord Diseases
Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene.
Spinal Dysraphism
A 2015 global update on folic acid-preventable spina bifida and anencephaly.
A 2017 global update on folic acid-preventable spina bifida and anencephaly.
Reductions in child mortality by preventing spina bifida and anencephaly: Implications in achieving Target 3.2 of the Sustainable Development Goals in developing countries.
Spinocerebellar Ataxias
Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family--a follow-up autopsy report.
Role of the disease in the psychological impact of pre-symptomatic testing for SCA2 and FAP ATTRV30M: Experience with the disease, kinship and gender of the transmitting parent.
[Variable clinical manifestations of familial amyloid polyneuropathy and living related liver transplantation]
Spinocerebellar Degenerations
Clinical features and diagnosis by recombinant DNA techniques of familial amyloid polyneuropathy in Japan.
Spondylitis, Ankylosing
Coexistence of Peripheral Spondyloarthritis and Familial Adenomatous Polyposis: A Rare Case Report with Treatment Contradictions and Review of the Literature.
Squamous Cell Carcinoma of Head and Neck
Detection of HPV in oral rinse samples from OPSCC and non-OPSCC patients.
Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
[Construction of a eukaryotic expression vector of fibroblast activation protein and establishment of its stable over-expression in the oral squamous cell carcinoma].
ST Elevation Myocardial Infarction
Changes in concentrations of circulating fibroblast activation protein alpha are associated with myocardial damage in patients with acute ST-elevation MI.
Stomach Neoplasms
A Clinicopathologic Evaluation of Incidental Fundic Gland Polyps With Dysplasia: Implications for Clinical Management.
APC mutational patterns in gastric adenocarcinoma are enriched for missense variants with associated decreased survival.
Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers.
Clinical outcomes of gastric polyps and neoplasms in patients with familial adenomatous polyposis.
Dye chromoendoscopy leads to a higher adenoma detection in the duodenum and stomach in patients with familial adenomatous polyposis.
Endoscopic Surveillance of Duodenal Polyposis After Total Gastrectomy in Familial Adenomatous Polyposis.
Evaluation of two consecutive regimens in advanced gastric cancer.
FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review.
Gastric adenocarcinoma arising from fundic gland polyps in a patient with familial adenomatous polyposis syndrome.
Gastric cancer in FAP: a concerning rise in incidence.
Gastric tumours in FAP.
Gastrointestinal tract cancers: Genetics, heritability and germ line mutations.
Laparoscopic double-tract reconstruction after total gastrectomy for postoperative duodenal surveillance: Case series.
MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype.
Polyphyllin I inhibits gastric cancer cell proliferation by downregulating the expression of fibroblast activation protein alpha (FAP) and hepatocyte growth factor (HGF) in cancer-associated fibroblasts.
Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases.
Roles of fibroblasts from the interface zone in invasion, migration, proliferation and apoptosis of gastric adenocarcinoma.
Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ ?-catenin pathway.
Surveillance for pathology associated with cancer on endoscopy (SPACE): criteria to identify high-risk gastric polyps in familial adenomatous polyposis.
Tumor-associated mesothelial cells are negative prognostic factors in gastric cancer and promote peritoneal dissemination of adherent gastric cancer cells by chemotaxis.
[A case of advanced gastric cancer responding to an FAP (5-FU, ADM, platinum compounds) combined chemotherapy]
[Cases of postoperative hepatic metastasis from gastric cancer in which hepatic arterial infusion chemotherapy with 5-FU, adriamycin and cisplatin was performed after TS-1 chemotherapy]
[Combination therapy of doxifluridine, pirarubicin and cisplatin for human gastric cancers implanted in nude mice]
[FEP and FAP combination chemotherapy in advanced gastric cancer. Research Group for Gastric Cancer]
[New interesting chemotherapeutic regimens in advanced gastric cancer]
[Preneoplastic gastric lesions and helicobacter pylori in endoscopic detection and early diagnosis of gastric cancer in a population of a medium and high socio-economic level]
Stomach Ulcer
Roles of Fibroblast Activation Protein and Hepatocyte Growth Factor Expressions in Angiogenesis and Metastasis of Gastric Cancer.
Stroke
Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity.
Footprint peak time and functional ambulation profile reflect the potential for hemiparetic gait recovery.
Gait characteristics and functional ambulation profile in patients with chronic unilateral stroke.
Syncope
Impact of age on the vasovagal response provoked by sublingual nitroglycerine in routine tilt testing.
Synovitis
Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritis.
[MMP- and FAP-mediated non-inflammation-related destruction of cartilage and bone in rheumatoid arthritis]
Syringoma
Fibroblast-activation protein: valuable marker of cutaneous epithelial malignancy.
Tachycardia, Ventricular
Domino living donor liver transplantation of familial amyloid polyneuropathy patient - A case report.
Thrombosis
High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy.
Iatrogenic Pseudoaneurysm: An Uncommon Cause of Deep Vein Thrombosis.
Liver transplantation at a university hospital, faculty of the medicine of Ribeirão Preto, University of São Paulo: results for the first 60 recipients.
Transthyretin proteins regulate angiogenesis by conferring different molecular identities to endothelial cells.
[Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports]
Thymoma
The Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein, a toll-like receptor 4 agonist, enhances dendritic cell-based cancer vaccine potency.
Thyroid Cancer, Papillary
A distinct variant of papillary thyroid carcinoma indicating familial adenomatous polyposis (FAP): a case report and brief review.
Clinical curiosity: cribriform-morular variant of papillary thyroid carcinoma.
Cribriform variant papillary thyroid cancer: a characteristic of familial adenomatous polyposis.
Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP.
CRIBRIFORM-MORULAR VARIANT OF THYROID CANCER - A RED FLAG FOR FAMILIAL ADENOMATOUS POLYPOSIS.
Differentiated thyroid cancer associated with intestinal polyposis syndromes: A review.
Familial adenomatous polyposis (Gardner's syndrome) and thyroid carcinoma. A case report and review of the literature.
Familial Adenomatous Polyposis-Associated Papillary Thyroid Cancer.
FAP Associated Papillary Thyroid Carcinoma: A Peculiar Subtype of Familial Nonmedullary Thyroid Cancer.
FAP associated thyroid carcinoma in mother and her daughter.
Gender-Specific Aspects of Lynch Syndrome and Familial Adenomatous Polyposis.
Mutation spectrum of the APC gene in 83 Korean FAP families.
Mutational Analysis of the APC Gene in Cribriform-Morula Variant of Papillary Thyroid Carcinoma.
Mutational analysis of the APC gene in cribriform-morula variant of papillary thyroid carcinoma.
Pancreatic islet cell tumour in a patient with familial adenomatous polyposis.
The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas.
Thyroid cancer in patients with familial adenomatous polyposis.
Thyroid carcinoma in patients with familial adenomatous polyposis.
Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D.
[A case of familial adenomatous polyposis presenting with thyroid cancer].
[A Case of Papillary Carcinoma of Thyroid Associated with Familial Adenomatous Polyposis in a Younger Woman].
[Familial adenomatous polyposis with papillary thyroid cancer:a case report].
Thyroid Diseases
Characteristics of benign and malignant thyroid disease in familial adenomatous polyposis patients and recommendations for disease surveillance.
Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations.
Prevalence of thyroid diseases in familial adenomatous polyposis: a systematic review and meta-analysis.
The Prevalence of Thyroid Cancer and Benign Thyroid Disease in Patients With Familial Adenomatous Polyposis May Be Higher Than Previously Recognized.
Thyroid Neoplasms
A case of familial adenomatous polyposis complicated by thyroid carcinoma, carcinoma of the ampulla of vater and adrenocortical adenoma.
A unique case of two somatic APC mutations in an early onset cribriform-morular variant of papillary thyroid carcinoma and overview of the literature.
Age- and Gender-Specific Risk of Thyroid Cancer in Patients with Familial Adenomatous Polyposis.
Analysis of adenomatous polyposis coli gene in thyroid tumours.
Aspiration and imprint cytopathology of thyroid carcinoma associated with familial adenomatous polyposis.
Broad phenotypic spectrum in familial adenomatous polyposis; from early onset and severe phenotypes to late onset of attenuated polyposis with the first manifestation at age 72.
Cancer: screening for thyroid cancer in patients with FAP is worthwhile.
Characteristics of benign and malignant thyroid disease in familial adenomatous polyposis patients and recommendations for disease surveillance.
Cribiform-morular variant of papillary thyroid carcinoma and familial adenomatous polyposis: Report of a case.
CRIBRIFORM-MORULAR VARIANT OF THYROID CANCER - A RED FLAG FOR FAMILIAL ADENOMATOUS POLYPOSIS.
Differentiated thyroid cancer associated with intestinal polyposis syndromes: A review.
Familial adenomatous polyposis (Gardner's syndrome) and thyroid carcinoma. A case report and review of the literature.
Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.
Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study.
Familial adenomatous polyposis-rendering a diagnosis based on recognition of an unusual primary thyroid neoplasm.
FAP Associated Papillary Thyroid Carcinoma: A Peculiar Subtype of Familial Nonmedullary Thyroid Cancer.
FAP associated thyroid carcinoma in mother and her daughter.
Gender-Specific Aspects of Lynch Syndrome and Familial Adenomatous Polyposis.
Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma.
Germ-line and somatic mutations of the APC gene and/or ss catenin gene in the occurrence of FAP associated thyroid carcinoma.
Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group.
Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma.
Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis.
Nuclear localization of immunoreactive beta-catenin is specific to familial adenomatous polyposis in papillary thyroid carcinoma.
Occurrence of thyroid carcinoma in Dutch patients with familial adenomatous polyposis. An epidemiological study and report of new cases.
Outcome of thyroid ultrasound screening in FAP patients with a normal baseline exam.
Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review.
Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations.
Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis.
Somatic mutation of the APC gene in thyroid carcinoma associated with familial adenomatous polyposis.
Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals.
Thyroid cancer in two siblings with FAP syndrome and APC mutation.
Thyroid carcinoma associated with familial adenomatous polyposis.
Thyroid carcinoma in patients with familial adenomatous polyposis.
Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D.
[A case of Gardner's syndrome associated with thyroid carcinoma]
[A Case of Metachronous Multiple Thyroid Papillary Carcinoma with FAP].
[A Case of Papillary Carcinoma of Thyroid Associated with Familial Adenomatous Polyposis in a Younger Woman].
[Familial nonmedullary thyroid cancer]
Thyroid Nodule
Clinical curiosity: cribriform-morular variant of papillary thyroid carcinoma.
Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients.
Thyroiditis
The Prevalence of Thyroid Cancer and Benign Thyroid Disease in Patients With Familial Adenomatous Polyposis May Be Higher Than Previously Recognized.
Tooth, Impacted
[Dentistry anomalies in patients with Lynch syndrome and familial adenomatous polyposis]
Tooth, Supernumerary
Assay for Detecting the I1307K Susceptibility Allele within the Adenomatous Polyposis ColiGene.
Familial adenomatous polyposis.
Tooth, Unerupted
Oral and maxillofacial manifestations of familial adenomatous polyposis.
Tuberculosis
Characterization of the fibronectin-attachment protein of Mycobacterium avium reveals a fibronectin-binding motif conserved among mycobacteria.
Interaction of Mycobacterium tuberculosis with human respiratory mucosa.
Tuberous Sclerosis
Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.
Ulnar Nerve Compression Syndromes
The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy.
Ureteral Obstruction
Mesenteric fibromatosis (desmoid tumour) - a rare case report.
Urinary Bladder Neck Obstruction
Corino-Andrade disease (familial amyloidotic polineuropathy type I) in Spain: urological and andrological disorders.
Urinary Bladder Neoplasms
Fibronectin attachment protein from bacillus Calmette-Guerin as targeting agent for bladder tumor cells.
Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer.
The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity.
Urinary Bladder, Neurogenic
End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors.
Urinary Incontinence
Familial amyloidotic polyneuropathy (ATTR Ser50Ile): the first autopsy case report.
The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation.
[Autonomic dysfunction in FAP: its therapeutic effect by liver transplantation]
Vaccinia
Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer.
Varicose Ulcer
Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers.
Vasculitis
Immunolocalization and activation of transcription factor nuclear factor kappa B in dysimmune neuropathies and familial amyloidotic polyneuropathy.
Venous Thrombosis
Iatrogenic Pseudoaneurysm: An Uncommon Cause of Deep Vein Thrombosis.
The incidence of postoperative venous thrombosis among patients with ulcerative colitis.
Ventricular Fibrillation
Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.
Warts
Detection and typing of common human papillomaviruses among Jordanian patients.
Wasting Syndrome
Signaling pathways regulating the fate of fibro/adipogenic progenitors (FAPs) in skeletal muscle regeneration and disease.
Werner Syndrome
Familial follicular cell-derived thyroid carcinoma.
Wound Infection
Multivariate analysis of risk factors for complications after loop ileostomy closure.
Xeroderma Pigmentosum
Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.